<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN"  "JATS-archivearticle1-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.2"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">67464</article-id><article-id pub-id-type="doi">10.7554/eLife.67464</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Neuroscience</subject></subj-group></article-categories><title-group><article-title>β2-subunit alternative splicing stabilizes Cav2.3 Ca<sup>2+</sup> channel activity during continuous midbrain dopamine neuron-like activity</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-226227"><name><surname>Siller</surname><given-names>Anita</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-226228"><name><surname>Hofer</surname><given-names>Nadja T</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-152545"><name><surname>Tomagra</surname><given-names>Giulia</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-226229"><name><surname>Burkert</surname><given-names>Nicole</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-82055"><name><surname>Hess</surname><given-names>Simon</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-226230"><name><surname>Benkert</surname><given-names>Julia</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-226231"><name><surname>Gaifullina</surname><given-names>Aisylu</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-226232"><name><surname>Spaich</surname><given-names>Desiree</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-226233"><name><surname>Duda</surname><given-names>Johanna</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-226234"><name><surname>Poetschke</surname><given-names>Christina</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-226235"><name><surname>Vilusic</surname><given-names>Kristina</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con11"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-226236"><name><surname>Fritz</surname><given-names>Eva Maria</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con12"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-229183"><name><surname>Schneider</surname><given-names>Toni</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="con13"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-80601"><name><surname>Kloppenburg</surname><given-names>Peter</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-4554-404X</contrib-id><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con14"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-161519"><name><surname>Liss</surname><given-names>Birgit</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="other" rid="fund6"/><xref ref-type="other" rid="fund9"/><xref ref-type="other" rid="fund10"/><xref ref-type="fn" rid="con15"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-226237"><name><surname>Carabelli</surname><given-names>Valentina</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con16"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-116893"><name><surname>Carbone</surname><given-names>Emilio</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-2239-6280</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund3"/><xref ref-type="other" rid="fund4"/><xref ref-type="fn" rid="con17"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-226238"><name><surname>Ortner</surname><given-names>Nadine Jasmin</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-3882-3283</contrib-id><email>nadine.ortner@uibk.ac.at</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund5"/><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con18"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" corresp="yes" id="author-34041"><name><surname>Striessnig</surname><given-names>Jörg</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-9406-7120</contrib-id><email>joerg.striessnig@uibk.ac.at</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund7"/><xref ref-type="other" rid="fund8"/><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con19"/><xref ref-type="fn" rid="conf2"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/054pv6659</institution-id><institution>Department of Pharmacology and Toxicology, Institute of Pharmacy, Center for Molecular Biosciences Innsbruck, University of Innsbruck</institution></institution-wrap><addr-line><named-content content-type="city">Innsbruck</named-content></addr-line><country>Austria</country></aff><aff id="aff2"><label>2</label><institution>Department of Drug Science, NIS Centre, University of Torino</institution><addr-line><named-content content-type="city">Torino</named-content></addr-line><country>Italy</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/032000t02</institution-id><institution>Institute of Applied Physiology, University of Ulm, Ulm, Germany</institution></institution-wrap><addr-line><named-content content-type="city">Ulm</named-content></addr-line><country>Germany</country></aff><aff id="aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00rcxh774</institution-id><institution>Institute for Zoology, Biocenter, University of Cologne</institution></institution-wrap><addr-line><named-content content-type="city">Cologne</named-content></addr-line><country>Germany</country></aff><aff id="aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00rcxh774</institution-id><institution>Institute of Neurophysiology, University of Cologne</institution></institution-wrap><addr-line><named-content content-type="city">Cologne</named-content></addr-line><country>Germany</country></aff><aff id="aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/052gg0110</institution-id><institution>Linacre College &amp; New College, University of Oxford</institution></institution-wrap><addr-line><named-content content-type="city">Oxford</named-content></addr-line><country>United Kingdom</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Colecraft</surname><given-names>Henry M</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00hj8s172</institution-id><institution>Columbia University</institution></institution-wrap><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Aldrich</surname><given-names>Richard W</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00hj54h04</institution-id><institution>The University of Texas at Austin</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><pub-date publication-format="electronic" date-type="publication"><day>06</day><month>07</month><year>2022</year></pub-date><pub-date pub-type="collection"><year>2022</year></pub-date><volume>11</volume><elocation-id>e67464</elocation-id><history><date date-type="received" iso-8601-date="2021-02-11"><day>11</day><month>02</month><year>2021</year></date><date date-type="accepted" iso-8601-date="2022-07-04"><day>04</day><month>07</month><year>2022</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint at .</event-desc><date date-type="preprint" iso-8601-date="2021-02-10"><day>10</day><month>02</month><year>2021</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2021.02.10.430224"/></event></pub-history><permissions><copyright-statement>© 2022, Siller et al</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Siller et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-67464-v4.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-67464-figures-v4.pdf"/><abstract><p>In dopaminergic (DA) <italic>Substantia nigra</italic> (SN) neurons Cav2.3 R-type Ca<sup>2+</sup>-currents contribute to somatodendritic Ca<sup>2+</sup>-oscillations. This activity may contribute to the selective degeneration of these neurons in Parkinson’s disease (PD) since Cav2.3-knockout is neuroprotective in a PD mouse model. Here, we show that in tsA-201-cells the membrane-anchored β2-splice variants β2a and β2e are required to stabilize Cav2.3 gating properties allowing sustained Cav2.3 availability during simulated pacemaking and enhanced Ca<sup>2+</sup>-currents during bursts. We confirmed the expression of β2a- and β2e-subunit transcripts in the mouse SN and in identified SN DA neurons. Patch-clamp recordings of mouse DA midbrain neurons in culture and SN DA neurons in brain slices revealed SNX-482-sensitive R-type Ca<sup>2+</sup>-currents with voltage-dependent gating properties that suggest modulation by β2a- and/or β2e-subunits. Thus, β-subunit alternative splicing may prevent a fraction of Cav2.3 channels from inactivation in continuously active, highly vulnerable SN DA neurons, thereby also supporting Ca<sup>2+</sup> signals contributing to the (patho)physiological role of Cav2.3 channels in PD.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>voltage-gated calcium channels</kwd><kwd>calcium channel blockers</kwd><kwd>mouse midbrain dopamine neurons</kwd><kwd>mouse brain slices</kwd><kwd>calcium channel modulation</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd><kwd>Other</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100002428</institution-id><institution>Austrian Science Fund</institution></institution-wrap></funding-source><award-id>P27809</award-id><principal-award-recipient><name><surname>Striessnig</surname><given-names>Jörg</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100009968</institution-id><institution>Tyrolean Science Fund</institution></institution-wrap></funding-source><award-id>UNI-0404/2345</award-id><principal-award-recipient><name><surname>Ortner</surname><given-names>Nadine Jasmin</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution>Italian Miur</institution></institution-wrap></funding-source><award-id>2015FNWP34</award-id><principal-award-recipient><name><surname>Carbone</surname><given-names>Emilio</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100007388</institution-id><institution>Compagnia di San Paolo</institution></institution-wrap></funding-source><award-id>CSTO165284</award-id><principal-award-recipient><name><surname>Carbone</surname><given-names>Emilio</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100002428</institution-id><institution>Austrian Science Fund</institution></institution-wrap></funding-source><award-id>P35087</award-id><principal-award-recipient><name><surname>Ortner</surname><given-names>Nadine Jasmin</given-names></name></principal-award-recipient></award-group><award-group id="fund6"><funding-source><institution-wrap><institution>Hamburg Institute for Advanced Study</institution></institution-wrap></funding-source><award-id>Research Fellowship</award-id><principal-award-recipient><name><surname>Liss</surname><given-names>Birgit</given-names></name></principal-award-recipient></award-group><award-group id="fund7"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100002428</institution-id><institution>Austrian Science Fund</institution></institution-wrap></funding-source><award-id>CavX-DOC 30 doc.fund</award-id><principal-award-recipient><name><surname>Striessnig</surname><given-names>Jörg</given-names></name></principal-award-recipient></award-group><award-group id="fund8"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100002428</institution-id><institution>Austrian Science Fund</institution></institution-wrap></funding-source><award-id>P35722</award-id><principal-award-recipient><name><surname>Striessnig</surname><given-names>Jörg</given-names></name></principal-award-recipient></award-group><award-group id="fund9"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001659</institution-id><institution>German Research Foundation</institution></institution-wrap></funding-source><award-id>LI-1745/1, GRK1789</award-id><principal-award-recipient><name><surname>Liss</surname><given-names>Birgit</given-names></name></principal-award-recipient></award-group><award-group id="fund10"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100005306</institution-id><institution>Alfried Krupp von Bohlen und Halbach Foundation</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Liss</surname><given-names>Birgit</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Regulation of Cav2.3 Ca<sup>2+</sup> channels by membrane-bound β2 subunit splice variants permits long-lasting channel activity even during prolonged and continuous activity in dopamine neurons, with implications for Parkinson's disease pathophysiology.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Parkinson’s disease (PD) is one of the most common neurodegenerative disorders. Its motor symptoms are characterized by progressive degeneration of dopamine (DA)-releasing neurons in the <italic>Substantia nigra</italic> (SN), while neighboring DA neurons in the ventral tegmental area (VTA) remain largely unaffected (<xref ref-type="bibr" rid="bib16">Damier et al., 1999</xref>; <xref ref-type="bibr" rid="bib26">Giguère et al., 2018</xref>; <xref ref-type="bibr" rid="bib86">Surmeier et al., 2017</xref>). Current PD therapy is only symptomatic and primarily based on the substitution of striatal DA by administration of L-DOPA or dopamine D2 receptor agonists. Unfortunately, none of the existing therapeutic approaches for PD patients is disease-modifying and can prevent disease progression (for review see <xref ref-type="bibr" rid="bib50">Liss and Striessnig, 2019</xref>; <xref ref-type="bibr" rid="bib85">Surmeier et al., 2011</xref>; <xref ref-type="bibr" rid="bib86">Surmeier et al., 2017</xref>).</p><p>The development of novel neuroprotective strategies for the treatment of early PD requires the understanding of the cellular mechanisms responsible for the high vulnerability of SN DA neurons. Among these mechanisms, elevated metabolic stress appears to play a central role (for review see <xref ref-type="bibr" rid="bib50">Liss and Striessnig, 2019</xref>), eventually triggering lysosomal, proteasomal and mitochondrial dysfunction (<xref ref-type="bibr" rid="bib14">Burbulla et al., 2017</xref>; <xref ref-type="bibr" rid="bib86">Surmeier et al., 2017</xref>). Intrinsic physiological properties of SN DA neurons, in particular increased cytosolic DA levels and high energy demand due to large axonal arborization favor metabolic stress (<xref ref-type="bibr" rid="bib9">Bolam and Pissadaki, 2012</xref>; <xref ref-type="bibr" rid="bib50">Liss and Striessnig, 2019</xref>). In addition, these neurons must handle a constant intracellular Ca<sup>2+</sup>-load resulting from dendritic and somatic Ca<sup>2+</sup>-oscillations triggered during their continuous electrical activity (<xref ref-type="bibr" rid="bib61">Ortner et al., 2017</xref>; <xref ref-type="bibr" rid="bib85">Surmeier et al., 2011</xref>). Dendritic Ca<sup>2+</sup>-transients largely depend on the activity of voltage-gated Ca<sup>2+</sup> channels, in particular Cav1.3 L-type (LTCCs) and T-type channels (<xref ref-type="bibr" rid="bib32">Guzman et al., 2018</xref>). Cav1.3 channels can activate at subthreshold membrane potentials (<xref ref-type="bibr" rid="bib43">Koschak et al., 2001</xref>; <xref ref-type="bibr" rid="bib45">Lieb et al., 2014</xref>; <xref ref-type="bibr" rid="bib96">Xu and Lipscombe, 2001</xref>) and do not completely inactivate during continuous pacemaking activity (<xref ref-type="bibr" rid="bib32">Guzman et al., 2018</xref>; <xref ref-type="bibr" rid="bib31">Guzman et al., 2009</xref>; <xref ref-type="bibr" rid="bib61">Ortner et al., 2017</xref>). Some, but not all, in vivo studies (<xref ref-type="bibr" rid="bib50">Liss and Striessnig, 2019</xref>) showed neuroprotection by the systemic administration of dihydropyridine (DHP) LTCC blockers in 6-OHDA and MPTP animal models of PD thus further supporting a role of LTCCs as potential neuroprotective drug target. Based on these preclinical data and supporting observational clinical evidence (<xref ref-type="bibr" rid="bib50">Liss and Striessnig, 2019</xref>), the neuroprotective potential of the DHP isradipine (ISR) was tested in a double-blind, placebo-controlled, parallel-group phase 3 clinical trial (“STEADY-PD III”, NCT02168842; <xref ref-type="bibr" rid="bib6">Biglan et al., 2017</xref>). This trial reported no evidence for neuroprotection by ISR. Several explanations have been offered for this negative outcome (<xref ref-type="bibr" rid="bib36">Investigators, 2020</xref>). One likely explanation is that voltage-gated Ca<sup>2+</sup>-channels (Cavs) other than LTCCs also contribute to Ca<sup>2+</sup>-transients in SN DA neurons. This is supported by the observation that only about 50% of the Ca<sup>2+</sup>-transients are blocked by ISR in the dendrites of SN DA neurons (<xref ref-type="bibr" rid="bib32">Guzman et al., 2018</xref>) and that action potential-associated Ca<sup>2+</sup>-transients in the soma appear to be even resistant to ISR (<xref ref-type="bibr" rid="bib61">Ortner et al., 2017</xref>). Therefore, in addition to L-type, other types of Cavs expressed in SN DA neurons (<xref ref-type="bibr" rid="bib11">Branch et al., 2014</xref>; <xref ref-type="bibr" rid="bib22">Evans et al., 2017</xref>; <xref ref-type="bibr" rid="bib66">Philippart et al., 2016</xref>) may also contribute to Ca<sup>2+</sup>-induced metabolic stress in SN DA neurons. Cav2.3 (R-type) Ca<sup>2+</sup>-channels are very promising candidates. We have recently shown that SN DA neurons in mice lacking Cav2.3 channels were fully protected from neurodegeneration in the chronic MPTP-model of PD. Moreover, we found that Cav2.3 is the most abundant Cav expressed in SN DA neurons, and substantially contributes to activity-related somatic Ca<sup>2+</sup>-oscillations (<xref ref-type="bibr" rid="bib4">Benkert et al., 2019</xref>). These findings make Cav2.3 R-type Ca<sup>2+</sup> channels a promising target for neuroprotection in PD.</p><p>SN DA neurons are spontaneously active, pacemaking neurons, either firing in a low-frequency single-spike mode or transiently in a high-frequency burst mode (<xref ref-type="bibr" rid="bib28">Grace and Bunney, 1984</xref>; <xref ref-type="bibr" rid="bib63">Paladini and Roeper, 2014</xref>). During regular pacemaking their membrane potential is, on average, rather depolarized ranging from about –70 mV after an action potential (AP) to about –40 mV at firing threshold (<xref ref-type="bibr" rid="bib23">Gantz et al., 2018</xref>; <xref ref-type="bibr" rid="bib32">Guzman et al., 2018</xref>; <xref ref-type="bibr" rid="bib61">Ortner et al., 2017</xref>). The contribution of a particular Cav channel to Ca<sup>2+</sup>-entry is largely determined by its steady-state inactivation properties, which determines its availability at these depolarized voltages. Therefore, in SN DA neurons steady-state inactivation of Cav2.3 channels must occur within a voltage-range preventing inactivation of a substantial fraction of channels during the positive operating range of these continuously firing neurons. However, Cav2.3 α1-subunits have originally been cloned as a low-voltage-gated channel with a negative steady-state inactivation voltage-range (V<sub>0.5,inact</sub> –78 mV; <xref ref-type="bibr" rid="bib83">Soong et al., 1993</xref>) with almost complete inactivation at voltages positive to –50 mV. Interestingly, SNX-482-sensitive R-type currents mediated by Cav2.3 α1 subunits (<xref ref-type="bibr" rid="bib59">Newcomb et al., 1998</xref>) recorded from different neuronal cell types reveal a wide voltage-range of steady-state inactivation despite similar recording conditions (5–10 mM Ba<sup>2+</sup> as charge carrier): half-maximal voltages for steady-state inactivation (V<sub>0.5,inact</sub>) range from –90 to –70 mV in cerebellar, cortical and myenteric neurons (<xref ref-type="bibr" rid="bib5">Bian et al., 2004</xref>; <xref ref-type="bibr" rid="bib82">Sochivko et al., 2002</xref>; <xref ref-type="bibr" rid="bib88">Tottene et al., 2000</xref>) to –58 mV in neurohypophyseal terminals (<xref ref-type="bibr" rid="bib91">Wang et al., 1999</xref>) and to even as positive as –40 mV in GnRH-releasing neurons or GT1-7 cells (<xref ref-type="bibr" rid="bib38">Kato et al., 2003</xref>; <xref ref-type="bibr" rid="bib92">Watanabe et al., 2004</xref>). This raises the important question about potential molecular mechanisms accounting for this heterogeneity and its role for stabilization of R-type currents in SN DA neurons.</p><p>While alternative splicing of Cav2.3 α1 subunits is unlikely to account for such large shifts in steady-state inactivation (<xref ref-type="bibr" rid="bib65">Pereverzev et al., 2002</xref>), accessory β-subunits appear as obvious candidates for several reasons. First, like for other high-voltage-activated Ca<sup>2+</sup> channels (including Cav2.1 and Cav2.2, <xref ref-type="bibr" rid="bib51">Liu et al., 1996</xref>; <xref ref-type="bibr" rid="bib80">Scott et al., 1996</xref>) they form part of the Cav2.3 channel complex and thus affect its membrane targeting and gating properties (<xref ref-type="bibr" rid="bib99">Zamponi et al., 2015</xref>). Second, previous work has shown that β-subunits tightly control V<sub>0.5,inact</sub> of Cav2 channels, including Cav2.3. While all cytosolic β-subunit isoforms (β1 – β4 and cytosolic splice variants of β2) induce steady-state inactivation at negative potentials, being almost complete at voltages positive to –50 mV, the membrane-anchored β2 subunit splice variants β2a and β2e induce strong positive shifts of V<sub>0.5,inact</sub> of Cav2.3 channels and slow the time course of voltage-dependent inactivation (<xref ref-type="bibr" rid="bib37">Jones et al., 1998</xref>; <xref ref-type="bibr" rid="bib65">Pereverzev et al., 2002</xref>; <xref ref-type="bibr" rid="bib83">Soong et al., 1993</xref>; <xref ref-type="bibr" rid="bib94">Williams et al., 1994</xref>; <xref ref-type="bibr" rid="bib97">Yasuda et al., 2004</xref>). However, a specific physiological role for this modulatory effect has so far not been reported and the relative abundance of β2a and β2e subunits in neurons, including SN DA neurons, is unknown.</p><p>Here, we directly addressed the question if association of Cav2.3 channels with β2a or β2e but not with cytosolic β-subunits can prevent channel inactivation during SN DA activity patterns and could therefore serve as a mechanism allowing these channels to contribute to SN DA function. When co-expressed together with auxiliary α2δ1-subunits in tsA-201 cells we indeed found that during simulated SN DA neuron-like continuous tonic pacemaking or brief burst activity (<xref ref-type="bibr" rid="bib61">Ortner et al., 2017</xref>) Cav2.3 channels remained active only when associated with β2a or β2e, but not the cytosolic β3 and β4 subunits. In contrast, steady-state inactivation of Cav1.3 channels was largely unaffected by β2a, suggesting that Cav1.3 availability is much less dependent on the presence of β2a subunits. Using RNAscope we confirmed the presence of both β2a and β2e transcripts in identified mouse SN and VTA DA neurons and quantitative PCR analysis showed that β2-subunits represent about 25% of all β-subunit transcripts in the mouse SN and VTA with about 50% comprising β2a and β2e variants. In patch-clamp recordings of SN DA neurons in mouse brain slices, we detected SNX-482-sensitive R-type Ca<sup>2+</sup>-currents with voltage-dependent inactivation properties suggesting a contribution of β2a- or β2e-stabilized Cav2.3-currents. Recordings in cultured DA midbrain neurons confirmed R-type current activity during the pacemaking cycle. Taken together, our data further support a role of Cav2.3 in SN DA neuron Ca<sup>2+</sup>-signaling and imply a potential (patho)physiological role of β-subunit alternative splicing.</p></sec><sec id="s2" sec-type="results"><title>Results</title><p>To explore how Cav2.3 channels can contribute to DA neuron Ca<sup>2+</sup>-entry during sustained neuronal activity we expressed Cav2.3 α1-subunits together with its accessory α2δ1 and different β-subunits in tsA-201 cells under near-physiological conditions (<xref ref-type="fig" rid="fig1">Figure 1</xref>). For this purpose, we employed physiological extracellular Ca<sup>2+</sup> (2 mM), weak intracellular Ca<sup>2+</sup>-buffering (0.5 mM EGTA, see methods), and, in addition to square pulse protocols, used typical AP waveforms previously recorded from SN DA neurons in mouse midbrain slices (2.5 Hz) or simulated bursts as command voltages as described (<xref ref-type="bibr" rid="bib61">Ortner et al., 2017</xref>; see methods). Moreover, we specifically employed the Cav2.3e α1-subunit splice variant for our recordings, which among the six major Cav2.3 α1-subunit splice variants, was the only one detected in UV laser-microdissected mouse SN DA neurons in experiments using a qualitative single-cell RT-qPCR approach (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A, B</xref>).</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Biophysical properties of Cav2.3 channels co-transfected with different β-subunits (and α2δ1) in tsA-201 cells.</title><p>(<bold>A</bold>) Current densities (pA/pF) with or without (gray) co-transfection of indicated β-subunits. Color code and n-numbers are given in the graphs. (<bold>B</bold>) Voltage-dependence of steady-state activation (normalized conductance G, right axis, solid lines) and inactivation (normalized I<sub>Ca</sub> of test pulses, left axis, dashed lines, left n-numbers in parentheses). (<bold>C</bold>) Inactivation time course during 5 s depolarizing pulses to V<sub>max</sub> starting from a holding potential of –119 mV. Inset shows the first 200 ms of the 5 s pulse. Respective stimulation protocols are shown above each graph. The curves represent the means ± SEM for the indicated number of experiments (N = β2a: 5; β2d, β2e: 2; β3, β4, no β: 3). For statistics see <xref ref-type="table" rid="table1">Table 1</xref>. V<sub>max</sub>, voltage of maximal inward current. (<bold>D</bold>) Window currents measured in the presence of the indicated β-subunits were calculated by multiplying mean current densities (pA/pF) of I-V-relationships by the fractional current inactivation from steady-state inactivation curves at the indicated voltages. Data represent the means ± SEM for the indicated number of experiments (N = β2a: 5; β2d, β2e: 2; β3, β4: 3). Statistical significance was determined using one-way ANOVA with Bonferroni post-hoc test and is indicated: *** p&lt;0.001; ** p&lt;0.01; * p&lt;0.05. Source data provided in <xref ref-type="supplementary-material" rid="fig1sdata1">Figure 1—source data 1</xref>.</p><p><supplementary-material id="fig1sdata1"><label>Figure 1—source data 1.</label><caption><title>Source data for data shown in <xref ref-type="fig" rid="fig1">Figure 1</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-67464-fig1-data1-v4.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-67464-fig1-v4.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Determination of the expressed Cav2.3 splice variants in SN DA neurons.</title><p>(<bold>A</bold>) Cartoon of the exon structure of all Cav2.3 splice variants. The murine Cacna1e gene, coding for the Cav2.3 α1-subunits contains 48 exons with six major alternative splice variants (right panel). The splicing events include the variable use of exon 19, 21 nucleotides of exon 20 and exon 45. The outer and inner primer pairs chosen for identification of the different splice variants are located in the II-III loop and the C-terminus, covering the three described splicing sites. Expressed exons are shown as white boxes and splicing sites are indicated in red. (<bold>B</bold>). Agarose gel electrophoresis image showing two PCR products (363 bp II-III loop nested PCR fragment and 498 bp C-terminus nested PCR fragment) coding for the Cav2.3e splice variant of Cav2.3 (Cacna1e) found in mouse laser-dissected SN DA neuron derived cDNA (n=40, left). In contrast, all five PCR products (363 bp, 399 bp, and 420 bp in the II-III loop and 369 bp and 498 bp in the C-terminus nested PCR fragments) coding for all six major splice variants were found in whole brain tissue-derived cDNA (as positive control, right panel).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-67464-fig1-figsupp1-v4.tif"/></fig><fig id="fig1s2" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 2.</label><caption><title>Effect of β2a palmitoylation on the biophysical properties of Cav2.3 and Cav1.3 Ca<sup>2+</sup> channels in tsA-201 cells.</title><p>Since palmitoylation is reversible and regulated in an activity-dependent localized manner (<xref ref-type="bibr" rid="bib7">Bijlmakers and Marsh, 2003</xref>; <xref ref-type="bibr" rid="bib53">Matt et al., 2019</xref>), we also investigated the contribution of palmitoylation of β2a for Cav2.3e modulation under our experimental conditions. To mimic the de-palmitoylated form, we replaced the two N-terminal cysteines to serines (<sub>C3S/C4S</sub>β2a) which prevents plasma membrane anchoring of β2a (<xref ref-type="bibr" rid="bib25">Gebhart et al., 2010</xref>; <xref ref-type="bibr" rid="bib70">Qin et al., 1998</xref>). Data are shown for Cav1.3 (C-terminally long splice variant, <xref ref-type="bibr" rid="bib8">Bock et al., 2011</xref>) or Cav2.3 α1-subunits co-expressed with α2δ1 and β2a (orange), C3S/C4Sβ2a (red) or β3 (green). Respective command voltages are given in each panel. To disrupt palmitoylation-mediated membrane anchoring, the two N-terminal cysteines of β2a (see <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>) were replaced by serines in C3S/C4Sβ2a. (<bold>A, B</bold>) Inactivation kinetics during a 5 s long depolarizing step to V<sub>max</sub> for Cav1.3<sub>L</sub> (<bold>A</bold>), 15 mM Ca<sup>2+</sup>, holding potential –89 mV or Cav2.3 (<bold>B</bold>), 2 mM Ca<sup>2+</sup>, holding potential –119 mV. Curves represent means ± SEM for the indicated number of experiments. For statistics see <xref ref-type="table" rid="table1">Table 1</xref> and <xref ref-type="supplementary-material" rid="supp6">Supplementary file 6</xref>. (<bold>C, D</bold>) Voltage-dependence of activation (solid lines, normalized conductance G) and inactivation (dashed lines, normalized I<sub>Ca</sub> of 20-ms test pulses) for Cav1.3<sub>L</sub> (<bold>C</bold>) 15 mM Ca<sup>2+</sup>, holding potential –89 mV or Cav2.3 (<bold>D</bold>), 2 mM Ca<sup>2+</sup>, holding potential –119 mV. Means ± SEM. For statistics see <xref ref-type="table" rid="table1">Table 1</xref> and <xref ref-type="supplementary-material" rid="supp6">Supplementary file 6</xref>. <sub>C3S/C4S</sub>β2a significantly shifted V<sub>0.5,inact</sub> of Cav2.3 to more positive voltages as compared to β3 but to a much smaller extent (&lt;14 mV) than β2a (+35 mV) (<xref ref-type="table" rid="table1">Table 1</xref>). Due to this prominent role of palmitoylation on the V<sub>0.5,inact</sub> of Cav2.3 channels, the palmitoylation state of β2a should allow further fine-tuning of non-inactivating current components of Cav2.3 channels in SN DA neurons. The effects of β2a palmitoylation on the inactivation kinetics and inactivation voltage of Cav1.3 L-type channels (<bold>A, C</bold>) were different from Cav2.3, suggesting that palmitoylation/depalmitoylation events would regulate Ca<sup>2+</sup> channel function in a subtype-selective manner. Unlike β2a, <sub>C3S/C4S</sub>β2a was unable to slow the inactivation time course of Cav1.3, thus stabilizing faster inactivation similar to β3 (<xref ref-type="supplementary-material" rid="supp6">Supplementary file 6</xref>, <xref ref-type="bibr" rid="bib25">Gebhart et al., 2010</xref>). In contrast, preventing palmitoylation of β2a did not affect the inactivation time course of Cav2.3e (<xref ref-type="table" rid="table1">Table 1</xref>). Moreover, unlike observed for Cav2.3, steady-state inactivation was not significantly different for Cav1.3 co-transfected with β2a, β3, or <sub>C3S/C4S</sub>β2a (<xref ref-type="supplementary-material" rid="supp6">Supplementary file 6</xref>). Source data provided in <xref ref-type="supplementary-material" rid="fig1s2sdata1">Figure 1—figure supplement 2—source data 1</xref>.</p><p><supplementary-material id="fig1s2sdata1"><label>Figure 1—figure supplement 2—source data 1.</label><caption><title>Source data for data shown in <xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-67464-fig1-figsupp2-data1-v4.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-67464-fig1-figsupp2-v4.tif"/></fig></fig-group><sec id="s2-1"><title>β-subunit isoform-dependent regulation of Cav2.3 channel gating</title><p>We first used standard square pulse protocols to quantify the effect of different β-subunits on the voltage-dependence of channel gating under our experimental conditions. In addition to β3, β4, and β2a analyzed in previous studies (<xref ref-type="bibr" rid="bib37">Jones et al., 1998</xref>; <xref ref-type="bibr" rid="bib97">Yasuda et al., 2004</xref>), we also included membrane-anchored β2e and β2d, a cytosolic β2 splice variant, in our head-to-head comparison (<xref ref-type="fig" rid="fig1">Figure 1</xref>). In agreement with earlier studies (<xref ref-type="bibr" rid="bib37">Jones et al., 1998</xref>; <xref ref-type="bibr" rid="bib97">Yasuda et al., 2004</xref>), we found that recombinant Cav2.3 channels when associated with cytosolic β3 or β4 subunits inactivate at negative voltages (V<sub>0.5,inact</sub> &lt; –70 mV) and with a rapid inactivation time course (≥50% within 50 ms, <xref ref-type="fig" rid="fig1">Figure 1B–C</xref>, <xref ref-type="table" rid="table1">Table 1</xref>). The cytosolic β2d splice variant also showed a gating behavior very similar to β4. In contrast, β2a, which is anchored to the plasma membrane through N-terminal palmitoylation, slowed the inactivation time course and shifted Cav2.3 voltage-dependent inactivation by ~30 mV to more positive potentials compared to β4 (and β3). Likewise, with co-expressed β2e, which is membrane anchored through N-terminal phospholipid interaction (<xref ref-type="bibr" rid="bib13">Buraei and Yang, 2010</xref>; <xref ref-type="bibr" rid="bib55">Miranda-Laferte et al., 2014</xref>), gating properties were similar to β2a-containing Cav2.3 channel complexes (<xref ref-type="fig" rid="fig1">Figure 1A–C</xref>, <xref ref-type="table" rid="table1">Table 1</xref>). In the case of β2a, the shift in the voltage-dependence of inactivation, but not the slowing of the inactivation time course, was largely dependent on N-terminal palmitoylation as shown with the palmitoylation-deficient mutant <sub>C3S/C4S</sub>β2a (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2</xref>). The voltage-dependence of activation was similar for all tested β-subunits (<xref ref-type="fig" rid="fig1">Figure 1A</xref>, <xref ref-type="table" rid="table1">Table 1</xref>). Due to the voltage-dependent inactivation at more depolarized potentials and the resulting overlap of the steady-state activation and inactivation curves (<xref ref-type="fig" rid="fig1">Figure 1B</xref>), β2a and β2e subunits induce window currents, i.e. steady-state Ca<sup>2+</sup> influx, at negative potentials (<xref ref-type="fig" rid="fig1">Figure 1D</xref>). Our findings confirm and extend previous observations that membrane-anchored β2 subunits give rise to slowly inactivating Cav2.3 currents available at more positive voltages that could participate in the formation of such SNX-482-sensitive current components in neurons.</p><table-wrap id="table1" position="float"><label>Table 1.</label><caption><title>Voltage-dependence of activation and inactivation, and time course of inactivation of Cav2.3 co-transfected with α2δ1 and different β subunits in tsA-201 cells.</title><p><supplementary-material id="table1sdata1"><label>Table 1—source data 1.</label><caption><title>Source data for data shown in <xref ref-type="table" rid="table1">Table 1</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-67464-table1-data1-v4.xlsx"/></supplementary-material></p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom" rowspan="2">β-subunit</th><th align="left" valign="bottom" colspan="6">Cav2.3 - Activation 2 mM Ca<sup>2+</sup></th><th align="left" valign="bottom" colspan="4">Cav2.3 - Inactivation 2 mM Ca<sup>2+</sup></th></tr><tr><th align="left" valign="bottom">V<sub>0.5</sub>[mV]</th><th align="left" valign="bottom">k[mV]</th><th align="left" valign="bottom">V<sub>rev</sub>[mV]</th><th align="left" valign="bottom">act thresh[mV]</th><th align="left" valign="bottom">current density[pA/pF]</th><th align="left" valign="bottom">n</th><th align="left" valign="bottom">V<sub>0.5, inact</sub>[mV]</th><th align="left" valign="bottom">k<sub>inact</sub>[mV]</th><th align="left" valign="bottom">plateau[%]</th><th align="left" valign="bottom">n</th></tr></thead><tbody><tr><td align="left" valign="bottom">no β</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">–10.7±1.1</td><td align="char" char="." valign="bottom">23</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">β2a</td><td align="char" char="plusmn" valign="bottom">–14.8±1.2</td><td align="char" char="plusmn" valign="bottom">4.8±0.2</td><td align="char" char="plusmn" valign="bottom">37.1±0.9</td><td align="char" char="plusmn" valign="bottom">–32.0±0.9</td><td align="left" valign="bottom">–130.0<sup>+++</sup>±15.2</td><td align="char" char="." valign="bottom">26</td><td align="char" char="plusmn" valign="bottom">–40.6±1.6</td><td align="char" char="plusmn" valign="bottom">7.3±0.5</td><td align="char" char="plusmn" valign="bottom">0.4±1.1</td><td align="char" char="." valign="bottom">13</td></tr><tr><td align="left" valign="bottom"><sub>C3S/C4S</sub>β2a</td><td align="char" char="plusmn" valign="bottom">–13.9±1.7</td><td align="char" char="plusmn" valign="bottom">4.7±0.3</td><td align="char" char="plusmn" valign="bottom">38.2±1.1</td><td align="char" char="plusmn" valign="bottom">–30.9±0.7</td><td align="left" valign="bottom">–105.7<sup>+++</sup>±21.4</td><td align="char" char="." valign="bottom">12</td><td align="left" valign="bottom">–62.6***<sup>/###/§§§</sup>±1.6</td><td align="left" valign="bottom">8.3<sup>##</sup>±0.4</td><td align="char" char="plusmn" valign="bottom">3.8±1.6</td><td align="char" char="." valign="bottom">9</td></tr><tr><td align="left" valign="bottom">β2d</td><td align="left" valign="bottom">–15.9<sup>§</sup>±1.1</td><td align="char" char="plusmn" valign="bottom">4.6±0.2</td><td align="char" char="plusmn" valign="bottom">37.2±1.1</td><td align="left" valign="bottom">–32.1<sup>§</sup>±0.7</td><td align="left" valign="bottom">–107.7<sup>+++</sup>±13.4</td><td align="char" char="." valign="bottom">17</td><td align="left" valign="bottom">–69.9***<sup>/###</sup>±2.0</td><td align="left" valign="bottom">8.2<sup>##</sup>±0.2</td><td align="char" char="plusmn" valign="bottom">2.0±0.7</td><td align="char" char="." valign="bottom">10</td></tr><tr><td align="left" valign="bottom">β2e</td><td align="char" char="plusmn" valign="bottom">–14.1±0.9</td><td align="char" char="plusmn" valign="bottom">4.8±0.2</td><td align="char" char="plusmn" valign="bottom">40.3*±0.6</td><td align="char" char="plusmn" valign="bottom">–31.5±0.7</td><td align="left" valign="bottom">–96.8<sup>+++</sup>±14.3</td><td align="char" char="." valign="bottom">32</td><td align="char" char="plusmn" valign="bottom">–39.9±1.9</td><td align="char" char="plusmn" valign="bottom">6.5±0.3</td><td align="char" char="plusmn" valign="bottom">3.8±1.2</td><td align="char" char="." valign="bottom">24</td></tr><tr><td align="left" valign="bottom">β3</td><td align="char" char="plusmn" valign="bottom">–10.5±0.7</td><td align="char" char="plusmn" valign="bottom">5.2±0.2</td><td align="char" char="plusmn" valign="bottom">39.8±0.9</td><td align="char" char="plusmn" valign="bottom">–29.2±0.7</td><td align="left" valign="bottom">–64.6<sup>++</sup>±12.8</td><td align="char" char="." valign="bottom">17</td><td align="left" valign="bottom">–76.2***<sup>/###</sup>±1.0</td><td align="char" char="plusmn" valign="bottom">7.0±0.1</td><td align="char" char="plusmn" valign="bottom">4.1±0.7</td><td align="char" char="." valign="bottom">14</td></tr><tr><td align="left" valign="bottom">β4</td><td align="char" char="plusmn" valign="bottom">–13.1±0.7</td><td align="char" char="plusmn" valign="bottom">5.0±0.2</td><td align="char" char="plusmn" valign="bottom">38.5±0.5</td><td align="char" char="plusmn" valign="bottom">–31.0±0.5</td><td align="left" valign="bottom">–74.8<sup>+++</sup>±11.9</td><td align="char" char="." valign="bottom">17</td><td align="left" valign="bottom">–70.3***<sup>/###</sup>±1.2</td><td align="char" char="plusmn" valign="bottom">7.5±0.1</td><td align="char" char="plusmn" valign="bottom">2.4±0.4</td><td align="char" char="." valign="bottom">11</td></tr><tr><th align="left" valign="bottom" colspan="8">Cav2.3–5 s Inactivation time course 2 mM Ca<sup>2+</sup></th></tr><tr><th align="left" valign="bottom">β-subunit</th><th align="left" valign="bottom">r50 [%]</th><th align="left" valign="bottom">r100 [%]</th><th align="left" valign="bottom">r250 [%]</th><th align="left" valign="bottom">r500 [%]</th><th align="left" valign="bottom">r1000 [%]</th><th align="left" valign="bottom">r5000 [%]</th><th align="left" valign="bottom">n</th></tr><tr><td align="left" valign="bottom">β2a</td><td align="char" char="plusmn" valign="bottom">71.3±2.1</td><td align="char" char="plusmn" valign="bottom">52.4±2.8</td><td align="char" char="plusmn" valign="bottom">27.8±2.9</td><td align="char" char="plusmn" valign="bottom">14.3±2.3</td><td align="char" char="plusmn" valign="bottom">6.5±1.2</td><td align="char" char="plusmn" valign="bottom">1.3±0.3</td><td align="char" char="." valign="bottom">17</td></tr><tr><td align="left" valign="bottom"><sub>C3S/C4S</sub>β2a</td><td align="left" valign="bottom">67.4<sup>§§§/%</sup>±5.2</td><td align="left" valign="bottom">47.3<sup>#/§§§/%%</sup>±6.4</td><td align="left" valign="bottom">23.4<sup>§</sup>±5.3</td><td align="char" char="plusmn" valign="bottom">11.6±3.3</td><td align="char" char="plusmn" valign="bottom">6.2±1.7</td><td align="char" char="plusmn" valign="bottom">3.4±1.1</td><td align="char" char="." valign="bottom">11</td></tr><tr><td align="left" valign="bottom">β2d</td><td align="left" valign="bottom">57.4*<sup>/###/§§§</sup>±2.8</td><td align="left" valign="bottom">32.6***<sup>/###/§§</sup>±2.4</td><td align="left" valign="bottom">11.3*<sup>/###</sup>±1.7</td><td align="left" valign="bottom">4.4**<sup>/###</sup>±0.9</td><td align="left" valign="bottom">2.4**<sup>/###</sup>±0.6</td><td align="char" char="plusmn" valign="bottom">1.7±0.5</td><td align="char" char="." valign="bottom">21</td></tr><tr><td align="left" valign="bottom">β2e</td><td align="char" char="plusmn" valign="bottom">77.5±2.9</td><td align="char" char="plusmn" valign="bottom">64.2±3.3</td><td align="char" char="plusmn" valign="bottom">41.1±3.2</td><td align="char" char="plusmn" valign="bottom">22.3±2.8</td><td align="char" char="plusmn" valign="bottom">10.1±2.0</td><td align="char" char="plusmn" valign="bottom">3.3±0.8</td><td align="char" char="." valign="bottom">27</td></tr><tr><td align="left" valign="bottom">β3</td><td align="left" valign="bottom">32.9***<sup>/###</sup>±2.9</td><td align="left" valign="bottom">14.2***<sup>/###</sup>±1.5</td><td align="left" valign="bottom">6.1***<sup>/###</sup>±1.0</td><td align="left" valign="bottom">4.4**<sup>/###</sup>±0.7</td><td align="left" valign="bottom">2.9<sup>#</sup>±0.5</td><td align="char" char="plusmn" valign="bottom">1.6±0.3</td><td align="char" char="." valign="bottom">16</td></tr><tr><td align="left" valign="bottom">β4</td><td align="left" valign="bottom">50.3***<sup>/###/§§</sup>±2.7</td><td align="left" valign="bottom">27.1***<sup>/###</sup>±2.5</td><td align="left" valign="bottom">8.6**<sup>/###</sup>±1.4</td><td align="left" valign="bottom">3.7**<sup>/###</sup>±0.8</td><td align="left" valign="bottom">2.0**<sup>/###</sup>±0.5</td><td align="char" char="plusmn" valign="bottom">1.0±0.2</td><td align="char" char="." valign="bottom">15</td></tr></tbody></table></table-wrap><p>Since Cav2.3 α1-subunits have also been reported to mediate I<sub>Ca</sub> even when expressed in the absence of β-subunits (<xref ref-type="bibr" rid="bib37">Jones et al., 1998</xref>; <xref ref-type="bibr" rid="bib97">Yasuda et al., 2004</xref>), we also tested to which extent β-subunit modulated channels are expected to contribute to Cav2.3 currents. In our experiments, all five tested β-subunits (β2a, β2d, β2e, β3, β4) caused a robust and highly significant (6–12-fold; <xref ref-type="fig" rid="fig1">Figure 1A</xref>, <xref ref-type="table" rid="table1">Table 1</xref>) increase in current densities. This implies that β-associated Cav2.3 channels contribute more to overall Cav2.3-mediated currents than channel complexes devoid of β-subunits and thus can be subject to differential modulation by β-subunits.</p><p>Taken together, these data suggest that through their effect on inactivation gating β2a- and β2e-subunits could contribute to sustained Cav2.3 activity and AP-associated Ca<sup>2+</sup> transients previously recorded in SN DA neurons (<xref ref-type="bibr" rid="bib4">Benkert et al., 2019</xref>).</p></sec><sec id="s2-2"><title>β-subunit transcripts in mouse SN and VTA</title><p>This prompted us to investigate if β2a and β2e splice variants are indeed expressed in SN tissue. First, we investigated β1 - β4 subunit expression patterns in the SN (and VTA for comparison, <xref ref-type="fig" rid="fig2">Figure 2A</xref>) dissected from brain slices of 12- to 14-week-old male C57Bl/6 N mice (<xref ref-type="fig" rid="fig2">Figure 2C</xref>) using a standard-curve-based absolute RT-qPCR assay (<xref ref-type="bibr" rid="bib77">Schlick et al., 2010</xref>; <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>, <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>, <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>, <xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref>). In both SN and VTA tissue, β4 (SN:~64%; VTA:~57%) and β2 (SN:~27%; VTA:~29%) represented the most abundant β-subunit transcripts, followed by β1 and β3 (~4–7%) (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). Our findings are in excellent agreement (β2: 31–35%, β4: 41–45%) with cell-type-specific RNA sequencing data from identified mouse midbrain DA neurons (<xref ref-type="bibr" rid="bib12">Brichta et al., 2015</xref>; <xref ref-type="bibr" rid="bib81">Shin, 2015</xref>).</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Transcript expression of various β-subunits and β2-subunit splice variants in mouse SN and VTA tissue.</title><p>(<bold>A</bold>) Expression of β1-β4 subunit transcripts in SN (n=3, N=3) (left) and VTA (n=3, N=3) (right) determined by RT-qPCR as described in Methods. (<bold>B</bold>) Expression of β2a-β2e subunit transcripts in SN (n=3, N=3) (left) and VTA (n=3, N=3) (right). Data are shown as the mean ± SEM. Statistical significance was determined using one-way ANOVA followed by Bonferroni post-hoc test: *** p&lt;0.001; *p <italic>P</italic>&lt;0.01; * p&lt;0.05. Data was normalized to Gapdh and Tfrc determined by geNorm. (<bold>C</bold>) Example for four SN (left) and two VTA (right) tissue punches obtained for cDNA preparation with diameters of 0.5 mm each (left) or 0.8 mm each (right) from 7 to 8 successive 100-μm-sections between Bregma –3.00 mm and –3.80 mm, stained with Cresyl violet. Source data provided in <xref ref-type="supplementary-material" rid="fig2sdata1">Figure 2—source data 1</xref>.</p><p><supplementary-material id="fig2sdata1"><label>Figure 2—source data 1.</label><caption><title>Source data for data shown in <xref ref-type="fig" rid="fig2">Figure 2</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-67464-fig2-data1-v4.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-67464-fig2-v4.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>Binding specificity of β1-β4 and β2a-β2e TaqMan assays and expression stability of endogenous control genes.</title><p>(<bold>A</bold>) Alignment of the N-terminal amino acid sequence of the investigated β-subunits (β2a, β2d, β2e, β3, or β4). Residues responsible for membrane anchoring of β2a (palmitoylated cysteine residues are highlighted in orange) and β2e (positively charged amino acids forming a lipid binding motif are highlighted in blue) are indicated. Homologous exons are shaded in gray. Sequence accession numbers (human CACNB2 (β2) splice variants): β2a (NP_000715.2), β2d (NP_963887.2), β2e (NP_963864.1), β3 (NP_000716.2), β4e (NP_001307651.1). (<bold>B</bold>) The indicated β-subunit isoforms (β1-β4; n=3; gene names in parenthesis) and β2 splice variants (n=3) were recognized with high specificity (low CT value) by the corresponding RT-qPCR assay even in the presence of a 10-fold higher concentration of the mismatching DNA fragments corresponding to other isoforms/splice variants (β1–4: n=1; β2 splice variants: n=1). High binding specificity was confirmed by inefficient detection (high CT value) of all non-matching DNA fragments. We additionally performed experiments with a mixture of the specific with mismatching β-subunit DNA at ratios of 1:1, 1:2, and 1:5, and only the 1:10 mix is shown (similar CT values for all combinations). (<bold>C</bold>) Average expression stability of endogenous control genes in SN and VTA tissue. All reference genes maintained comparable cDNA concentrations throughout the experiments. Data were normalized to the expression of Glyceraldehyde 3-phosphate dehydrogenase (Gapdh) and Transferrin receptor (Tfrc) determined by geNorm. Data are given as means ± SEM (n=6, N=6). Source data provided in <xref ref-type="supplementary-material" rid="fig2s1sdata1">Figure 2—figure supplement 1—source data 1</xref>.</p><p><supplementary-material id="fig2s1sdata1"><label>Figure 2—figure supplement 1—source data 1.</label><caption><title>Source data for data shown in <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1B and C</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-67464-fig2-figsupp1-data1-v4.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-67464-fig2-figsupp1-v4.tif"/></fig><fig id="fig2s2" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 2.</label><caption><title>Expression of β2-subunit splice variants in UV-LMD SN DA neurons.</title><p>(<bold>A</bold>) Left: Overview of a cresyl violet (CV) stained coronal midbrain section of a juvenile wildtype mouse after UV-LMD of 10 SN DA neurons (scale bar: 250 μm, upper). Image of one CV stained SN DA neuron of a juvenile wildtype mouse before and after UV-LMD (scale bar: 10 μm, lower). Middle: β2-subunit transcript relative mRNA quantification by reverse transcription quantitative PCR-based in UV-LMD mouse SN DA neurons (n=10). Right: Capillary gel electrophoresis image illustrating PCR products of β2-subunit (<italic>Cacnb2</italic>) splice variants amplified from a UV-LMD cDNA template corresponding to 2.9 cells. (<bold>B</bold>) Left: Representative images showing β2a and β2e (red) or tyrosine hydroxylase (TH (<italic>Th</italic>), green) RNAscope fluorescence signals (combined with nuclear DAPI staining, blue) of individual SN DA neurons from an adult wildtype mouse. Scale bar: 5 μm. Right: Absolute mRNA transcript numbers per cell for β2 (<italic>Cacnb2</italic>) - variants β2a or β2e in adult SN DA and VTA DA neurons of adult wildtype mice (N=6, each), as indicated. Tukey’s boxplots are shown. Significances are indicated by asterisks: *** p&lt;0.001, **** p&lt;0.0001. For statistics see details in <xref ref-type="supplementary-material" rid="supp4">Supplementary file 4</xref>. Source data provided in <xref ref-type="supplementary-material" rid="fig2s2sdata1">Figure 2—figure supplement 2—source data 1</xref>.</p><p><supplementary-material id="fig2s2sdata1"><label>Figure 2—figure supplement 2—source data 1.</label><caption><title>Source data for data shown in <xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2A and B</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-67464-fig2-figsupp2-data1-v4.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-67464-fig2-figsupp2-v4.tif"/></fig></fig-group><p>Since the relative abundance of β2-subunit splice variants in the brain is unknown, we used our standard curve-based RT-qPCR assay to specifically quantify their expression in the SN and VTA (<xref ref-type="fig" rid="fig2">Figure 2B</xref>; for alignment of N-terminal β2 splice variants see <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A</xref>). Assays were designed to specifically discriminate between β2a, β2b, and β2e. β2c and β2d N-termini were detected together (the β2d N-terminus is also present in β2c but with different alternative splicing in the HOOK region; <xref ref-type="bibr" rid="bib13">Buraei and Yang, 2010</xref>; see methods). In SN and VTA, β2a (~30%) and β2e (~26%) transcripts together comprised about half of all tested β2-subunit splice variants, cytosolic β2c and β2d-species about 42% and β2b only about 3% (<xref ref-type="fig" rid="fig2">Figure 2B</xref>). Therefore, β2a and β2e together should be able to form a substantial fraction of Cav2.3 channel complexes in these neurons.</p><p>We further confirmed the presence of the various N-terminal β2 splice variants in individual UV-laser microdissected mouse SN DA neurons at the mRNA level using a qualitative PCR approach (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2</xref>, <xref ref-type="supplementary-material" rid="supp4">Supplementary file 4</xref>, <xref ref-type="supplementary-material" rid="supp5">Supplementary file 5</xref>). Moreover, quantitative RNAscope analysis confirmed the expression of β2e and β2a in identified mouse SN and VTA DA neurons with β2e more abundantly expressed compared to β2a (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2</xref>).</p></sec><sec id="s2-3"><title>β2 splice variant-dependent regulation of Cav2.3 activity during SN DA neuron-like regular pacemaking activity</title><p>To test a possible role of β-subunits for Cav2.3 channel availability in SN DA neurons, we mimicked their electrical activity in tsA-201 cells because individual Ca<sup>2+</sup>-current components arising from Cav2.3 channel complexes associated with different β-subunits or even different splice variants cannot be isolated during continuous pacemaking in patch-clamp recordings of identified SN DA neurons. With co-expressed β3 and β4 isoforms simulated SN DA neuron regular pacemaker activity (initiated from a holding potential of –89 mV) induced large inward currents in response to single AP waveforms (<xref ref-type="fig" rid="fig3">Figure 3A and B</xref>). Cav2.3 channels conducted I<sub>Ca</sub> during the repolarization phase of the AP (I<sub>AP</sub>) without evidence for inward current during the interspike interval (ISI, <xref ref-type="fig" rid="fig3">Figure 3A and B</xref> bottom inset). However, I<sub>AP</sub> decreased rapidly during continuous activity and almost completely disappeared after 1 (co-transfected β3)–2 min (co-transfected β4; <xref ref-type="fig" rid="fig3">Figure 3A, B, E and F</xref>). The time course of I<sub>AP</sub> decrease was best fitted by a bi-exponential function (see legend to <xref ref-type="fig" rid="fig3">Figure 3</xref>). Our data, therefore, suggest that Cav2.3e α1-subunits, in complex with α2δ1 and β3 or β4, cannot support substantial inward currents during continuous SN DA neuron pacemaking activity. This is in contrast to our previously published finding of stable Cav1.3 Ca<sup>2+</sup>-channel activity persisting under near identical experimental conditions (Cav1.3 α1/α2δ1/β3 previously published data; <xref ref-type="bibr" rid="bib61">Ortner et al., 2017</xref>; illustrated for comparison in <xref ref-type="fig" rid="fig3">Figure 3E and F</xref>, in gray).</p><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Activity-dependent inactivation of Cav2.3 channels co-transfected with different β subunits (and α2δ1) during simulated SN DA neuron regular pacemaking activity in tsA-201 cells.</title><p>(<bold>A–D</bold>) Top panel: The SN DA neuron-derived command voltage was applied with a frequency of 2.5 Hz (only a time interval around the AP-spike is shown). Middle panel: Corresponding representative Ca<sup>2+</sup> current traces (2 mM charge carrier) for Cav2.3 channels co-expressed with α2δ1 and β3 (A, green), β4 (B, purple), β2a (C, orange), or β2e (D, blue) are shown for the indicated sweep number (1st, 10th, 100th, 295th, 720th). Cav2.3 currents were completely blocked by 100 μM Cadmium (Cd<sup>2+</sup>), and remaining Cd<sup>2+</sup>-insensitive current components were subtracted off-line (bottom panel). ISI, interspike interval. (<bold>E</bold>) Current decay during simulated 2.5 Hz SN DA neuron pacemaking. Normalized peak inward current during APs (I<sub>AP</sub>) is plotted against time as mean ± SEM for the indicated number of experiments. I<sub>AP</sub> amplitudes were normalized to the I<sub>AP</sub> amplitude of the first AP after holding the cell at –89 mV. Cav1.3<sub>L</sub> co-expressed with α2δ1 and β3 (gray, mean only) is shown for comparison (data taken from <xref ref-type="bibr" rid="bib61">Ortner et al., 2017</xref>). The I<sub>AP</sub> decay was fitted to a bi-exponential function (Cav2.3 β3: A<sub>slow</sub> = 39.4% ± 0.65 %, τ<sub>slow</sub> = 22.2 ± 0.15 min, A<sub>fast</sub> = 54.2 ± 0.76 %, τ<sub>fast</sub> = 2.86 ± 0.07 min, non-inactivating=4.47% ± 0.13%; β4: A<sub>slow</sub> = 48.5 ± 0.26 %, τ<sub>slow</sub> = 90.3 ± 1.07 min, A<sub>fast</sub> = 41.8 ± 0.40 %, τ<sub>fast</sub> = 8.39 ± 0.16 min, non-inactivating=5.12% ± 0.12%; β2a: A<sub>slow</sub> = 52.6 ± 0.47 %, τ<sub>slow</sub> = 299.3 ± 10.2 min, A<sub>fast</sub> = 13.4 ± 0.53 %, τ<sub>fast</sub> = 18.2 ± 1.47 min, non-inactivating=32.3% ± 0.77%; β2e: A<sub>slow</sub> = 67.7 ± 0.11 %, τ<sub>slow</sub> = 294.1 ± 1.77 min, A<sub>fast</sub> = 7.10.0±0.27 %, τ<sub>fast</sub> = 16.6 ± 1.24 min, non-inactivating=25.0% ± 0.12%). Curves represent the means ± SEM for the indicated number of experiments (independent transfections, N=Cav2.3/β3: 4; Cav2.3/β4: 2; Cav2.3/β2a: 4; Cav2.3/β2e: 2; Cav1.3<sub>L</sub>/β3: 6). (F) Normalized I<sub>AP</sub> decay after predefined time points for Cav2.3 with β3, β4, β2a or β2e, and Cav1.3<sub>L</sub> (with β3). Color-code and n-numbers as in panel E. Statistical significance was determined using one-way ANOVA followed by Bonferroni post-hoc test: *** p&lt;0.001; ** p&lt;0.01; * p&lt;0.05. Source data provided in <xref ref-type="supplementary-material" rid="fig3sdata1">Figure 3—source data 1</xref>.</p><p><supplementary-material id="fig3sdata1"><label>Figure 3—source data 1.</label><caption><title>Source data for data shown in <xref ref-type="fig" rid="fig3">Figure 3</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-67464-fig3-data1-v4.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-67464-fig3-v4.tif"/></fig><p>In contrast, the depolarizing shifts in steady-state inactivation and the slowing of inactivation kinetics by β2a and β2e subunits are sufficient to stabilize Cav2.3e currents during simulated regular pacemaking activity. When analyzed in parallel under identical experimental conditions I<sub>AP</sub> decreased with a much slower time course with about 40% of the maximal initial I<sub>AP</sub> still remaining even after 5 min of continuous activity (<xref ref-type="fig" rid="fig3">Figure 3C–F</xref>). The time course of I<sub>AP</sub> decrease could be fitted by a bi-exponential function predicting a steady-state reached at 32.3% ± 0.77% (n=12) of the initial I<sub>AP</sub> for β2a and 25.0% ± 0.12% (n=9) for β2e (see legend to <xref ref-type="fig" rid="fig3">Figure 3</xref>). Similar to co-transfected β3 or β4 subunits, β2a or β2e supported Cav2.3 I<sub>Ca</sub> predominantly during the repolarization phase after the AP spike. However, in accordance with enhanced window currents at negative voltages (<xref ref-type="fig" rid="fig1">Figure 1D</xref>) these subunits also supported an inward current during the interspike interval (ISI) as evident from the first few sweeps (with the largest current amplitudes) (<xref ref-type="fig" rid="fig3">Figure 3C and D</xref>, bottom insets). I<sub>AP</sub> persisting after 2 min (β3, β4) or 5 min (β2a, β2e) of pacemaking was completely blocked by 100 µM Cd<sup>2+</sup> with almost complete recovery upon washout (<xref ref-type="fig" rid="fig3">Figure 3A–E</xref>).</p><p>Irreversible loss of I<sub>Ca</sub>, a phenomenon also known as current &quot;run-down&quot; widely described for both native and recombinant Cavs (<xref ref-type="bibr" rid="bib39">Kepplinger et al., 2000</xref>; <xref ref-type="bibr" rid="bib61">Ortner et al., 2017</xref>; <xref ref-type="bibr" rid="bib79">Schneider et al., 2018</xref>) during patch-clamp recordings, may also contribute to the current decay observed during simulated pacemaking. We, therefore, quantified the contribution of current run-down for Cav2.3 co-expressed with α2δ1 and β2a or β3 subunits first by applying short (20 ms) square pulses to V<sub>max</sub> (holding potential –89 mV) with a frequency of 0.1 Hz (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). With this protocol (short pulse, long inter-sweep interval, hyperpolarized holding potential) activity- and voltage-dependent inactivation of Cav2.3 channels should be minimized. While β3 co-transfected Cav2.3 channels showed a time-dependent current run-down to about 60% of the peak I<sub>Ca</sub> after 5 min, β2a prevented the current decline during this period (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). To further quantify the current run-down during simulated pacemaking, we interrupted the pacemaking protocol after different time periods by 20 s long pauses at –89 mV to allow channel recovery from inactivation (<xref ref-type="fig" rid="fig4">Figure 4B</xref>). Thus, the percent run-down can be estimated from the non-recovering current component (<xref ref-type="fig" rid="fig4">Figure 4B</xref>, horizontal dashed lines). After 30 s of pacemaking the current amplitude during the first AP after the pause was similar to I<sub>AP</sub> during the initial AP with both β-subunits (β3: 96.9% ± 3.63%, 95% CI: 86.8–107.0, n=5, N=2; β2a: 107.3% ± 3.66%, 95% CI: 99.3–115.4, n=12, N=2, of the initial I<sub>AP</sub>). After the pause that followed another 1 min of pacemaking, 83.6% ± 7.33% (95% CI: 63.2–103.9) of the initial current was still recovered with co-transfected β3 but after 2 more minutes of pacemaking recovery decreased to 54.7% ± 6.27% (95% CI: 34.7–74.7, <xref ref-type="fig" rid="fig4">Figure 4B</xref>;~45% run-down after 4.5 min in total, n=5). This time course is in good agreement with values obtained using the square-pulse protocol (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). Again, run-down was largely prevented by co-expressed β2a-subunits (<xref ref-type="fig" rid="fig4">Figure 4B</xref>;~16% run-down after 4.5 min in total, n=12).</p><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>β-subunit-dependent run-down of Cav2.3 channel Ca<sup>2+</sup> current in tsA-201 cells.</title><p>Data for Cav2.3 co-expressed with α2δ1 and β2a (orange) or β3 (green) are shown. (<bold>A</bold>). Run-down during a 0.1 Hz square pulse protocol (20 ms to V<sub>max</sub>, holding potential –89 mV). Currents were normalized to the I<sub>Ca</sub> of the sweep with the maximal peak inward current observed during the recording. After a full block with 100 µM Cd<sup>2+</sup> currents recovered to the amplitude preceding the Cd<sup>2+</sup> application. (<bold>B</bold>) Cells were held at –89 mV and then stimulated using the regular SN DA neuron pacemaking protocol for 30 s, 1 min, and 2 min each followed by 20 s long pauses (vertical dashed lines) at hyperpolarized potentials (–89 mV) to allow channel recovery from inactivation. I<sub>AP</sub> of individual APs was normalized to the inward current of the first AP. The current run-down component can be estimated from the non-recovering current component (horizontal dashed lines). Traces represent means ± SEM from the indicated number of experiments (N=2). BS, bath solution.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-67464-fig4-v4.tif"/></fig><p>These data clearly demonstrate that the I<sub>AP</sub> decrease in response to simulated SN DA neuron pacemaking (2.5 Hz) is almost completely due to the reversible accumulation of Cav2.3 channels in inactivated states, an effect partially prevented by β2a and β2e.</p></sec><sec id="s2-4"><title>Cav2.3 Ca<sup>2+</sup> currents during simulated SN DA burst firing activity</title><p>In addition to regular pacemaking activity (in vitro) or irregular single spike mode (in vivo), burst firing with transient increases in intracellular Ca<sup>2+</sup>-load has been associated with neurodegeneration and selective neuronal vulnerability in Parkinson’s disease (<xref ref-type="bibr" rid="bib19">Dragicevic et al., 2015</xref>; <xref ref-type="bibr" rid="bib75">Schiemann et al., 2012</xref>). Thus, we investigated to which extent Cav2.3 Ca<sup>2+</sup>-channels can contribute to Ca<sup>2+</sup>-entry during bursts and after post-burst hyperpolarizing pauses of SN DA neurons. After reaching steady-state I<sub>AP</sub> during simulated SN DA neuron pacemaking (β4: 1–2 min, β2a/β2e: 5–6 min, see also <xref ref-type="fig" rid="fig3">Figure 3E and F</xref>) we applied a computer modeled typical three-spike burst, followed by a 1.5 s long afterhyperpolarization-induced pause at more negative potentials as a command voltage as previously described (<xref ref-type="bibr" rid="bib61">Ortner et al., 2017</xref>; <xref ref-type="fig" rid="fig5">Figure 5A</xref>). First, we quantified to which extent total burst Ca<sup>2+</sup>-charge, that is I<sub>Ca</sub> integrated over the duration of the burst, changes as compared to total Ca<sup>2+</sup>-charge during the same duration of a single AP in steady-state (calculated as the mean of 3 APs preceding the burst). Integrated I<sub>Ca</sub> during the burst was four- to sixfold higher than the mean integrated I<sub>Ca</sub> during a steady-state AP with all co-expressed β-subunits (β2a, β2e, β4) (<xref ref-type="fig" rid="fig5">Figure 5B</xref>, left panel). However, it has to be considered that with co-expressed β4 only ~6% of the initial I<sub>AP</sub> remained in steady-state during regular pacemaking (<xref ref-type="fig" rid="fig3">Figure 3E and F</xref>). Therefore, this relative increase will cause a much smaller rise in absolute Ca<sup>2+</sup> charge compared to β2a/β2e-associated Cav2.3 where ~ 40% of I<sub>AP</sub> persisted in steady-state (<xref ref-type="fig" rid="fig5">Figure 5B</xref>, <xref ref-type="fig" rid="fig3">Figure 3E and F</xref>).</p><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Effects of different β-subunits on Cav2.3 currents during a simulated SN DA neuron three-spike burst and post-burst APs in tsA-201 cells.</title><p>The burst command voltage was elicited after ~5–6 min (β2a, β2e) or ~1–2 min (β4) of regular pacemaking to reach steady-state I<sub>AP</sub> (β2a and β2e:~30% of the initial I<sub>AP</sub>, β4:~6% of the initial I<sub>AP</sub>, see <xref ref-type="fig" rid="fig3">Figure 3</xref>). (<bold>A</bold>) Normalized current responses of Cav2.3 channels co-expressed with β2a, β2e or β4 subunits (and α2δ1) induced by a command voltage (top panel) simulating a typical three-spike burst followed by a hyperpolarization phase at hyperpolarized potentials (lowest voltage: –82 mV) for 1.5 seconds. Remaining Cd<sup>2+</sup>-insensitive current components (100 µM Cd<sup>2+</sup>) were subtracted off-line to extract pure Cav2.3 mediated I<sub>Ca</sub>. One of at least four experiments with similar results is shown. (<bold>B</bold>) The integrated I<sub>Ca</sub> during a single AP before the burst (obtained as the mean of the three preceding APs) was set to 100% and compared with I<sub>Ca</sub> during the three-spike burst integrated over the time period equivalent to one AP (left) or the first APs after the pause (right). All investigated β-subunits resulted in increased integrated I<sub>Ca</sub> during the burst. Data represent the means ± SEM for the indicated number of experiments (N = β2a: 4; β2e: 2; β4: 2). Statistical significance was determined using one-way ANOVA followed by Bonferroni post-test (whole burst) or Kruskal-Wallis followed by Dunn’s multiple comparison test (post-burst APs): *** p&lt;0.001; ** p&lt;0.01; * p&lt;0.05. (<bold>C</bold>) Square-pulse protocol (top) used to determine recovery from inactivation after the indicated time intervals for β2a and β4-associated Cav2.3 channels (see Materials and methods for details). Data represent the means ± SEM for the indicated number of experiments (N=3). For statistics see <xref ref-type="table" rid="table2">Table 2</xref>. Source data provided in <xref ref-type="supplementary-material" rid="fig5sdata1">Figure 5—source data 1</xref>.</p><p><supplementary-material id="fig5sdata1"><label>Figure 5—source data 1.</label><caption><title>Source data for data shown in <xref ref-type="fig" rid="fig5">Figure 5</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-67464-fig5-data1-v4.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-67464-fig5-v4.tif"/></fig><p>We also investigated if post-burst afterhyperpolarizations would allow Cav2.3 channels to recover from inactivation and thus mediate increased Ca<sup>2+</sup>-entry during the first APs after the burst. We first determined the recovery from inactivation of Cav2.3 channels co-expressed with α2δ1 and β4 or β2a using a square-pulse protocol (<xref ref-type="fig" rid="fig5">Figure 5C</xref>, <xref ref-type="table" rid="table2">Table 2</xref>; 1 s conditioning prepulse to V<sub>max</sub> to inactivate Cav2.3 channels followed by a 10 ms step to V<sub>max</sub> after different time periods at –89 mV). About 30% of currents recovered under these experimental conditions after 1.5 s at –89 mV with both co-expressed β4 and β2a (~sixfold increase of the remaining I<sub>Ca</sub> after 1 s at V<sub>max</sub>). In contrast, recovery during the hyperpolarizing pause after the burst of the AP protocol was much less pronounced (β4) or absent (β2a, β2e; <xref ref-type="fig" rid="fig5">Figure 5B</xref>, right panel). This may be due to the different pulse protocols inducing channel inactivation over different time periods and may stabilize inactivated states with different recovery times.</p><table-wrap id="table2" position="float"><label>Table 2.</label><caption><title>Recovery from inactivation of Cav2.3 channels co-transfected with either β2a or β4 in combination with α2δ1 in tsA-201 cells.</title><p><supplementary-material id="table2sdata1"><label>Table 2—source data 1.</label><caption><title>Source data for data shown in <xref ref-type="table" rid="table2">Table 2</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-67464-table2-data1-v4.xlsx"/></supplementary-material></p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom" colspan="6">Cav2.3 - recovery from inactivation 2 mM Ca<sup>2+</sup></th></tr><tr><th align="left" valign="bottom">β-subunit</th><th align="left" valign="bottom">r100 [%]</th><th align="left" valign="bottom">r1500 [%]</th><th align="left" valign="bottom">r4000 [%]</th><th align="left" valign="bottom">r10000 [%]</th><th align="left" valign="bottom">n</th></tr></thead><tbody><tr><td align="left" valign="bottom">β2a</td><td align="char" char="plusmn" valign="bottom">15.7±2.4</td><td align="char" char="plusmn" valign="bottom">39.3±4.6</td><td align="char" char="plusmn" valign="bottom">53.4<break/>±4.5</td><td align="char" char="plusmn" valign="bottom">74.2±3.6</td><td align="char" char="." valign="bottom">17</td></tr><tr><td align="left" valign="bottom">β4</td><td align="char" char="plusmn" valign="bottom">12.7±1.7</td><td align="char" char="plusmn" valign="bottom">35.6±2.4</td><td align="char" char="plusmn" valign="bottom">51.3<break/>±2.8</td><td align="char" char="plusmn" valign="bottom">72.0±1.9</td><td align="char" char="." valign="bottom">9</td></tr></tbody></table></table-wrap><p>Taken together, these data predict that β2a- and β2e-associated Cav2.3 channels can contribute to enhanced Ca<sup>2+</sup>-entry during brief burst activity but not during post-burst APs.</p></sec><sec id="s2-5"><title>Steady-state activation and inactivation of R-type currents in mouse DA neurons</title><p>We have recently shown in whole-cell patch-clamp recordings that 100 nM SNX-482 inhibit ~30% of total Cav currents in mouse SN DA neurons (<xref ref-type="bibr" rid="bib4">Benkert et al., 2019</xref>) when stimulated from a negative holding potential of –70 mV. If V<sub>0.5,inact</sub> of Cav2.3 channels in SN DA neurons is indeed stabilized at more positive potentials, then the voltage-dependent inactivation of the R-type currents should allow a fraction of channels to be available even at voltages positive to –40 mV.</p><p>Using whole-cell patch-clamp recordings (<xref ref-type="fig" rid="fig6">Figure 6</xref>), we therefore measured the steady-state inactivation of R-type I<sub>Ca</sub> in identified SN DA neurons in mouse midbrain slices. First, R-type current (i.e. current reminaing after blocking other Cav channels) was isolated as reported in previous publications by preincubation of slices with selective inhibitors of Cav1 (1 µM ISR), Cav2 (Cav2.1, Cav2.2; 1 µM ω-conotoxin MVIIC) and Cav3 (10 µM Z941) (<xref ref-type="fig" rid="fig6">Figure 6A</xref>, blue traces/symbols, see also methods section). R-type current evoked from –100 mV activated at ~8 mV more positive voltages than total I<sub>Ca</sub> (<xref ref-type="fig" rid="fig6">Figure 6A</xref>, <xref ref-type="table" rid="table3">Table 3</xref> for statistics). This observation is in accordance with the positive activation voltage-range of Cav2.3e channels measured in tsA-201 cells. The R-type current V<sub>0.5,inact</sub> was ~5 mV more positive compared to total I<sub>Ca</sub> (–47.5 mV vs. –52.7 mV; <xref ref-type="fig" rid="fig6">Figure 6A</xref>, <xref ref-type="table" rid="table3">Table 3</xref>) and therefore ~7 mV more negative than recombinant Cav2.3 currents expressed with β2a or β2e subunits (~ –40 mV, <xref ref-type="table" rid="table1">Table 1</xref>) and ~23–29 mV more positive than recombinant Cav2.3 currents expressed with β4 or β3. Since R-type currents may include current components not mediated by Cav2.3 (<xref ref-type="bibr" rid="bib59">Newcomb et al., 1998</xref>; <xref ref-type="bibr" rid="bib82">Sochivko et al., 2002</xref>; <xref ref-type="bibr" rid="bib88">Tottene et al., 2000</xref>; <xref ref-type="bibr" rid="bib95">Wilson et al., 2000</xref>), we also isolated SNX-482-sensitive currents, which must be mediated by Cav2.3 (<xref ref-type="bibr" rid="bib99">Zamponi et al., 2015</xref>) by subtracting current remaining in the presence of SNX-482 from control current (<xref ref-type="fig" rid="fig6">Figure 6B</xref>). Although the slope of the voltage-dependence of activation was different for the SNX-482-sensitive current as compared to R-type current, steady-state inactivation was again observed at significantly more positive voltages as compared to control current (–44.6 mV vs. –52.9 mV, <xref ref-type="fig" rid="fig6">Figure 6B</xref>, <xref ref-type="table" rid="table3">Table 3</xref>), and ~5 mV more negative than recombinant Cav2.3 currents associated with β4 or β3 (<xref ref-type="table" rid="table3">Table 3</xref>). Although these experiments do not directly prove the contribution of β2a and/or β2e to R-type current in SN DA neurons, the strong requirement of β-subunits for Cav2.3 channel activity and the inability of other cytosolic β-subunit variants to account for the observed voltage-dependence of R-type current (<xref ref-type="fig" rid="fig1">Figure 1A and B</xref>) strongly suggests a contribution of these membrane-associated β-subunits for preventing complete inactivation of Cav2.3-mediated currents during typical activity patterns in these cells.</p><fig-group><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>Voltage-dependence of gating of R-type currents in mouse SN DA neurons recorded in brain slices.</title><p>(<bold>A</bold>) I<sub>Ca</sub> recorded in SN DA neurons without (Control, black, n=16) or after preincubation (&quot;R-type&quot;, blue, n=19) of slices with a Cav channel blocker cocktail to inhibit Cav3 (10 µM Z941), Cav1 (1 µM I), Cav2.1 and Cav2.2 (1 µM ω-conotoxin-MVIIC) (see Methods). Left panel: representative current traces of recordings at –20 mV test potentials (holding potential –100 mV); notice that similar amplitudes of control and R-type current were chosen to facilitate comparison of current kinetics. Right panel: voltage-dependence of steady-state activation and inactivation, curve fits to a Boltzman equation of all individual data points are shown. Data are means ± SEM. For parameters and statistics see <xref ref-type="table" rid="table3">Table 3</xref>. (<bold>B</bold>). SNX-482-sensitive currents (light blue) were obtained by subtracting current measured in the presence of SNX-482 (green) from the respective control I<sub>Ca</sub> before addition of SNX-482 (black) (n=9). Left panel: Representative recording of a SNX-482 sensitive current component compared to the respective control (holding potential –100 mV, –10 mV test potential). Steady-state activation and inactivation of control and SNX-482-sensitive current. Test protocols: holding potential –100 mV; voltage-dependence of activation: 150 ms test potentials to indicated voltages; voltage-dependence of inactivation: 5 s conditioning pulses to indicated voltages preceded (I<sub>control</sub>) and followed by 20 ms test pulses to V<sub>max</sub>. (<bold>C</bold>) Exemplary neuron as seen under the patch-clamp microscope with patch pipette next to it (left; BF, brightfield) and a neuron after histochemical staining for tyrosine hydroxylase (TH, green) and neurobiotin (Nb, red). Detailed parameters and statistics are given in <xref ref-type="table" rid="table3">Table 3</xref>. Source data provided in <xref ref-type="supplementary-material" rid="fig6sdata1">Figure 6—source data 1</xref>.</p><p><supplementary-material id="fig6sdata1"><label>Figure 6—source data 1.</label><caption><title>Source data for data shown in <xref ref-type="fig" rid="fig6">Figure 6</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-67464-fig6-data1-v4.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-67464-fig6-v4.tif"/></fig><fig id="fig6s1" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 1.</label><caption><title>Inhibition of I<sub>Ca</sub> in SN DA neurons of adult (12 weeks) mice by 100 nM SNX-482.</title><p>To further prove the presence of SNX-482-sensitive R-type currents in SN DA neurons, we performed perforated-patch recordings. These allow stable recordings over a long period of time and to test for reversibility of channel block by 100 nM SNX-482. Recordings were performed with the pulse protocol shown in A (holding potential –60 mV) after blocking I<sub>A</sub> K<sup>+</sup>-currents known to be present in these cells to exclude block of I<sub>A</sub> by SNX-482 (<xref ref-type="bibr" rid="bib41">Kimm and Bean, 2014</xref>) as described previously (<xref ref-type="bibr" rid="bib4">Benkert et al., 2019</xref>). 100 nM SNX-482 significantly reduced current to 87% ± 4% of control I<sub>Ca</sub> (n=8, p=0.012, one-sample t-test, for statistics see <xref ref-type="supplementary-material" rid="supp7">Supplementary file 7</xref>) and this inhibition was slowly reversible. (<bold>A</bold>) I<sub>Ca</sub> before (black), during (red) and after (blue) SNX-482 application. (<bold>B</bold>) Example of peak I<sub>Ca</sub> plotted over time during SNX-482 application. The asterisks mark the time points of the recordings shown on the left. Single depolarizing voltage steps to 0 mV were applied from a holding potential of –60 mV every 10 s. (<bold>C</bold>) Mean effect of SNX-482 on peak I<sub>Ca</sub>. *, p&lt;0.05 (n=8; two-tailed paired t-test). (<bold>D</bold>) Remaining peak I<sub>Ca</sub> after SNX-482 inhibition. *, p&lt;0.05 (two-tailed one sample t-test). Box plots: Whiskers indicate minimal and maximal values, ‘+’-sign: mean, horizontal line: median. No complete concentration-response curves were generated since higher concentrations of SNX-482 are known to also inhibit other Cav channels (<xref ref-type="bibr" rid="bib10">Bourinet et al., 2001</xref>; <xref ref-type="bibr" rid="bib59">Newcomb et al., 1998</xref>). Therefore, our experiments may underestimate the overall contribution of Cav2.3 channel to total I<sub>Ca</sub>, also because a fraction of channels must already be inactivated at the selected holding potential (–60 mV) of these experiments. (<bold>E–H</bold>) Under identical experimental conditions, nifedipine reduced I<sub>Ca</sub> to 90% ± 1.4% of control (p=0.031, Wilcoxon-test, for statistics see <xref ref-type="supplementary-material" rid="supp7">Supplementary file 7</xref>), and this inhibition was fully reversible. (<bold>E</bold>) Perforated patch-clamp recording of I<sub>Ca</sub> before (black), during (red) and after (blue) nifedipine application. (<bold>F</bold>) Example of peak I<sub>Ca</sub> plotted over time during nifedipine application. The asterisks mark the time points of the recordings shown on the left. Single depolarizing voltage steps to –10 mV were applied from a holding potential of –60 mV every 10 s. (<bold>G</bold>) Mean effect of nifedipine on peak I<sub>Ca</sub>. *, p&lt;0.05 (n=6; two-tailed paired t-test). (<bold>H</bold>) Remaining peak I<sub>Ca</sub> under nifedipine. p&lt;0.05 (two-tailed Wilcoxon signed-rank test). Box plots: Whiskers indicate minimal and maximal values, ‘+’-sign: mean, horizontal line: median. For statistics see <xref ref-type="supplementary-material" rid="supp7">Supplementary file 7</xref>. (<bold>I</bold>) Current clamp recording of a DA neuron in the SN pars compacta to demonstrate the pre-identifying electrophysiological properties including sag potential during hyperpolarization, broad action potentials, and regular pacemaking. Arrowhead: largely reduced slow afterhyperpolarization due to partial block of K<sup>+</sup> channels by Cs<sup>+</sup> diffusion into the neuron during the perforation process. (<bold>J</bold>) Post-recording analysis shows co-localization of biocytin (recorded neuron; magenta) and tyrosine hydroxylase (TH, green). Source data provided in <xref ref-type="supplementary-material" rid="fig6s1sdata1">Figure 6—figure supplement 1—source data 1</xref>.</p><p><supplementary-material id="fig6s1sdata1"><label>Figure 6—figure supplement 1—source data 1.</label><caption><title>Source data for data shown in <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1</xref>, panels C, D and G, H.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-67464-fig6-figsupp1-data1-v4.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-67464-fig6-figsupp1-v4.tif"/></fig></fig-group><table-wrap id="table3" position="float"><label>Table 3.</label><caption><title>Voltage-dependence of activation and inactivation of Ca<sup>2+</sup>-currents in SN DA neurons.</title><p><supplementary-material id="table3sdata1"><label>Table 3—source data 1.</label><caption><title>Source data for data shown in <xref ref-type="table" rid="table3">Table 3</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-67464-table3-data1-v4.xlsx"/></supplementary-material></p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom" rowspan="2"/><th align="left" valign="bottom" colspan="3">Activation</th><th align="left" valign="bottom" colspan="3">Inactivation</th></tr><tr><th align="left" valign="bottom">V<sub>0.5,act</sub> (95% CI) [mV]</th><th align="left" valign="bottom">k<sub>act</sub> (95% CI) [mV]</th><th align="left" valign="bottom">n/N</th><th align="left" valign="bottom">V<sub>0.5, inact</sub> (95% CI) [mV]</th><th align="left" valign="bottom">k<sub>inact</sub> (95% CI) [mV]</th><th align="left" valign="bottom">n/N</th></tr></thead><tbody><tr><td align="left" valign="bottom"><bold>Control A</bold><break/>(without Cav-blocker cocktail)</td><td align="left" valign="bottom">–37.8 (−39.3,–36.3)</td><td align="left" valign="bottom">9.17 (7.90, 10.6)</td><td align="left" valign="bottom">16/8</td><td align="left" valign="bottom">–52.7 (−53.9,–51.5)</td><td align="left" valign="bottom">10.5 (−11.6,–9.48)</td><td align="left" valign="bottom">16/8</td></tr><tr><td align="left" valign="bottom"><bold>+Cav blocker cocktail</bold><break/>(&quot;R-type&quot;)</td><td align="left" valign="bottom">–29.9 (−30.8,–29.1)***</td><td align="left" valign="bottom">5.49 (4.73, 6.30)***</td><td align="left" valign="bottom">19/5</td><td align="left" valign="bottom">–47.5 (−48.7,–46.4)***</td><td align="left" valign="bottom">9.15 (−10.2,–8.16)</td><td align="left" valign="bottom">19/5</td></tr><tr><td align="left" valign="bottom"><bold>Control B</bold><break/>(before SNX-482)</td><td align="left" valign="bottom">–34.4 (−35.7,–33.2)</td><td align="left" valign="bottom">9.68 (8.59, 10.8)</td><td align="left" valign="bottom">9/6</td><td align="left" valign="bottom">–52.9 (−53.7,–52.1)</td><td align="left" valign="bottom">9.30 (−10.9,–8.61)</td><td align="left" valign="bottom">9/6</td></tr><tr><td align="left" valign="bottom"><bold>SNX-482 - sensitive current</bold></td><td align="left" valign="bottom">–34.9 (−37.7,–32.0)</td><td align="left" valign="bottom">10.6 (8.26, 13.3)</td><td align="left" valign="bottom">9/6</td><td align="left" valign="bottom">–44.6 (−46.9,–42.2)<sup>+++</sup></td><td align="left" valign="bottom">10.1 (−12.1,–8.24)</td><td align="left" valign="bottom">9/6</td></tr></tbody></table></table-wrap><p>We independently also tested the availability of SNX-482-sensitive R-type currents at more depolarized voltages using perforated patch recordings (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1</xref>), which allow very stable recordings in identified SN DA neurons (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1I, J</xref>). We held cells at a more positive holding potential of –60 mV, a voltage within the spontaneous depolarization phase of the ISI, where a substantial fraction of Cav2.3 channels must already be inactivated (<xref ref-type="fig" rid="fig6">Figure 6</xref>). Indeed, under these conditions still about 13% of the total I<sub>Ca</sub> was inhibited by acute bath application of SNX-482 and inhibition was partially reversible upon washout (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1A-D</xref>, <xref ref-type="supplementary-material" rid="supp7">Supplementary file 7</xref>). Under these conditions, about 10% of current were blocked reversibly by the L-type channel blocker nifedipine (10 µM, <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1E-H</xref>).</p><p>To further confirm the presence of inactivation-resistant R-type currents, we also recorded SNX-482-sensitive Ca<sup>2+</sup> currents elicited from a holding potential of –70 mV in primary cultures of mouse DA midbrain neurons after 8–9 days in vitro. When added after the complete block of LTCC currents by 3 µM isradipine (comprising 24.7% ± 4.2% of total Ca<sup>2+</sup>-current, n=15), 100 nM SNX-482 significantly reduced non-LTCC currents by 41% ± 4% (95% CI: 33–49, n=20, N=4, paired Student’s t-test; <italic>P</italic>&lt;0.001) (<xref ref-type="fig" rid="fig7">Figure 7A–D</xref>). All residual I<sub>Ca</sub> components were blocked by adding 2 μM Cd<sup>2+</sup> to the bath solution (<xref ref-type="fig" rid="fig7">Figure 7A and B</xref>).</p><fig-group><fig id="fig7" position="float"><label>Figure 7.</label><caption><title>SNX-482–sensitive R-type currents in cultured mouse midbrain DA neurons.</title><p>(<bold>A</bold>) Representative traces illustrating the inhibition of non-L-type ICa by 100 nM SNX-482 (red). Cells were initially perfused with a bath solution containing 3 μM isradipine (black). Full block was obtained using 2 μM Cd<sup>2+</sup> (blue). Square pulses (50 ms) were applied to 0 mV from a holding potential of –70 mV (top) (<bold>B</bold>) Current amplitude values plotted as a function of time. After stabilization of ICa with ISR (black circles), 100 nM SNX-482 was applied. The remaining currents was blocked by 2 μM Cd<sup>2+</sup>. Current run-down in the absence of drugs during 150 s was less than 1% (0.48 ± 0.18%; n=4 cells). (<bold>C</bold>) SNX-482 inhibition expressed as % of control I<sub>Ca</sub> after LTCC block using 3 μM ISR. (<bold>D</bold>) Mean current amplitude at the end of ISR application and at the end of SNX-482 application. Absolute current amplitude decreased from 529±57 pA (95% CI: 409–649) to 313±33 pA (95% CI: 245–381, n=20, p&lt;0.01, paired Students t-test). Data represent the means ± SEM for the indicated number of experiments (N=4). Statistical significance was determined using paired Student’s t-test: *** p&lt;0.001; **p&lt;0.01; *p&lt;0.05. (<bold>E</bold>) Left: Depolarizations of 50 ms were repeated every 10 s to the indicated potentials from a holding potential of –70 mV (inset). The voltage dependence of the conductance, g(V), was calculated with the equation g(V)=I<sub>Ca</sub>/(V− E<sub>Ca</sub>) with E<sub>Ca</sub>=+65 mV for the currents recorded in the presence of 3 µM ISR (control; black squares; n=9–14 per voltage) and after subtraction of the currents insensitive to 100 nM SNX-482 (n=4–7) to yield (SNX-sensitive R-type; blue circles). Data were fitted to a Boltzman function. At each test potential (V) I<sub>Ca</sub> was estimated at the peak of the current trace. Right: representative current traces recorded during pulses to −50, –40, –30 and 0 mV. (<bold>F</bold>). Left: To determine the voltage-dependence of steady-state inactivation, test pulses of 50 ms to 0 mV were preceded by 1 min prepulses to voltages from –80 to –10 mV. This stimulation protocol (inset) was better tolerated by cultured DA midbrain neurons than the classical protocol used previously with other cells (<xref ref-type="bibr" rid="bib15">Calorio et al., 2019</xref>; <xref ref-type="bibr" rid="bib67">Pinggera et al., 2015</xref>). SNX-sensitive R-type currents (blue) were obtained after subtraction of the currents insensitive to 100 nM SNX-482 (n=3–8 per voltage) from non-L control current (black, n=8–15). Right: representative traces recorded at 0 mV from a holding potential of −20,–40, –60, and –80 mV. Inactivation curves could be best fit to Boltzman functions with the following parameters: R-type: V<sub>0.5,inact</sub> = -58.1±0.6 mV, k=–7.1 ± 1.2 mV; control: V<sub>0.5,inact</sub> = -48.0±0.9 mV, k=-11.1 ± 1.2 mV. The R-type currents (<bold>E, F</bold>) appear smaller than expected from the data in panels B and C (30–40% of non-L-type currents). This is due to a run-down of SNX-sensitive current during the repeated depolarizations used to determine the voltage-dependence of gating. This has only minimal effects on gating parameters. When accounting for a linear run-down of 40%, the V<sub>0.5,act</sub> would shift only from –58 to –56 mV. Source data provided in <xref ref-type="supplementary-material" rid="fig7sdata1">Figure 7—source data 1</xref>.</p><p><supplementary-material id="fig7sdata1"><label>Figure 7—source data 1.</label><caption><title>Source data for data shown in <xref ref-type="fig" rid="fig7">Figure 7</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-67464-fig7-data1-v4.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-67464-fig7-v4.tif"/></fig><fig id="fig7s1" position="float" specific-use="child-fig"><label>Figure 7—figure supplement 1.</label><caption><title>SNX-482 effects on pacemaking of cultured mouse midbrain DA neurons.</title><p>(<bold>A</bold>) Representative recording of spontaneous firing activity of cultured midbrain dopaminergic neurons before, during and after the application (wash-out) of 100 nM SNX-482. Below, enlargements of action potentials within the highlighted regions are shown. (<bold>B</bold>) Firing frequency [Hz], coefficient of variation of the interspike interval [%], and AHP peak [mV] before (control) and during the application of 100 nM SNX-482. Data represent the means ± SEM for the indicated number of experiments. Statistical significance was determined using paired Student’s t-test.: *** p&lt;0.001; ** p&lt;0.01; * p&lt;0.05. (<bold>C</bold>) Left panel: Phase-plane plot analysis (time derivative of voltage (dV/dt) vs. voltage (<bold>V</bold>)) before (control) and during the application of 100 nM SNX-482. Right panel: corresponding AP trace in control and in the presence of SNX-482 (obtained from trace in panel A, as indicated by the asterisks). SNX-482 significantly reduced the spontaneous firing frequency from 4.1±0.8 Hz (control, n=10, N=3; 95% CI: 2.1–6.1) to 1.1±0.2 Hz (SNX-482, n=10, 95% CI: 0.2–2.1, p=0.0036, paired Student’s t-test) and decreased the regularity of pacemaking coefficient of variation of the mean interspike interval increased from 0.25±0.06 (control, 95% CI: 0.15–0.39) to 0.78±0.13 (SNX-482, 95% CI: 0.49–1.09, p=0.0032, paired Student’s t-test). Slowing of firing was associated with hyperpolarization of the most negative voltage reached during the afterhyperpolarization (AHP) immediately after the spike (AHP peak), which decreased from –43.2±1.3 mV (control, 95% CI: –45.8––40.7) to –47.0±1.2 mV (SNX-482, 95% CI: –49.4 to –44.6, p=0.0005, paired Student’s t-test). Other changes in the AP waveform, which could represent indirect effects from the slowing of AP frequency or result from inhibition of Cav2.3 channels, were also noted: a reduced mean AP half-width (control: 5.1±0.3ms, 95% CI: 4.4–5.8; SNX-482: 4.2±0.3ms, 95% CI: 3.7–4.8; p=0.0050, paired Student’s t-test), and a trend toward increased maximum time-derivative of voltage (control: 45.3±4.9 mV/ms, 95% CI: 34.4–56.3; SNX-482: 74.3±13.5 mV/ms, 95% CI: 47.0–101.5, p=0.0625, paired Student’s t-test, estimated from the phase-plane plot of in C). The latter is likely due to the recruitment of more voltage-gated Na<sup>+</sup>-channels during the AP onset from the more hyperpolarized interspike membrane potential (<xref ref-type="bibr" rid="bib30">Guarina et al., 2018</xref>; <xref ref-type="bibr" rid="bib87">Tomagra et al., 2019</xref>). Source data provided in <xref ref-type="supplementary-material" rid="fig7s1sdata1">Figure 7—figure supplement 1—source data 1</xref>.</p><p><supplementary-material id="fig7s1sdata1"><label>Figure 7—figure supplement 1—source data 1.</label><caption><title>Source data for data shown in <xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1</xref>, panel B.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-67464-fig7-figsupp1-data1-v4.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-67464-fig7-figsupp1-v4.tif"/></fig></fig-group><p>We also determined the voltage-dependence of steady-state activation (<xref ref-type="fig" rid="fig7">Figure 7E</xref>) and inactivation (<xref ref-type="fig" rid="fig7">Figure 7F</xref>) before (non-L, control) and during application of 100 nM SNX-482 and calculated parameters for the SNX-482-sensitive R-type current by subtracting the current resistant to 100 nM SNX-482 from the control current (legend to <xref ref-type="fig" rid="fig7">Figure 7</xref> for details). SNX-482-sensitive currents (blue) activated with a half maximal activation voltage (V<sub>0.5,act</sub> –9.2±0.6 mV) slightly more positive than non-LTCC current (V<sub>0.5,inact</sub> = -12.5 ± 0.6 mV). To determine the steady-state inactivation, test pulses of 50 ms to 0 mV were preceded by 1 min prepulses to voltages from –80 to –10 mV (<xref ref-type="fig" rid="fig7">Figure 7F</xref>). SNX-482-sensitive current inactivation was best fit with a V<sub>0.5,inact</sub> of –58.1±0.6 mV, which was 12–18 mV more positive than recombinant Cav2.3 currents expressed with β4 or β3 (<xref ref-type="table" rid="table1">Table 1</xref>). Despite an ~13 mV more negative inactivation range compared to SN DA neurons (<xref ref-type="fig" rid="fig6">Figure 6</xref>, <xref ref-type="table" rid="table3">Table 3</xref>), this still allowed substantial channel availability at voltages positive to –50 mV (<xref ref-type="fig" rid="fig7">Figure 7F</xref>, in contrast to currents with co-expressed cytosolic β-subunits <xref ref-type="fig" rid="fig1">Figure 1D</xref>).</p><p>Finally, we tested if SNX-482 also affects the spontaneous AP firing of these cultured midbrain neurons. In current-clamp recordings 100 nM SNX-482 significantly reduced the spontaneous firing frequency from 4.1±0.8 Hz (control, n=10, N=3; 95% CI: 2.1–6.1) to 1.1±0.2 Hz (SNX-482, n=10, 95% CI: 0.2–2.1, p=0.0036, paired Student’s t-test; <xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1A, B</xref>), decreased the regularity of pacemaking and also caused changes in AP shape (<xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1A-C</xref>). Cav2.3-mediated currents may therefore also contribute to the pacemaking cycle in cultured DA neurons.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>Although the modulation of Cavs by β-subunits and the characteristic gating changes induced by N-terminally membrane-anchored β2-subunit splice variants have been well described in the literature, the physiological significance of these findings remained underexplored. Here, we provide strong evidence for an important role of β-subunit alternative splicing for Cav2.3 Ca<sup>2+</sup>-channel signaling during continuous SN DA neuron-like regular pacemaking activity. We show that only membrane-bound β2a and β2e stabilize Cav2.3 channel complexes with voltage-dependent inactivation properties preventing complete inactivation during the on-average depolarized membrane potentials encountered during the pacemaking cycle. This cannot only explain our previous finding of a substantial contribution of SNX-482-sensitive R-type currents to activity-dependent somatic Ca<sup>2+</sup>-oscillations in SN DA neurons in brain slices (<xref ref-type="bibr" rid="bib4">Benkert et al., 2019</xref>) but also to pacemaking in cultured DA neurons. We also provide evidence for the expression of β2a and β2e subunit splice variants in highly vulnerable mouse SN DA and in more resistant VTA DA neurons. Together with our finding that R-type currents in SN DA neurons are available within a voltage-range more positive than expected for association with β4-, β3- or other cytosolic β2-subunits, our data strongly suggest that β2a and β2e contribute to non-inactivating Cav2.3 R-type currents required for normal DA neuron function. This may therefore also be of pathophysiological relevance given the previously reported pathogenic potential of Cav2.3 Ca<sup>2+</sup>-channels in PD pathophysiology (<xref ref-type="bibr" rid="bib4">Benkert et al., 2019</xref>).</p><p>The large shift of V<sub>0.5,inact</sub> of Cav2.3 R-type current by membrane-anchored β2a and β2e subunits would predict that Cav2.3 channel availability can be adjusted along a wide range of potentials (about 30 mV; V<sub>0.5,inact</sub> –40 to –70 mV, <xref ref-type="table" rid="table1">Table 1</xref>) just by varying the abundance and local availability of these subunits relative to cytosolic β-subunits within a cell or nanodomain. This range is also reflected by an ~11–14 mV difference in V<sub>0.5,inact</sub> of R-type currents in our recordings from mouse midbrain DA neurons in culture and ex vivo slice recordings from SN DA neurons. However, the voltage-range of steady-state inactivation in both preparations is clearly more positive than predicted from heterologous expression with β4- or β3-subunits. This could be due to a different contribution of β2a and/or β2e to Cav2.3 channel complexes in these preparations. Our data predict that this contribution is higher in SN DA neurons than in cultured cells.</p><p>Our quantitative PCR analysis of β-subunit expression demonstrate that, although β4 (60%) is the predominant one in the SN and VTA, β2-subunit transcripts are also abundant and comprise about 27% of all β-subunits. These data are in excellent agreement with RNAseq data from mouse midbrain DA neurons with expression levels of about 33% for β2% and 43% for β4 (<xref ref-type="bibr" rid="bib12">Brichta et al., 2015</xref>; <xref ref-type="bibr" rid="bib81">Shin, 2015</xref>) and transcriptomic analysis of laser-captured SN DA neurons from 18 human postmortem brains (30% β2, 45% β4; 15% β3, 8% β1; <xref ref-type="bibr" rid="bib1">Aguila et al., 2021</xref>). While these transcriptomic data do not provide quantitative information about the expression of β2-splice variants, we clearly demonstrated the presence of both membrane-bound isoforms in identified SN DA neurons using PCR and RNAscope analysis.</p><p>Our transcript data (and confirmatory RNAseq data) show that β2a and β2e are present in SN DA neurons but still represent only a small fraction of all β-subunits present. However, our experimental data find a positive inactivation voltage-range suggesting that a majority of SNX-482-sensitive channels is associated with these β-subunits. At present biochemical data regarding preferential targeting of β-subunits to specific subcellular neuronal compartments and/or Cav-subtypes is absent but cannot be excluded. For example, β4-subunits may extensively target to channels at axonal presynaptic locations (as reported in cultured hippocampal neurons) or even to the nucleus (where they regulate gene transcription) and thus contribute less to Cav2.3 channel complexes at somatodendritic sites (<xref ref-type="bibr" rid="bib21">Etemad et al., 2014</xref>). Moreover, differences in the affinity of β-subunits for their α1-subunit interaction domain in the I-II-linker may also support preferential association with β2 (<xref ref-type="bibr" rid="bib17">De Waard et al., 1995</xref>).</p><p>Based on the finding that β-subunit association is required for expression of robust Cav2.3 channel currents (<xref ref-type="fig" rid="fig1">Figure 1A</xref>, <xref ref-type="table" rid="table1">Table 1</xref>), they must also play a key role in determining the gating properties of individual channel complexes. However, this does not exclude a modulatory role of other posttranslational modifications of Cav2.3 channels or protein interaction partners expressed at somatodendritic locations of SN DA neurons that could enhance Cav2.3 availability at more positive membrane potentials (such as Rab3-interacting proteins at axonal sites, <xref ref-type="bibr" rid="bib42">Kiyonaka et al., 2007</xref>; <xref ref-type="bibr" rid="bib73">Robinson et al., 2019</xref>).</p><p>A limitation of our work is that we cannot provide direct proof for a role of β2-subunit splice variants for R-type current modulation in DA neurons. Direct proof for the existence of such complexes would require biochemical studies requiring immunoprecipitation of Cav2.3 complexes from laser-dissected SN DA neurons. However, such studies, as well as other approaches, such as proximity ligation assays are hampered by the fact, that suitable β2-splice variant-specific antibodies are not available. We also found no suitable combination of antibodies raised in different species for such studies. Two mouse anti-β2 (not even splice variant-specific) antibodies that could be combined with our previously used rabbit anti-Cav2.3 α1 subunit antibody turned out to bind to other nonspecific bands or cross-reacted with β3 (not shown, data available upon request). Alternatively, direct proof for a role of β2-subunit splice variants could be obtained by a splice variant-specific gene knockout or siRNA-mediated knock-down of both β2a and β2e subunits in SN DA neurons, followed by isolation of Cav2.3 current components or Ca<sup>2+</sup> transients of which only a fraction would be mediated by β2a/β2e-associated channels. This would be methodologically extremely challenging in these neurons.</p><p>We have previously shown that Cav2.3-knockout mice are protected from the selective loss of SN DA neurons in the chronic MPTP/probenecid PD model (<xref ref-type="bibr" rid="bib4">Benkert et al., 2019</xref>). At least in this rodent model of PD, the observed protection provides strong evidence for a role of these channels in PD pathology. Pharmacological inhibition of Cav2.3 alone or together with other Cavs may therefore confer beneficial disease-modifying effects and a novel approach for neuroprotection in PD. The recent failure of the LTCC blocker ISR in the STEADY-PD III trial (<xref ref-type="bibr" rid="bib36">Investigators, 2020</xref>) to prevent disease progression in early PD patients indicates that inhibition of LTCCs alone may not be sufficient for neuroprotection. Our previous preclinical findings identified also Cav2.3 channels as novel drug targets for neuroprotective PD-therapy. Therefore, the inhibition of Cav2.3 in addition to Cav1.3 may be required for clinically meaningful neuroprotection. However, Cav2.3-mediated R-type currents are notoriously drug-resistant (<xref ref-type="bibr" rid="bib78">Schneider et al., 2013</xref>), and so far no selective potent small-molecule Cav2.3/R-type blocker has been reported.</p><p>Our findings reported here provide the rationale for exploring novel neuroprotective strategies based on Cav2.3 channel inhibition. These could take advantage of the predicted strong dependence of continuous Cav2.3 channel activity on gating properties such as those stabilized by β2a and/or β2e. Rather than inhibiting Ca<sup>2+</sup>-entry through the pore-forming α1-subunit, such a strategy could aim at reducing its contribution to the R-type current component persisting during continuous activity in SN DA neurons by interfering with the association of β2a and β2e subunits. Even if other β-subunits would replace them in the channel complex and ensure its stable expression, our data suggest that they would not be able to shift the steady-state inactivation voltage into the operating voltage-range of SN DA neurons like β2a and β2e. Such an approach appears realistic due to the availability of novel genetically encoded Ca<sup>2+</sup>-channel inhibitors for a cell-type-specific gene therapeutic intervention. One such approach (CaVablator) has elegantly been used to specifically target Ca<sup>2+</sup>-channel β-subunits for degradation by fusing β-specific nanobodies with the catalytic HECT domain of Nedd4L, an E3 ubiquitin ligase (<xref ref-type="bibr" rid="bib56">Morgenstern et al., 2019</xref>). This strongly reduces Cav1- and Cav2-mediated Ca<sup>2+</sup>-currents in different cell types. At present, it is unclear to which extent other high-voltage-activated Cav2 channels (Cav2.1, Cav2.2) also contribute to the high vulnerability of SN DA neurons. However, our recent quantitative RNAscope analyses in mature SN DA neurons (<xref ref-type="bibr" rid="bib4">Benkert et al., 2019</xref>) clearly demonstrate that Cav2.3 α1-subunit (<italic>Cacna1e</italic>) transcripts are the most abundant α1-subunit expressed in these cells, in excellent agreement with cell-type-specific RNAseq data of identified midbrain DA neurons (<xref ref-type="bibr" rid="bib12">Brichta et al., 2015</xref>; <xref ref-type="bibr" rid="bib81">Shin, 2015</xref>).</p><p>We also show that in cultured mouse DA neurons, 100 nM SNX-482 slows pacemaking. While SNX-482 is highly suitable to isolate Cav2.3-mediated Ca<sup>2+</sup> current components, effects on pacemaking also must take into account that this toxin is also a potent blocker of Kv4.3 channels (<xref ref-type="bibr" rid="bib41">Kimm and Bean, 2014</xref>) underlying A-type K<sup>+</sup>-currents (I<sub>A</sub>). 60 nM nearly fully block reconstituted Kv4.3 currents in HEK cells (IC<sub>50</sub> ~3 nM). Therefore, one can argue that in current-clamp recordings, 50–300 nM SNX-482 could alter pacemaking or the AP shape by effectively blocking Kv4.3 channels. However, the observed SNX-482-induced shortening of APs and the reduction of spontaneous firing are difficult to reconcile with a block of I<sub>A</sub> channels, which typically induces a broadening of APs in several neuronal preparations (<xref ref-type="bibr" rid="bib40">Kim et al., 2005</xref>) and an increased frequency in DA neurons (<xref ref-type="bibr" rid="bib48">Liss et al., 2001</xref>).</p><p>Therefore, the observed SNX-482 effects in cultured neurons provided no final answer to the question about a potential role of Cav2.3 on pacemaking. In brain slices of Cav2.3 knockout mice, small changes in AP spike waveforms were observed, without major changes in pacemaking activity (<xref ref-type="bibr" rid="bib4">Benkert et al., 2019</xref>). Similarly, inconsistent findings for the contribution of LTCC currents for pacemaking in slice recordings (<xref ref-type="bibr" rid="bib18">Dragicevic et al., 2014</xref>; <xref ref-type="bibr" rid="bib31">Guzman et al., 2009</xref>; <xref ref-type="bibr" rid="bib54">Mercuri et al., 1994</xref>; <xref ref-type="bibr" rid="bib61">Ortner et al., 2017</xref>) and cultured neurons (<xref ref-type="bibr" rid="bib69">Puopolo et al., 2007</xref>) have been reported but the reasons for this remain unclear.</p><p>Despite providing no direct biochemical evidence, we here show the first example for a potential physiological and perhaps even pathophysiological role of β2-subunit alternative splicing emphasizing a need for further investigation in other types of neurons.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="top">Reagent type (species) or resource</th><th align="left" valign="top">Designation</th><th align="left" valign="top">Source or reference</th><th align="left" valign="top">Identifiers</th><th align="left" valign="top">Additional information</th></tr></thead><tbody><tr><td align="left" valign="top">Mouse strain:C57Bl/6N, C57Bl/6J</td><td align="left" valign="top">C57Bl/6N, C57Bl/6J</td><td align="left" valign="top">Charles River</td><td align="left" valign="top">C57Bl/6N, C57Bl/6J</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Mouse strain:C57Bl/6-TH-GFP mice</td><td align="left" valign="top">C57Bl/6-TH-GFP</td><td align="left" valign="top"><xref ref-type="bibr" rid="bib52">Matsushita et al., 2002</xref>; <xref ref-type="bibr" rid="bib74">Sawamoto et al., 2001</xref></td><td align="left" valign="top"/><td align="left" valign="top">GFP-expression under TH-promotor</td></tr><tr><td align="left" valign="top">Transfected construct</td><td align="left" valign="top">Human Cav1.3<sub>L</sub> α1-subunit (C-terminally long Cav1.3 splice variant)</td><td align="left" valign="top"><xref ref-type="bibr" rid="bib43">Koschak et al., 2001</xref></td><td align="left" valign="top">GenBank accession number EU363339</td><td align="left" valign="top">Cloned into proprietary vector lacking GFP (&quot;GFP<sup>minus</sup>&quot;), described in <xref ref-type="bibr" rid="bib27">Grabner et al., 1998</xref></td></tr><tr><td align="left" valign="top">Transfected construct</td><td align="left" valign="top">Human Cav2.3 α1-subunit</td><td align="left" valign="top"><xref ref-type="bibr" rid="bib65">Pereverzev et al., 2002</xref></td><td align="left" valign="top"/><td align="left" valign="top">Cloned into pcDNA3 vector</td></tr><tr><td align="left" valign="top">Transfected construct</td><td align="left" valign="top">Rat β3-subunit</td><td align="left" valign="top"><xref ref-type="bibr" rid="bib43">Koschak et al., 2001</xref></td><td align="left" valign="top">GenBank: NM_012828,</td><td align="left" valign="top">Cloned into pCMV6 vector</td></tr><tr><td align="left" valign="top">Transfected construct</td><td align="left" valign="top">Rat β2a-subunit</td><td align="left" valign="top"><xref ref-type="bibr" rid="bib43">Koschak et al., 2001</xref></td><td align="left" valign="top">GenBank: M80545</td><td align="left" valign="top">Cloned into pCMV6 vector</td></tr><tr><td align="left" valign="top">Transfected construct</td><td align="left" valign="top">Mouse β2d-subunit</td><td align="left" valign="top">β2aN1, <xref ref-type="bibr" rid="bib47">Link et al., 2009</xref></td><td align="left" valign="top">GenBank: FM872408.1</td><td align="left" valign="top">Cloned into pCAGGS vector</td></tr><tr><td align="left" valign="top">Transfected construct</td><td align="left" valign="top">Mouse β2e-subunit</td><td align="left" valign="top">β2aN5, <xref ref-type="bibr" rid="bib47">Link et al., 2009</xref></td><td align="left" valign="top">GenBank: FM872407</td><td align="left" valign="top">Cloned into pCAGGS vector</td></tr><tr><td align="left" valign="top">Transfected construct</td><td align="left" valign="top"><sub>C3S/C4S</sub>β2a</td><td align="left" valign="top">Cysteine residues in position 3 and 4 of β2a replaced by serines, <xref ref-type="bibr" rid="bib25">Gebhart et al., 2010</xref></td><td align="left" valign="top"/><td align="left" valign="top">Cloned into pCMV6 vector</td></tr><tr><td align="left" valign="top">Transfected construct</td><td align="left" valign="top">Rat β4-subunit (splice variant β4e)</td><td align="left" valign="top"><xref ref-type="bibr" rid="bib21">Etemad et al., 2014</xref></td><td align="left" valign="top"/><td align="left" valign="top">Cloned into pβA vector</td></tr><tr><td align="left" valign="top">Cell line (<italic>Homo sapiens</italic>)</td><td align="left" valign="top">TsA-201 cells</td><td align="left" valign="top">European Collection of Authenticated Cell Cultures</td><td align="left" valign="top">ECACC, catalogue # 96121229, lot # 13D034</td><td align="left" valign="top">Tested Mycoplasma negative</td></tr><tr><td align="left" valign="top">Antibody</td><td align="left" valign="top">Anti-tyrosine hydroxylase (TH; rabbit polyclonal)</td><td align="left" valign="top">Merck Millipore</td><td align="left" valign="top">Cat#: 657012,</td><td align="char" char="." valign="top">1:1000</td></tr><tr><td align="left" valign="top">Commercial assay or kit</td><td align="left" valign="top">RNeasy Lipid Tissue Mini Kit</td><td align="left" valign="top">Qiagen GmbH, Germany</td><td align="left" valign="top">catalog # 1023539</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Commercial assay or kit</td><td align="left" valign="top">Phenol/guanidine-based Qiazol lysis reagent</td><td align="left" valign="top">Qiagen GmbH, Germany,</td><td align="left" valign="top">catalog # 79,306</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Commercial assay or kit</td><td align="left" valign="top">Maxima H Minus First Strand cDNA synthesis kit</td><td align="left" valign="top">Thermo Fisher Scientific, Waltham, MA, USA</td><td align="left" valign="top">catalog # K1682</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Commercial assay or kit</td><td align="left" valign="top">Quant-IT PicoGreen dsDNA Assay Kit</td><td align="left" valign="top">Thermo Fisher Scientific, Waltham, MA, USA</td><td align="left" valign="top">catalog # P7589</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Commercial assay or kit</td><td align="left" valign="top">Mycoplasma Detection Kit</td><td align="left" valign="top">ATCC</td><td align="left" valign="top">Universal Mycoplasma Detection Kit 30–1012 K</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Commercial assay or kit</td><td align="left" valign="top">TaqMan Universal PCR Master Mix</td><td align="left" valign="top">Thermo Fisher Scientific, Waltham, MA, USA</td><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Commercial assay or kit</td><td align="left" valign="top">RNAscope technology</td><td align="left" valign="top">Advanced Cell Diagnostics (ACD)</td><td align="left" valign="top">RNAscope Fluorescent Multiplex Detection Kit (ACD, Cat# 320851)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Chemical compound</td><td align="left" valign="top">Neurobiotin-labeling reagent: Streptavidin Alexa Fluor conjugate 647</td><td align="left" valign="top">Thermo Fisher Scientific, Waltham, MA, USA</td><td align="left" valign="top">catalog # S21374</td><td align="char" char="." valign="top">1:1000</td></tr><tr><td align="left" valign="top">Chemical compound</td><td align="left" valign="top">SNX-482</td><td align="left" valign="top">Alomone Labs, Jerusalem, Israel</td><td align="left" valign="top">catalog # RTS-500</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Software, algorithm</td><td align="left" valign="top">Clampfit</td><td align="left" valign="top">Clampfit</td><td align="left" valign="top">Version 10.0 or 10.7, RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_011323">SCR_011323</ext-link></td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Software, algorithm</td><td align="left" valign="top">QuantStudioTM</td><td align="left" valign="top">Thermo Fisher Scientific, Waltham, MA, USA</td><td align="left" valign="top">Quantstudio 3 Software</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Software, algorithm</td><td align="left" valign="top">Fiji</td><td align="left" valign="top"><ext-link ext-link-type="uri" xlink:href="https://imagej.net/Fiji">https://imagej.net/Fiji</ext-link>, <xref ref-type="bibr" rid="bib76">Schindelin et al., 2012</xref></td><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Software, algorithm</td><td align="left" valign="top">GraphPad Prism</td><td align="left" valign="top">GraphPad</td><td align="left" valign="top">GraphPad Prism Ver 5, 7.04 and 8 (RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_002798">SCR_002798</ext-link>)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Software, algorithm</td><td align="left" valign="top">SigmaPlot</td><td align="left" valign="top">Systat Software, Germany</td><td align="left" valign="top">SigmaPlot Ver 14, RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_003210">SCR_003210</ext-link></td><td align="left" valign="top"/></tr></tbody></table></table-wrap><sec id="s4-1"><title>Animals</title><p>For quantitative real-time PCR (RT-qPCR) experiments, male C57Bl/6 N mice were bred in the animal facility of the Centre for Chemistry and Biomedicine (CCB) of the University of Innsbruck (approved by the Austrian Animal Experimentation Ethics Board). For electrophysiological experiments of cultured midbrain DA neurons, C57Bl/6 TH-GFP mice (<xref ref-type="bibr" rid="bib52">Matsushita et al., 2002</xref>; <xref ref-type="bibr" rid="bib74">Sawamoto et al., 2001</xref>) were kept heterozygous via breeding them with C57Bl/6 mice (in accordance with the European Community’s Council Directive 2010/63/UE and approved by the Italian Ministry of Health and the Local Organism responsible for animal welfare at the University of Torino; authorization DGSAF 0011710 P-26/07/2017). All animals were housed under a 12 hr light/dark cycle with food and water ad libitum. For whole cell voltage-clamp recordings of SN DA neurons in acute brain slices, as well as single-cell RT-qPCR, juvenile male C57Bl/6J mice (PN11-13) were bred at the animal facility of Ulm University. For RNAscope analysis, adult male C57Bl/6J mice and Cav2.3 WT mice were bred at the animal facility of Ulm University. Animal procedures at the Universities of Ulm (Regierungspräsidium Tübingen, Ref: 35/9185.81–3; Reg. Nr. o.147) and Cologne (LANUV NRW, Recklinghausen, Germany (84–02.05.20.12.254) were approved by the local authorities).</p></sec><sec id="s4-2"><title>RNA isolation and cDNA synthesis for tissue RT-qPCR</title><p>Tissue was dissected after mice had been sacrificed by cervical dislocation under isoflurane (Vetflurane, Vibac UK, 1000 mg/g) anesthesia. The freshly extracted mouse brains from 12 to 14 weeks old male mice were snap-frozen in isopentane (Carl Roth, catalog #3926.2) that was pre-cooled with dry ice (–40 °C). To dissect VTA and SN tissue, 100-µm-thick sections were cut on a cryostat (CM1950, Leica, Germany) and collected on glass coverslips. After cooling the coverslips on dry ice, regions of interest were punched under a dissection microscope using a pre-cooled sample corer (Fine Science Tools, Germany) (VTA: inner diameter 0.8 mm, 1 punch per hemisphere; SN: inner diameter 0.5 mm, 2 punches per hemisphere). For each brain region, tissue punches from both hemispheres of 7–8 successive 100 µm sections between Bregma –3.00 mm and –3.80 mm (according to <xref ref-type="bibr" rid="bib64">Paxinos and Franklin, 2004</xref>) were collected in the sample corer. The tissue punches were transferred into an Eppendorf tube and again snap-frozen in liquid nitrogen. The punched brain sections were stained with cresyl violet (Nissl’s staining) for histological verification. Briefly, the slides with the punched sections were incubated in 4% PFA overnight. On the next day, the sections were rinsed in H<sub>2</sub>O and the following staining steps were performed: H<sub>2</sub>O 1 min, 70% ethanol 5 min, 100% EtOH 5 min, 0.5% cresyl violet solution pH 3.9 (2.5 g cresyl violet acetate, 30 ml 1 M Na-acetate*3 H<sub>2</sub>O and 170 ml 1 M acetic acid) 10 min, 70% ethanol 2 min, 100% ethanol 2 min, Xylol 1 min. The sections were coverslipped immediately with Eukitt (Sigma-Aldrich, catalog #03989), left to harden overnight and imaged on a bright-field microscope at 2 x.</p><p>RNeasy Lipid Tissue Mini Kit (Qiagen GmbH, Germany, catalog #1023539) was used to isolate total RNA from brain tissues. Briefly, the tissue was disrupted and homogenized by vortexing samples for 5–10 min in 500 μl (SN, VTA) of phenol/guanidine-based Qiazol lysis reagent (Qiagen GmbH, Germany, catalog #79306) and passing the lysate ten times through a 21-gauge needle. All further steps, including purification of RNA with QIAGEN silica gel membrane technology (Qiagen GmbH, Germany), were performed according to the manufacturer’s protocol. For the final elution 15 μl of RNase-free water were used twice. An optional on-column DNase digestion (Qiagen GmbH, Germany, catalog #79254) was performed to reduce genomic DNA contamination. The RNA concentration was determined photometrically yielding approximately 20 ng/µl for VTA and SN or 1–2 µg/µl for whole brain.</p><p>RNA was reverse transcribed using Maxima H Minus First Strand cDNA synthesis kit with random hexamer primers following the manufacturer’s instructions (Thermo Fisher Scientific, Waltham, MA, USA). One µg or 13 μl of total RNA were used as template for reverse transcription. One µl cDNA corresponds to 0.65 x the amount of RNA equivalent.</p></sec><sec id="s4-3"><title>Standard curve method-based RT-qPCR for quantification of β-subunit expression in SN and VTA</title><p>In order to generate DNA templates of known concentrations for RT-qPCR standard curves, the concentration of the digested fragments was determined using the Quant-IT PicoGreen dsDNA Assay Kit (Invitrogen, Carlsbad, CA, USA). Subsequently, standard curves were generated using a serial dilution ranging from 10<sup>7</sup> to 10<sup>1</sup> DNA molecules in water containing 1 <italic>μ</italic>g/ml of poly-dC DNA (Midland Certified Reagent Company Inc, Midland, TX, USA). RT-qPCRs of standard curves and samples were performed as described previously (<xref ref-type="bibr" rid="bib62">Ortner et al., 2020</xref>; <xref ref-type="bibr" rid="bib77">Schlick et al., 2010</xref>). Samples for RT-qPCR quantification (50 cycles) contained 5 ng of total RNA equivalent of cDNA, the respective TaqMan gene expression assay, and TaqMan Universal PCR Master Mix (Thermo Fisher Scientific). Specificity of all assays was confirmed using different DNA ratios of corresponding and mismatched DNA fragments for the β1–4 and for the β2a-2e assays, respectively. Importantly, all assays specifically recognized the corresponding fragment even in the presence of a 10-fold higher concentration of other splice variants (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>). RT-qPCR was performed in duplicates from three independent RNA preparations from three biological replicates. Samples without template served as negative controls. No RT RNA controls could not be included since all obtained RNA was transcribed into cDNA due to low yields. The expression of seven different endogenous control genes was routinely measured and used for data normalization as previously described (<xref ref-type="bibr" rid="bib90">Vandesompele et al., 2002</xref>; <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>, <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>): <italic>Actb</italic> (β-actin), <italic>B2m</italic> (β2-microglobulin), <italic>Gapdh</italic> (Glyceraldehyde 3-phosphate dehydrogenase), <italic>Hprt1</italic> (Hypoxanthine phosphoribosyltransferase 1), <italic>Tbp</italic> (TATA box-binding protein), <italic>Tfrc</italic> (Transferrin receptor), and <italic>Sdha</italic> (Succinate dehydrogenase subunit A) (<xref ref-type="bibr" rid="bib62">Ortner et al., 2020</xref>; <xref ref-type="bibr" rid="bib77">Schlick et al., 2010</xref>). Briefly, data were normalized to the most stably expressed endogenous control genes (<italic>Gapdh</italic> and <italic>Tfrc</italic>) determined by geNorm (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>, <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>). Normalized molecule numbers were calculated for each assay based on their respective standard curve. Standard curve parameters are given in (<xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref>). qPCR analyses were performed using the 7,500 Fast System (Applied Biosystems, Foster Systems, CA, USA).</p></sec><sec id="s4-4"><title>Quantitative RT-qPCR of mouse brain tissue samples</title><p>Fragments of β-subunits and β2 splice variants were amplified from mouse whole brain cDNA utilizing specific primers (<xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>) and subcloned into the Cav1.3 8 a 42 pGFP<sup>minus</sup> vector after restriction enzyme digestion using SalI and HindIII. Primer sequences for β1-β4 have been described previously (<xref ref-type="bibr" rid="bib77">Schlick et al., 2010</xref>), but additional SalI and HindIII restriction enzyme sites (underlined in <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>) were inserted to allow subsequent ligation of fragments into the digested vector. TaqMan gene expression assays (Thermo Fisher Scientific, Waltham, MA, USA) and custom-made TaqMan gene expression assays were designed to span exon-exon boundaries (<xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>) as already described (<xref ref-type="bibr" rid="bib62">Ortner et al., 2020</xref>).</p><p>The expression of β1, β2, β3, β4, β2a, β2b, β2c-d, and β2e was assessed using a standard curve method-based on PCR fragments of known concentration (<xref ref-type="bibr" rid="bib62">Ortner et al., 2020</xref>; <xref ref-type="bibr" rid="bib77">Schlick et al., 2010</xref>). β2c and β2d were detected by a common assay as selective primer design failed due to high sequence similarity. This assay binds at the exon-exon boundary of exons 2 A and 3 of β2c and β2d and also recognizes a number of splice variants comprising the β2d N-terminus but with different alternative splicing in the HOOK region of the subunit (<xref ref-type="bibr" rid="bib13">Buraei and Yang, 2010</xref>). Details about assay specificity are given in <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref> and <xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref>.</p></sec><sec id="s4-5"><title>cDNA constructs</title><p>For transient transfections hCav2.3e (cloned into pcDNA3, <xref ref-type="bibr" rid="bib65">Pereverzev et al., 2002</xref>) or hCav1.3<sub>L</sub> (human C-terminally long Cav1.3 splice variant; GenBank accession number EU363339) α1 subunits were transfected together with the previously described accessory subunit constructs: β3 (rat, NM_012828, <xref ref-type="bibr" rid="bib43">Koschak et al., 2001</xref>), β2a (rat, M80545, <xref ref-type="bibr" rid="bib43">Koschak et al., 2001</xref>), β2d (mouse, β2aN1, FM872408.1; <xref ref-type="bibr" rid="bib47">Link et al., 2009</xref>), β2e (mouse, β2aN5, FM872407; <xref ref-type="bibr" rid="bib47">Link et al., 2009</xref>, where β2d and β2e were kindly provided by V. Flockerzi, Saarland University, Homburg), <sub>C3S/C4S</sub>β2a (cysteine residues in position 3 and 4 of β2a replaced by serines, <xref ref-type="bibr" rid="bib25">Gebhart et al., 2010</xref>) or β4 (rat, splice variant β4e, kindly provided by Dr. Bernhard Flucher, Medical University Innsbruck; <xref ref-type="bibr" rid="bib21">Etemad et al., 2014</xref>) and α2δ1 (rabbit, NM_001082276, <xref ref-type="bibr" rid="bib43">Koschak et al., 2001</xref>).</p></sec><sec id="s4-6"><title>Cell culture and transfection</title><p>TsA-201 cells were obtained from the European Collection of Authenticated Cell Cultures (ECACC, catalogue number 96121229, lot number 13D034) at passage 6. Cell stocks of passage 8 were frozen and cultures were re-expanded from stocks for not more than 20 passages. Cell cultures were tested negative (Universal Mycoplasma Detection Kit 30–1012 K, American Type Culture Collection) for mycoplasma infection. TsA-201 cells were cultured as described (<xref ref-type="bibr" rid="bib62">Ortner et al., 2020</xref>) in Dulbecco’s modified Eagle’s medium (DMEM; Sigma-Aldrich, catalog #D6546) that was supplemented with 10% fetal bovine serum (FBS, Gibco, catalog #10270–106), 2 mM L-glutamine (Gibco, catalog #25030–032), penicillin (10 units/ml, Sigma, P-3032) and streptomycin (10 μg/ml, Sigma, S-6501). Cells were maintained at 37 °C and 5% CO<sub>2</sub> in a humidified incubator and were subjected to a splitting procedure after reaching ~80% confluency. For splitting, cells were dissociated using 0.05% trypsin after implementing a washing step using 1 x phosphate buffered saline (PBS). TsA-201 cells were replaced and freshly thawed when they exceeded passage no. 21. For electrophysiology, cells were plated on 10 cm culture dishes and subjected to transient transfections on the following day. Cells were transiently transfected using Ca<sup>2+</sup>-phosphate as previously described (<xref ref-type="bibr" rid="bib60">Ortner et al., 2014</xref>) with 3 μg of α1 subunits, 2 μg of β subunits, 2.5 μg of α2δ1 subunits and 1.5 µg of eGFP to visualize transfected cells. On the next day, cells were plated onto 35 mm culture dishes that were coated with poly-L-lysine, kept at 30 °C and 5% CO<sub>2</sub> and were then subjected to whole-cell patch-clamp experiments after 24–72 hr.</p></sec><sec id="s4-7"><title>Primary cell culture of midbrain DA neurons</title><p>As described in <xref ref-type="bibr" rid="bib87">Tomagra et al., 2019</xref>, the methods for the primary culture of mesencephalic dopamine neurons from <italic>Substantia nigra</italic> (SN) were adapted from <xref ref-type="bibr" rid="bib68">Pruszak et al., 2009</xref>. Briefly, the ventral mesencephalon area was dissected from embryonic (E15) C57Bl/6 TH-GFP mice (<xref ref-type="bibr" rid="bib52">Matsushita et al., 2002</xref>; <xref ref-type="bibr" rid="bib74">Sawamoto et al., 2001</xref>) that were kept heterozygous via breeding them with C57Bl/6 J mice. HBSS (Hank’s balanced salt solution, without CaCl<sub>2</sub> and MgCl<sub>2</sub>), enriched with 0.18% glucose, 1% BSA, 60% papain (Worthington, Lakewood, NJ, United States), 20% DNase (Sigma-Aldrich) was stored at 4 °C and used as digestion buffer. Neurons were plated at final densities of 600 cells per mm<sup>2</sup> on Petri dishes. Cultured neurons were used at 8–9 days in vitro (DIV) for current-clamp and voltage-clamp experiments. Petri dishes were coated with poly-L-Lysine (0.1 mg/ml) as substrate adhesion. Cells were incubated at 37 °C in a 5% CO<sub>2</sub> atmosphere, with Neurobasal Medium containing 1% pen-strep, 1% ultra-glutamine, 2% B-27, and 2.5% FBS dialyzed (pH 7.4) (as previously described in <xref ref-type="bibr" rid="bib87">Tomagra et al., 2019</xref>).</p></sec><sec id="s4-8"><title>Whole-cell patch-clamp recordings in tsA-201 cells</title><p>For whole-cell patch-clamp recordings, patch pipettes with a resistance of 1.5–3.5 MΩ were pulled from glass capillaries (Borosilicate glass, catalog #64–0792, Harvard Apparatus, USA) using a micropipette puller (Sutter Instruments) and fire-polished with a MF-830 microforge (Narishige, Japan). Recordings were obtained in the whole-cell configuration using an Axopatch 200B amplifier (Axon Instruments, Foster City, CA), digitized (Digidata 1,322 A digitizer, Axon Instruments) at 50 kHz, low-pass filtered at 5 kHz and subsequently analyzed using Clampfit 10.7 Software (Molecular Devices). Linear leak and capacitive currents were subtracted online using the P/4 protocol (20 ms I-V protocol) or offline using a 50 ms hyperpolarizing voltage step from –89 to –99 mV or –119 to –129 mV. All voltages were corrected for a liquid junction potential (JP) of –9 mV (<xref ref-type="bibr" rid="bib45">Lieb et al., 2014</xref>). Compensation was applied for 70–90% of the series resistance.</p><p>The pipette internal solution for recordings of Cav2.3 contained (in mM): 144.5 CsCl, 10 HEPES, 0.5 Cs-EGTA, 1 MgCl<sub>2</sub>, 4 Na<sub>2</sub>ATP adjusted to pH 7.4 with CsOH (299 mOsm/kg). The pipette internal solution for recordings of Cav1.3 contained (in mM): 135 CsCl, 10 HEPES, 10 Cs-EGTA, 1 MgCl<sub>2</sub>, 4 Na<sub>2</sub>ATP adjusted to pH 7.4 with CsOH (275 mOsm/kg). The bath solution for recordings of Cav2.3 contained (in mM): 2 CaCl<sub>2</sub>, 10 HEPES, 170 Choline-Cl and 1 MgCl<sub>2</sub> adjusted to pH 7.4 with CsOH. The bath solution for recordings of Cav1.3 contained (in mM): 15 CaCl<sub>2</sub>, 10 HEPES, 150 Choline-Cl and 1 MgCl<sub>2</sub> adjusted to pH 7.4 with CsOH.</p><p>Current-voltage (I-V) relationships were obtained by applying a 20 ms long square pulse protocol to various test potentials (5 mV voltage steps) starting from a holding potential of –119 mV or –89 mV (recovery of inactivation). The resulting I-V curves were fitted to the following equation:<disp-formula id="equ1"><mml:math id="m1"><mml:mi>I</mml:mi><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi>G</mml:mi></mml:mrow><mml:mrow><mml:mi>m</mml:mi><mml:mi>a</mml:mi><mml:mi>x</mml:mi></mml:mrow></mml:msub><mml:mo>(</mml:mo><mml:mi>V</mml:mi><mml:mo>-</mml:mo><mml:msub><mml:mrow><mml:mi>V</mml:mi></mml:mrow><mml:mrow><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mi>v</mml:mi></mml:mrow></mml:msub><mml:mo>)</mml:mo><mml:mo>/</mml:mo><mml:mo>(</mml:mo><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:mrow><mml:mrow><mml:mi mathvariant="normal">exp</mml:mi></mml:mrow><mml:mo>⁡</mml:mo><mml:mrow><mml:mfenced open="[" close="]" separators="|"><mml:mrow><mml:mo>-</mml:mo><mml:mfrac><mml:mrow><mml:mi>V</mml:mi><mml:mo>-</mml:mo><mml:msub><mml:mrow><mml:mi>V</mml:mi></mml:mrow><mml:mrow><mml:mn>0.5</mml:mn></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi>k</mml:mi></mml:mrow></mml:mfrac></mml:mrow></mml:mfenced></mml:mrow></mml:mrow><mml:mo>)</mml:mo></mml:math></disp-formula></p><p>where I is the peak current amplitude, G<sub>max</sub> is the maximum conductance, V is the test potential, V<sub>rev</sub> is the extrapolated reversal potential, V<sub>0.5</sub> is the half-maximal activation voltage, and k is the slope factor. The voltage dependence of Ca<sup>2+</sup>-conductance was fitted using the following Boltzmann relationship:<disp-formula id="equ2"><mml:math id="m2"><mml:mi>G</mml:mi><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi>G</mml:mi></mml:mrow><mml:mrow><mml:mi>m</mml:mi><mml:mi>a</mml:mi><mml:mi>x</mml:mi></mml:mrow></mml:msub><mml:mo>/</mml:mo><mml:mo>(</mml:mo><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:mrow><mml:mrow><mml:mi mathvariant="normal">exp</mml:mi></mml:mrow><mml:mo>⁡</mml:mo><mml:mrow><mml:mfenced open="[" close="]" separators="|"><mml:mrow><mml:mo>-</mml:mo><mml:mfrac><mml:mrow><mml:mi>V</mml:mi><mml:mo>-</mml:mo><mml:msub><mml:mrow><mml:mi>V</mml:mi></mml:mrow><mml:mrow><mml:mn>0.5</mml:mn></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi>k</mml:mi></mml:mrow></mml:mfrac></mml:mrow></mml:mfenced></mml:mrow></mml:mrow><mml:mo>)</mml:mo></mml:math></disp-formula></p><p>The voltage dependence of inactivation was assessed by application of 20 ms test pulses to the voltage of maximal activation (V<sub>max</sub>) before and after holding the cell at various conditioning test potentials for 5 s (30 s inter-sweep interval; 10 mV voltage steps; holding potential –119 mV). Inactivation was calculated as the ratio between the current amplitudes of the 20 ms test pulses. Steady-state inactivation parameters were obtained by fitting the data to a modified Boltzmann equation:<disp-formula id="equ3"><mml:math id="m3"><mml:mi>I</mml:mi><mml:mo>=</mml:mo><mml:mo>(</mml:mo><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:msub><mml:mrow><mml:mi>I</mml:mi></mml:mrow><mml:mrow><mml:mi>n</mml:mi><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>)</mml:mo><mml:mo>/</mml:mo><mml:mo>(</mml:mo><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:mrow><mml:mrow><mml:mi mathvariant="normal">exp</mml:mi></mml:mrow><mml:mo>⁡</mml:mo><mml:mrow><mml:mfenced open="[" close="]" separators="|"><mml:mrow><mml:mfrac><mml:mrow><mml:mi>V</mml:mi><mml:mo>-</mml:mo><mml:msub><mml:mrow><mml:mi>V</mml:mi></mml:mrow><mml:mrow><mml:mn>0.5</mml:mn><mml:mo>,</mml:mo><mml:mi> </mml:mi><mml:mi> </mml:mi><mml:mi> </mml:mi><mml:mi>i</mml:mi><mml:mi>n</mml:mi><mml:mi>a</mml:mi><mml:mi>c</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mi>n</mml:mi><mml:mi>a</mml:mi><mml:mi>c</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac></mml:mrow></mml:mfenced></mml:mrow></mml:mrow><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi>I</mml:mi></mml:mrow><mml:mrow><mml:mi>n</mml:mi><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>)</mml:mo></mml:math></disp-formula></p><p>where V<sub>0.5, inact</sub> is the half-maximal inactivation voltage, k<sub>inact</sub> is the inactivation slope factor and I<sub>ni</sub> is the fraction of non-inactivating current in steady-state.</p><p>The amount of inactivation during a 5 s depolarizing pulse from a holding potential of –119 mV to the V<sub>max</sub> was quantified by calculating the remaining current fraction after 50, 100, 250, 500, 1000, and 5000 ms. Recovery from inactivation was determined by 10 ms test pulses to V<sub>max</sub> at different time-points (in s: 0.001, 0.003, 0.01, 0.03, 0.1, 0.3, 0.6, 1, 1.5, 2, 3, 4, 6, 8, 10, 15, 20) after a 1 s conditioning pulse to V<sub>max</sub> (holding potential –89 mV). Window current was determined by multiplying mean current densities by fractional currents form steady-state inactivation curves to obtain the fraction of available channels at a given potential as described previously (<xref ref-type="bibr" rid="bib34">Hofer et al., 2020</xref>). The SN DA regular pacemaking command voltage protocol obtained from an identified TH<sup>+</sup> SN DA neuron in a mouse brain slice (male, P12) and the SN DA burst firing protocol were generated as previously described (<xref ref-type="bibr" rid="bib61">Ortner et al., 2017</xref>). Cells were perfused by an air pressure-driven perfusion system (BPS-8 Valve Control System, ALA Scientific Instruments) with bath solution and a flow rate of 0.6 ml/min. For Cd<sup>2+</sup>-block, cells were perfused with 100 µM Cd<sup>2+</sup> to achieve full block, followed by wash-out with bath solution. A complete exchange of the solution around the cell was achieved within &lt;50 ms. All experiments were performed at room temperature (~22 °C).</p></sec><sec id="s4-9"><title>Voltage- and current-clamp recordings in cultured midbrain DA neurons</title><p>Macroscopic whole-cell currents and APs were recorded using an EPC 10 USB HEKA amplifier and Patchmaster software (HEKA Elektronik GmbH) following the procedures described previously (<xref ref-type="bibr" rid="bib3">Baldelli et al., 2005</xref>; <xref ref-type="bibr" rid="bib24">Gavello et al., 2018</xref>). Traces were sampled at 10 kHz and filtered using a low-pass Bessel filter set at 2 kHz. Borosilicate glass pipettes (Kimble Chase life science, Vineland, NJ, USA) with a resistance of 7–8 MΩ were used. Uncompensated capacitive currents were reduced by subtracting the averaged currents in response to P/4 hyperpolarizing pulses. Off-line data analysis was performed with pClamp 10.0 software for current clamp recordings. Ca<sup>2+</sup> currents were evoked by applying a single depolarization step (50 ms duration), from a holding of –70 mV to 0 mV. Fast capacitive transients due to the depolarizing pulse were minimized online by the patch-clamp analog compensation. Series resistance was compensated by 80% and monitored during the experiment.</p><p>For current-clamp experiments the pipette internal solution contained in mM: 135 gluconic acid (potassium salt: K-gluconate), 10 HEPES, 0.5 EGTA, 2 MgCl<sub>2</sub>, 5 NaCl, 2 ATP-Tris and 0.4 Tris-GTP (<xref ref-type="bibr" rid="bib87">Tomagra et al., 2019</xref>). For voltage-clamp recordings the pipette internal solution contained in mM: 90 CsCl, 20 TEA-Cl, 10 EGTA, 10 glucose, 1 MgCl<sub>2</sub>, 4 ATP, 0.5 GTP and 15 phosphocreatine adjusted to pH 7.4. The extracellular solution for current/voltage-clamp recordings (Tyrode’s solution) contained in mM: 2 CaCl<sub>2</sub>, 10 HEPES, 130 NaCl, 4 KCl, 2 MgCl<sub>2</sub>, 10 glucose adjusted to pH 7.4. Patch-clamp experiments were performed using pClamp software (Molecular Devices, Silicon Valley, CA, United States). All experiments were performed at a temperature of 22–24°C. Data analysis was performed using Clampfit software. To study the contribution of Cav2.3 channels to the total Ca<sup>2+</sup> current, cells were perfused with recording solution (containing in mM: 135 TEA, 2 CaCl<sub>2</sub>, 2 MgCl<sub>2</sub>, 10 HEPES, 10 glucose adjusted to pH 7.4) complemented with 300 nM TTX and 3 µM ISR to block voltage-dependent Na<sup>+</sup> and L-type Ca<sup>2+</sup> channels. SNX-482 (100 nM) was used in current- and voltage-clamp experiments. Furthermore, kynurenic acid (1 mM), 6,7-dinitroquinoxaline-2,3-dione (DNQX) (20 µM) and picrotoxin (100 µM) were present in the extracellular solution for current- and voltage-clamp experiments.</p></sec><sec id="s4-10"><title>Whole cell voltage-clamp recordings of SN DA neurons in ex vivo brain slices</title><p>Whole-cell patch-clamp recordings were performed essentially as previously described (<xref ref-type="bibr" rid="bib4">Benkert et al., 2019</xref>). In brief, murine (PN11-13) coronal midbrain slices were prepared in ice-cold ACSF using a VibrosliceTM (Campden Instruments). Chemicals were obtained from Sigma Aldrich unless stated otherwise. ACSF contained in mM: 125 NaCl, 25 NaHCO<sub>3</sub>, 2.5 KCl, 1.25 NaH<sub>2</sub>PO<sub>4</sub>, 2 CaCl<sub>2</sub>, 2 MgCl<sub>2</sub> and 25 glucose, and was gassed with Carbogen (95% O<sub>2</sub>, 5% CO<sub>2</sub>, pH 7.4, osmolarity was 300–310 mOsm/kg). Slices were allowed to recover for 30 min at room temperature (22°C–25°C) before use for electrophysiology. Recordings were carried out in a modified ACSF solution containing in mM: 125 NaCl, 25 NaHCO<sub>3</sub>, 2.5 KCl, 1.25 NaH<sub>2</sub>PO<sub>4</sub>, 2.058 MgCl<sub>2</sub>, 1.8 CaCl<sub>2</sub>, 2.5 glucose, 5 CsCl, 15 tetraethylammonium, 2.5 4-aminopyridine, 600 nM TTX (Tocris), 20 µM CNQX (Tocris), 4 µM SR 95531 (Tocris) and 10 µM DL-AP5 (Tocris), pH adjusted to 7.4, osmolarity was 300–315 mOsm/kg. Data were digitalized with 2 kHz, and filtered with Bessel Filter 1: 10 kHz; Bessel Filter 2: 5 kHz. All recordings were performed at a bath temperature of 33 °C±1. Patch pipettes (2.5–3.5 MΩ) were filled with internal solution containing in mM: 180 N-Methyl-D-glucamine, 40 HEPES, 0.1 EGTA, 4 MgCl<sub>2</sub>, 5 Na-ATP, 1 Lithium-GTP, 0.1% neurobiotin tracer (Vector Laboratories); pH was adjusted to 7.35 with H<sub>2</sub>SO<sub>4</sub>, osmolarity was 285–295 mOsm/kg. Neurons were filled with neurobiotin during the recording, fixed with a 4% PFA solution and stained for tyrosine hydroxylase (TH; rabbit anti-TH, 1:1000, Cat#: 657012, Merck Millipore) and neurobiotin (Streptavidin Alexa Fluor conjugate 647, 1:1000, Cat# S21374, Thermo Fisher Scientific). Only TH and neurobiotin-positive cells were used for the statistical analysis.</p><p>Steady-state activation was measured by applying 150 ms depolarizing square pulses to various test potentials (10  mV increments) starting from –90 mV with a 10 s interpulse interval. Holding potential between the pulses was −100 mV. Voltage at maximal Ca<sup>2+</sup> current amplitude (V<sub>max</sub>) was determined during the steady-state activation recordings. Voltage-dependence of the steady-state inactivation was measured by applying a 20 ms control test pulse (from holding potential –100 mV to V<sub>max</sub>) followed by 5 s conditioning steps to various potentials (10  mV increments) and a subsequent 20 ms test pulse to V<sub>max</sub> with a 10 s interpulse interval. Inactivation was calculated as the ratio between the current amplitudes of the test versus control pulse. Currents were leak subtracted on-line using the P/5 subtraction. The series resistance was compensated by 60–90%. Data were not corrected for liquid junction potential (–5 mV, measured according to <xref ref-type="bibr" rid="bib57">Neher, 1992</xref>). Midbrain slices were preincubated (bath-perfusion) at least 30 min in selective T-type (10 µM Z941; <xref ref-type="bibr" rid="bib89">Tringham et al., 2012</xref>), L-type (1 µM isradipine, ISR; <ext-link ext-link-type="uri" xlink:href="https://www.guidetopharmacology.org/">https://www.guidetopharmacology.org/</ext-link>), N- and P/Q-type (1 µM ω-conotoxin-MVIIC; <ext-link ext-link-type="uri" xlink:href="https://www.guidetopharmacology.org/">https://www.guidetopharmacology.org/</ext-link>) or R-type (100 nM SNX-482; <ext-link ext-link-type="uri" xlink:href="https://www.guidetopharmacology.org/">https://www.guidetopharmacology.org/</ext-link>, <xref ref-type="bibr" rid="bib59">Newcomb et al., 1998</xref>) Ca<sup>2+</sup> channel blockers; except Z941, which was kindly obtained from T. Snutch (University of British Columbia, Canada), all Cav blocker were from Tocris.</p><p>Steady-state activation and inactivation curves were fitted as described above.</p></sec><sec id="s4-11"><title>Perforated patch recordings in SN DA neurons in ex vivo brain slices</title><p>Animals were anesthetized with isoflurane (B506; AbbVie Deutschland GmbH and Co KG, Ludwigshafen, Germany) and subsequently decapitated. The brain was rapidly removed and a block of tissue containing the mesencephalon was immediately dissected. Coronal slices (250–300 μm) containing the SN were cut with a vibration microtome (HM-650 V; Thermo Scientific, Walldorf, Germany) under cold (4 °C), carbogenated (95% O<sub>2</sub> and 5% CO<sub>2</sub>), glycerol-based modified artificial cerebrospinal fluid (GACSF; <xref ref-type="bibr" rid="bib98">Ye et al., 2006</xref>) containing (in mM): 250 glycerol, 2.5 KCl, 2 MgCl<sub>2</sub>, 2 CaCl<sub>2</sub>, 1.2 NaH<sub>2</sub>PO<sub>4</sub>, 10 HEPES, 21 NaHCO<sub>3</sub>, 5 glucose adjusted to pH 7.2 (with NaOH) resulting in an osmolarity of ~310 mOsm. Brain slices were transferred into carbogenated artificial cerebrospinal fluid (ACSF). First, they were kept for 20 min in a 35 °C 'recovery bath' and then stored at room temperature (24 °C) for at least 30 min prior to recording. ACSF contained (in mM): 125 NaCl, 2.5 KCl, 2 MgCl<sub>2</sub>, 2 CaCl<sub>2</sub>, 1.2 NaH<sub>2</sub>PO<sub>4</sub>, 21 NaHCO<sub>3</sub>, 10 HEPES, and 5 Glucose adjusted to pH 7.2 (with NaOH) resulting in an osmolarity of ~310 mOsm.</p><p>SN dopaminergic neurons were identified according to their sag component / slow I<sub>h</sub>-current (hyperpolarization-activated cyclic nucleotide-gated cation current), broad action potentials or post hoc by TH/DAT-immunohistochemistry (<xref ref-type="bibr" rid="bib44">Lacey et al., 1989</xref>; <xref ref-type="bibr" rid="bib58">Neuhoff et al., 2002</xref>; <xref ref-type="bibr" rid="bib72">Richards et al., 1997</xref>; <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1I, J</xref>). Biocytin-streptavidin labeling was combined with TH-immuno-histochemistry (<xref ref-type="bibr" rid="bib33">Hess et al., 2013</xref>).</p><p>After preparation, brain slices were transferred to a recording chamber (~1.5 ml volume) and initially superfused with carbogenated ACSF at a flow rate of ~2 ml/min. During the perforation process, the electrophysiological identification of the neuron was performed in current clamp mode. Afterwards, the ACSF was exchanged for the Ca<sup>2+</sup> current recording solution which contained in mM: 66.5 NaCl, 2 MgCl<sub>2</sub>, 3 CaCl<sub>2</sub>, 21 NaHCO<sub>3</sub>, 10 HEPES, 5 Glucose adjusted to pH 7.2 (with HCl). Sodium currents were blocked by 1 µM tetrodotoxin (TTX). Potassium currents and the I<sub>h</sub> current were blocked by: 40 mM TEA-Cl, 0.4 mM 4-AP, 1 µM M phrixotoxin-2 (Alomone, Cat # STP-710; <xref ref-type="bibr" rid="bib84">Subramaniam et al., 2014</xref>) and 20 mM CsCl. Experiments were carried out at ~28 °C. Recordings were performed with an EPC10 amplifier (HEKA, Lambrecht, Germany) controlled by the software PatchMaster (version 2.32; HEKA). In parallel, data were sampled at 10 kHz with a CED 1401 using Spike2 (version 7) (both Cambridge Electronic Design, UK) and low-pass filtered at 2 kHz with a four-pole Bessel filter. The liquid junction potential between intracellular and extracellular solution was compensated (12 mV; calculated with Patcher’s Power Tools plug-in for Igor Pro 6 (Wavemetrics, Portland, OR, USA)).</p><p>Perforated patch recordings were performed using protocols modified from <xref ref-type="bibr" rid="bib35">Horn and Marty, 1988</xref> and (<xref ref-type="bibr" rid="bib2">Akaike and Harata, 1994</xref>). Electrodes with tip resistances between 2 and 4 MΩ were fashioned from borosilicate glass (0.86 mm inner diameter; 1.5 mm outer diameter; GB150- 8 P; Science Products) with a vertical pipette puller (PP-830; Narishige, London, UK). Patch recordings were performed with ATP and GTP-free pipette solution containing (in mM): 138 Cs-methanesulfonate, 10 CsCl<sub>2</sub>, 2 MgCl<sub>2</sub>, 10 HEPES and adjusted to pH 7.2 (with CsOH). ATP and GTP were omitted from the intracellular solution to prevent uncontrolled permeabilization of the cell membrane (<xref ref-type="bibr" rid="bib46">Lindau and Fernandez, 1986</xref>). The patch pipette was tip filled with internal solution and back filled with 0.02% tetraethylrhodamine-dextran (D3308, Invitrogen, Eugene, OR, USA) and amphotericin-containing internal solution (~400 μg/ml; G4888; Sigma-Aldrich, Taufkirchen, Germany) to achieve perforated patch recordings. Amphotericin was dissolved in dimethyl sulfoxide (final concentration: 0.2%–0.4%; DMSO; D8418, Sigma-Aldrich) (<xref ref-type="bibr" rid="bib71">Rae et al., 1991</xref>), and was added to the modified pipette solution shortly before use. The used DMSO concentration had no obvious effect on the investigated neurons. During the recordings access resistance (<italic>R</italic><sub>a</sub>) was constantly monitored and experiments were started after <italic>R</italic><sub>a</sub> was &lt;20 MΩ. In the analyzed recordings <italic>R</italic><sub>a</sub> was comparable, did not change significantly over recording time, and was not significantly different between the distinct experimental groups. A change to the whole-cell configuration was indicated by a sudden change in <italic>R</italic><sub>a</sub> and diffusion of tetraethylrhodamine-dextran into the neuron. Such experiments were rejected. GABAergic and glutamatergic synaptic input was reduced by addition of 0.4 mM picrotoxin (P1675; Sigma-Aldrich), 50 µM D-AP5 (A5282; Sigma-Aldrich), and 10 µM CNQX (C127; Sigma-Aldrich) to the ACSF. For inhibition experiments, 100 nM SNX-482 (Alomone, Cat # RTS-500 dissolved in ACSF) or 10 µM nifedipine (Alomone, Cat # N-120 diluted into ACSF from a freshly prepared 10 mM stock solution in DMSO) was bath applied (in ACSF).</p></sec><sec id="s4-12"><title>Identification of β-subunit transcripts in identified SN DA and VTA DA neurons</title><sec id="s4-12-1"><title>RNAscope in situ hybridization</title><p>In situ hybridization experiments were performed on fresh frozen mouse brain tissue using the RNAscope technology (Advanced Cell Diagnostics, ACD), according to the manufacturer’s protocol under RNase-free conditions and essentially as described (<xref ref-type="bibr" rid="bib4">Benkert et al., 2019</xref>). Briefly, 12 µm coronal cryosections were prepared (<xref ref-type="bibr" rid="bib20">Duda et al., 2018</xref>), mounted on SuperFrost Plus glass slides, dried for 1 hr at –20 °C and stored at -80°C. Directly before starting the RNAscope procedure, sections were fixed with 4% PFA for 15 min at 4 °C and dehydrated using an increasing ethanol series (50%, 75%, 100%), for 5 min each. After treatment with protease IV (ACD, Cat# 322336) for 30 min at room temperature, sections were hybridized with the respective target probes for 2 hr at 40 °C in a HybEZ II hybridization oven (ACD). Target probe signals were amplified using the RNAscope Fluorescent Multiplex Detection Kit (ACD, Cat# 320851). All amplifier solutions were dropped on respective sections, incubated at 40 °C in the HybEZ hybridization oven, and washed twice with wash buffer (ACD) between each amplification step for 2 min each. Nuclei were counterstained with DAPI ready-to-use solution (ACD, included in Kit) and slides were coverslipped with HardSet mounting medium (VectaShield, Cat# H-1400) and dried overnight. Target probes were either obtained from the library of validated probes provided by Advanced Cell Diagnostics (ACD) or self-designed in cooperation with ACD to specifically discriminate between two splice variants of β2, namely β2a and β2e. Target probes (RNAscope assays) used for analysis were as follows: Tyrosine hydroxylase (TH) (<italic>Th</italic>), Cat No. (ACD) 317621, Assay target region: 483–1,603 of NM_009377.1; β2a (<italic>Cacnb2</italic>), Cat No. (ACD) 590951-C2, Assay target region: 2–296 of XM_011238946.2; β2e (<italic>Cacnb2</italic>), Cat No. (ACD) 823221-C2, Assay target region: 2–285 of NM_001309519.1.</p><p>Target genes, visualized with Atto550 fluorophore, were co-stained with Tyrosine hydroxylase (TH), visualized with AlexaFluor488, as a marker for dopaminergic neurons. The gene peptidyl-prolyl isomerase B (PPIB) was used as positive control.</p><p>Fluorescent images of midbrain sections were acquired by a Leica CTR6 LED microscope using a Leica DFC365FX camera as z-stacks, covering the full depth of cells at ×63 magnification. Z-stacks were reduced to maximum intensity Z-projections using Fiji (<ext-link ext-link-type="uri" xlink:href="http://imagej.net/Fiji">http://imagej.net/Fiji</ext-link>) and images were analyzed by utilizing a custom-designed algorithm (Wolution, Munich, Germany). The algorithm delineates cell shapes according to the TH marker gene signal and quantifies the number and the area of target-mRNA-derived fluorescence dots. Target probe hybridization results in one fluorescent dot for each mRNA molecule, allowing determination of target-mRNA molecule numbers, independent from fluorescence-intensities.</p></sec></sec><sec id="s4-13"><title>Multiplex-nested PCR, qualitative and quantitative PCR analysis in individual laser-microdissected DA neurons</title><p>Cryosectioning, laser-microdissection, reverse transcription: Cryosectioning, UV-laser microdissection (UV-LMD) and reverse transcription were carried out similarly as previously described in detail (<xref ref-type="bibr" rid="bib4">Benkert et al., 2019</xref>; <xref ref-type="bibr" rid="bib20">Duda et al., 2018</xref>; <xref ref-type="bibr" rid="bib29">Gründemann et al., 2011</xref>; <xref ref-type="bibr" rid="bib49">Liss, 2002</xref>). Briefly, coronal 12 µm mouse midbrain cryosections were cut with a cryomicrotome CM3050 S (Leica), mounted on PEN-membrane slides (Mirodissect), stained with a cresyl-violet (CV) ethanol solution and fixed with an ascending ethanol series. UV-LMD of SN dopaminergic neurons from cresyl-violet-stained midbrain sections from juvenile mice was carried out using an LMD7000 system (Leica Microsystems). Reverse transcription was carried out directly without a separate RNA isolation step in a one-tube procedure.</p><p>All cDNA samples were precipitated as described (<xref ref-type="bibr" rid="bib49">Liss, 2002</xref>). Qualitative multiplex-nested PCR and quantitative qPCRs were carried out essentially as described (<xref ref-type="bibr" rid="bib4">Benkert et al., 2019</xref>; <xref ref-type="bibr" rid="bib20">Duda et al., 2018</xref>; <xref ref-type="bibr" rid="bib29">Gründemann et al., 2011</xref>). Briefly, qualitative multiplex-nested PCR was performed with the GeneAmp PCR System 9700 (Thermo Fisher Scientific) using 1/3 of each individual cDNA sample, corresponding to ~3 SN DA neurons, for marker gene expression analysis: tyrosine hydroxylase (<italic>Th</italic>) as a marker for dopaminergic midbrain neurons, the glutamic acid decarboxylase isoforms <italic>Gad<sub>65</sub></italic> and <italic>Gad<sub>67</sub></italic> as markers for GABAergic neurons, the glial fibrillary acidic protein (<italic>Gfap</italic>) as a marker for astroglia cells and calbindin (<italic>Calb1</italic>) d28k (CBd28k), that is strongly expressed only in less vulnerable dopaminergic midbrain neurons. Only cDNA pools expressing the correct marker gene profile (i.e., <italic>Th</italic>-positive, <italic>Gad-</italic>, <italic>Gfap-</italic>, <italic>CBd28k</italic>-negative) were further analyzed via qualitative and quantitative PCR. Quantitative PCR for β2 (<italic>Cacnb2</italic>) splice variant expression analysis was performed with the QuantStudio 3 System (Thermo Fisher Scientific) using ~3 SN DA neurons. Qualitative PCR products were analyzed in a QIAxcel Advanced System (Qiagen).</p><p>Details of multiplex PCR (outer) and nested PCR (inner) primers for qualitative PCR are shown in <xref ref-type="supplementary-material" rid="supp5">Supplementary file 5</xref>.</p><p>For Cav2.3 (<italic>Cacna1e</italic>) splice variant analysis via qualitative RT-PCR, two cDNA fragments (mCav2.3 II-III loop and mCav2.3 C-terminus) covering the three respective splice sites were amplified in a duplex PCR, followed by two individual nested PCR reactions. PCR conditions: 15 min 95 °C; 35 cycles: 30 s 94 °C; 1 min 61 °C; 3 min 72 °C; 7 min 72 °C for duplex PCR; and 3 min 94 °C; 35 cycles: 30 s 94 °C; 1 min 61 °C; 1 min 72 °C; 7 min 72 °C for nested PCRs. Primer sequences are given in <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>. Outer duplex primer pairs were chosen using Oligo7.60 software (possible PCR amplicon sizes for mCav2.3 II-III loop: 816 bp, 795 bp and 759 bp; for mCav2.3 C-terminus: 770 bp and 641 bp). For the nested PCRs, primer sequences from <xref ref-type="bibr" rid="bib93">Weiergräber et al., 2005</xref> were used (possible PCR amplicon sizes for mCav2.3 II-III 980 loop: 420 bp, 399 bp and 363 bp; for mCav2.3 C-terminus: 498 bp and 369 bp). Nested PCR products were separated in a 4% agarose gel (MetaPhor agarose, Biozym), and expressed splice variants in individual SN DA neurons were identified according to the amplicon sizes of the nested PCR products (cDNA from mouse whole-brain tissue was used as positive control) as follows (II-III-loop+C-terminus): Cav2.3a: 363+369 bp; Cav2.3b: 399+369 bp; Cav2.3c: 420+369 bp; Cav2.3d. 420+498; Cav2.3e: 363+498 bp; Cav2.3f: 399+498 bp.</p><p>Quantitative real time PCR (qPCR) was performed with the QuantStudio 3 System (Thermo Fisher Scientific). qPCR assays (TaqMan), were marked with a 3’ BHQ (black hole quencher) and 5’ FAM (Carboxyfluorescein). TaqMan assays were carefully established and performance was evaluated by generating standard curves, using defined amounts of cDNA (derived from midbrain tissue mRNA), over four magnitudes of 10-fold dilutions as templates, in at least three independent experiments, as described (<xref ref-type="bibr" rid="bib20">Duda et al., 2018</xref>; <xref ref-type="bibr" rid="bib49">Liss, 2002</xref>).</p><p>Details of all qPCR assays (TaqMan), and standard curve parameters used for analysis are provided in <xref ref-type="supplementary-material" rid="supp4">Supplementary file 4</xref>.</p><p>Relative qPCR quantification data are given as cDNA amount [pg/cell] with respect to midbrain-tissue cDNA standard curves, calculated according to the following formula, and were normalized to the respective cell size by dividing respective expression values to the corresponding area of the individual microdissected neurons.<disp-formula id="equ4"><mml:math id="m4"><mml:mi>D</mml:mi><mml:mi>N</mml:mi><mml:mi>A</mml:mi><mml:mi> </mml:mi><mml:mi>a</mml:mi><mml:mi>m</mml:mi><mml:mi>o</mml:mi><mml:mi>u</mml:mi><mml:mi>n</mml:mi><mml:mi>t</mml:mi><mml:mi> </mml:mi><mml:mi>p</mml:mi><mml:mi>e</mml:mi><mml:mi>r</mml:mi><mml:mi> </mml:mi><mml:mi>c</mml:mi><mml:mi>e</mml:mi><mml:mi>l</mml:mi><mml:mi>l</mml:mi><mml:mi> </mml:mi><mml:mo>[</mml:mo><mml:mfrac><mml:mrow><mml:mi>p</mml:mi><mml:mi>g</mml:mi></mml:mrow><mml:mrow><mml:mi>c</mml:mi><mml:mi>e</mml:mi><mml:mi>l</mml:mi><mml:mi>l</mml:mi></mml:mrow></mml:mfrac><mml:mo>]</mml:mo><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msup><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mrow><mml:mo>[</mml:mo><mml:mo>(</mml:mo><mml:mi>C</mml:mi><mml:mi>t</mml:mi><mml:mo>-</mml:mo><mml:msub><mml:mrow><mml:mi>Y</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mi>n</mml:mi><mml:mi>t</mml:mi><mml:mi>e</mml:mi><mml:mi>r</mml:mi><mml:mi>c</mml:mi><mml:mi>e</mml:mi><mml:mi>p</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msub><mml:mo>)</mml:mo><mml:mo>/</mml:mo><mml:mi>s</mml:mi><mml:mi>l</mml:mi><mml:mi>o</mml:mi><mml:mi>p</mml:mi><mml:mi>e</mml:mi><mml:mo>]</mml:mo></mml:mrow></mml:msup></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>N</mml:mi><mml:mi>o</mml:mi></mml:mrow><mml:mrow><mml:mi>c</mml:mi><mml:mi>e</mml:mi><mml:mi>l</mml:mi><mml:mi>l</mml:mi><mml:mi>s</mml:mi></mml:mrow></mml:msub><mml:mo>∙</mml:mo><mml:mi>c</mml:mi><mml:mi>D</mml:mi><mml:mi>N</mml:mi><mml:mi>A</mml:mi><mml:mi> </mml:mi><mml:mi>f</mml:mi><mml:mi>r</mml:mi><mml:mi>a</mml:mi><mml:mi>c</mml:mi><mml:mi>t</mml:mi><mml:mi>i</mml:mi><mml:mi>o</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:mfrac></mml:math></disp-formula></p><p>With S=serial dilution factor of the standard curve (i.e. 10), No<sub>cells</sub> = number of SN DA neurons per sample (i.e. 10 here), cDNA fraction = fraction of the cDNA reaction used as template in the qPCR reaction (i.e. 5/17) and the Y-intercept and slope of the relative standards (see <xref ref-type="supplementary-material" rid="supp4">Supplementary file 4</xref>).</p><p>β2 (<italic>Cacnb2</italic>) TaqMan qPCR assay and standard curve information, used for relative qPCR-based transcript quantification: Note that the amplicon is very small (70 bp). The probe is 5’-FAM (6-carboxyfluorescein) and 3’-NFQ (non-fluorescent quencher) labelled. The assay Mm01333550_m1 (assay-ID) was used (assay location 583) spanning exon-boundary 4–5 of the mouse β2 gene (<italic>Cacnb2</italic>). Assay parameters were as follows: threshold for analysis: 0.05, Y-intercept of standard curve: 43.5±0.2, slope: –3.43±0.04, R<sup>2</sup>: 1.0±0.0: means ± SEM, n=5.</p></sec><sec id="s4-14"><title>Statistics</title><p>Data were analyzed using Clampfit 10.7 (Axon Instruments), Microsoft Excel, SigmaPlot 14.0 (Systat Software, Inc), and GraphPad Prism 5, 7.04 or 8 software (GraphPad software, Inc). Data were analyzed by appropriate statistical testing as indicated in detail for all experiments in the text, figure and table legends. Statistical significance was set at &lt;0.05. Brain slice patch-clamp data were also analyzed with FitMaster (v2 × 90.5, HEKA Elektronik). RNAscope and single-cell RT-qPCR data data were analyzed by Fiji (<ext-link ext-link-type="uri" xlink:href="https://imagej.net/Fiji">https://imagej.net/Fiji</ext-link>), QuantStudio Design and Analysis Software (Applied Biosystems) and GraphPad Prism 7.04. All values are presented as mean ± SEM (95% confidence interval) for the indicated number of experiments (n) from N independent experiments (biological replications) in the text and Figures unless stated otherwise.</p></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>The authors declare that they have no financial and non-financial competing interests</p></fn><fn fn-type="COI-statement" id="conf2"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Data curation, Formal analysis, Visualization, Writing – original draft, Writing – review and editing</p></fn><fn fn-type="con" id="con2"><p>Data curation, Formal analysis, Writing – review and editing</p></fn><fn fn-type="con" id="con3"><p>Data curation, Formal analysis, Writing – review and editing</p></fn><fn fn-type="con" id="con4"><p>Data curation, Writing – review and editing, Formal analysis</p></fn><fn fn-type="con" id="con5"><p>Data curation, Formal analysis, Writing – review and editing</p></fn><fn fn-type="con" id="con6"><p>Data curation, Formal analysis, Writing – review and editing</p></fn><fn fn-type="con" id="con7"><p>Data curation, Formal analysis, Writing – review and editing</p></fn><fn fn-type="con" id="con8"><p>Data curation, Formal analysis, Writing – review and editing</p></fn><fn fn-type="con" id="con9"><p>Data curation, Formal analysis, Writing – review and editing</p></fn><fn fn-type="con" id="con10"><p>Data curation, Formal analysis, Writing – review and editing</p></fn><fn fn-type="con" id="con11"><p>Data curation, Writing – review and editing</p></fn><fn fn-type="con" id="con12"><p>Methodology, Writing – review and editing</p></fn><fn fn-type="con" id="con13"><p>Resources, Writing – review and editing</p></fn><fn fn-type="con" id="con14"><p>Data curation, Formal analysis, Writing – review and editing</p></fn><fn fn-type="con" id="con15"><p>Supervision, Writing – review and editing, Formal analysis, Funding acquisition</p></fn><fn fn-type="con" id="con16"><p>Formal analysis, Supervision, Writing – review and editing</p></fn><fn fn-type="con" id="con17"><p>Formal analysis, Supervision, Funding acquisition, Writing – review and editing</p></fn><fn fn-type="con" id="con18"><p>Conceptualization, Formal analysis, Supervision, Funding acquisition, Methodology, Writing – original draft, Writing – review and editing</p></fn><fn fn-type="con" id="con19"><p>Conceptualization, Supervision, Funding acquisition, Writing – original draft, Project administration, Writing – review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>All animal experiments and procedures were performed in strict accordance with the European Community's Council Directive 2010/63/UE and approved by the Italian Ministry of Health and the Local Organism responsible for animal welfare at the University of Torino (authorization DGSAF 0011710-P-26/07/2017) and the local authorities at the University of Ulm (Regierungsprä;sidium Tübingen, Ref: 35/9185.81-3; Reg. Nr. o.147) and University of Cologne (LANUV NRW, Recklinghausen, Germany (84-02.05.20.12.254)).</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>Names, cellular functions and assay ID’s of endogenous control genes.</title><p>For details see methods.</p></caption><media xlink:href="elife-67464-supp1-v4.docx" mimetype="application" mime-subtype="docx"/></supplementary-material><supplementary-material id="supp2"><label>Supplementary file 2.</label><caption><title>TaqMan assays for β1–4 isoforms and N-terminal β2 splice variants including cDNA specific primer sequences for standard template cloning.</title><p>Additional SalI and HindIII restriction enzyme sites (see Methods) are underlined; the reverse (rev) primer used for standard template cloning including the HindIII restriction site was the same for β2a-e subunit variants; rev, reverse; fwd, forward.</p></caption><media xlink:href="elife-67464-supp2-v4.docx" mimetype="application" mime-subtype="docx"/></supplementary-material><supplementary-material id="supp3"><label>Supplementary file 3.</label><caption><title>Quantitative RT-PCR standard curve parameters.</title><p>SE-B, SE-Y, standard error of B and Y-intercept; Y-int., Y-intercept (CT value); R<sup>2</sup>, squared correlation coefficient; LOD, limit of detection (number of transcripts); LOQ, limit of quantification (number of transcripts); E (%), Efficiency in % (E=10–1/slope-1), 100% efficiency corresponds to a slope of –3.32.</p></caption><media xlink:href="elife-67464-supp3-v4.docx" mimetype="application" mime-subtype="docx"/></supplementary-material><supplementary-material id="supp4"><label>Supplementary file 4.</label><caption><title>Single cell gene expression data.</title><p>Data and statistics of genes as indicated for graphs shown in <xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2A</xref> (middle) and B (right). n represents number of analyzed dopaminergic neurons derived from N individual mice. Significances according to two-way ANOVA followed by Tukey’s multiple comparisons test: ***, <italic>P</italic>&lt;0.001.</p></caption><media xlink:href="elife-67464-supp4-v4.docx" mimetype="application" mime-subtype="docx"/></supplementary-material><supplementary-material id="supp5"><label>Supplementary file 5.</label><caption><title>Multiplex PCR (outer) and nested PCR (inner) primers for qualitative PCR.</title><p>F: forward primer, R: reverse primer</p></caption><media xlink:href="elife-67464-supp5-v4.docx" mimetype="application" mime-subtype="docx"/></supplementary-material><supplementary-material id="supp6"><label>Supplementary file 6.</label><caption><title>Voltage-dependence of activation and inactivation of Cav1.3 co-transfected with α2δ1 and different β-subunits in tsA-201 cells.</title><p>All values are given as mean ± SEM for the indicated number of experiments (n, N=2). Parameters were obtained as described in Materials and Methods from a holding potential of –89 mV using 15 mM Ca<sup>2+</sup> as the charge carrier. Voltage-dependence of gating: Parameters are as given in legend to <xref ref-type="table" rid="table1">Table 1</xref>. Statistical significance was determined using one-way ANOVA with Bonferroni post-hoc test (V<sub>0.5</sub>, V<sub>rev</sub>, act thresh, V<sub>0.5,inact</sub>, k<sub>inact</sub>, plateau) or Kruskal-Wallis followed by Dunn’s multiple comparison test (k). Statistical significances of post hoc tests are indicated for comparison vs. β2a (*, **, ***) or vs. β3 (<sup>§</sup>, <sup>§§</sup>, <sup>§§§</sup>): *** <italic>P</italic>&lt;0.001; ** <italic>P</italic>&lt;0.01; * <italic>P</italic>&lt;0.05. Inactivation time course: The r values represent the fraction of I<sub>Ca</sub> remaining after 50, 100, 250, 500, 1,000 or 5000 ms during a 5 s pulse to V<sub>max</sub>. Statistical significance was determined using one-way ANOVA with Bonferroni post-hoc test. Statistical significances of post hoc tests are indicated for comparison vs. β2a: *** <italic>P</italic>&lt;0.001; ** <italic>P</italic>&lt;0.01; * <italic>P</italic>&lt;0.05.</p></caption><media xlink:href="elife-67464-supp6-v4.docx" mimetype="application" mime-subtype="docx"/></supplementary-material><supplementary-material id="supp7"><label>Supplementary file 7.</label><caption><title>Inhibition of ICa in identified SN DA neurons of adult (12 weeks) mice by 100 nM SNX-482 and 10 µM nifedipine (perforated-patch clamp).</title><p>For details see results. Experiments were performed as described in detail in the Methods section and <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1</xref>.</p></caption><media xlink:href="elife-67464-supp7-v4.docx" mimetype="application" mime-subtype="docx"/></supplementary-material><supplementary-material id="transrepform"><label>Transparent reporting form</label><media xlink:href="elife-67464-transrepform1-v4.docx" mimetype="application" mime-subtype="docx"/></supplementary-material><supplementary-material id="sdata1"><label>Source data 1.</label><caption><title>Original images.</title></caption><media xlink:href="elife-67464-data1-v4.zip" mimetype="application" mime-subtype="zip"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>All data generated or analyzed during this study are included in the manuscript and supporting files. Raw data have been provided for mean population data shown in figures and tables.</p><p>The following previously published datasets were used:</p><p><element-citation publication-type="data" specific-use="references" id="dataset1"><person-group person-group-type="author"><name><surname>Shin</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2015">2015</year><data-title>RNASeq of DA neurons from SNpc and VTA. Dataset posted on 04.03.2015, 16:01 by William Shin</data-title><source>figshare</source><pub-id pub-id-type="doi">10.6084/m9.figshare.926519.v1</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset2"><person-group person-group-type="author"><collab>Aguila et al.</collab></person-group><year iso-8601-date="2021">2021</year><data-title>RNA Sequencing Identifies Robust Markers of Vulnerable and Resistant Human Midbrain Dopamine Neurons and Their Expression in Parkinson's Disease</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE114918">GSE114918</pub-id></element-citation></p></sec><ack id="ack"><title>Acknowledgements</title><p>We thank Dr. Veit Flockerzi for cDNA of β2 splice variants, and Jennifer Müller and Gospava Stojanovic for expert technical assistance.</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aguila</surname><given-names>J</given-names></name><name><surname>Cheng</surname><given-names>S</given-names></name><name><surname>Kee</surname><given-names>N</given-names></name><name><surname>Cao</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>M</given-names></name><name><surname>Deng</surname><given-names>Q</given-names></name><name><surname>Hedlund</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Spatial RNA sequencing identifies robust markers of vulnerable and resistant human midbrain dopamine neurons and their expression in parkinson’s disease</article-title><source>Frontiers in Molecular Neuroscience</source><volume>14</volume><elocation-id>699562</elocation-id><pub-id pub-id-type="doi">10.3389/fnmol.2021.699562</pub-id><pub-id pub-id-type="pmid">34305528</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akaike</surname><given-names>N</given-names></name><name><surname>Harata</surname><given-names>N</given-names></name></person-group><year iso-8601-date="1994">1994</year><article-title>Nystatin perforated patch recording and its applications to analyses of intracellular mechanisms</article-title><source>The Japanese Journal of Physiology</source><volume>44</volume><fpage>433</fpage><lpage>473</lpage><pub-id pub-id-type="doi">10.2170/jjphysiol.44.433</pub-id><pub-id pub-id-type="pmid">7534361</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baldelli</surname><given-names>P</given-names></name><name><surname>Hernandez-Guijo</surname><given-names>JM</given-names></name><name><surname>Carabelli</surname><given-names>V</given-names></name><name><surname>Carbone</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Brain-derived neurotrophic factor enhances GABA release probability and nonuniform distribution of N- and P/Q-type channels on release sites of hippocampal inhibitory synapses</article-title><source>The Journal of Neuroscience</source><volume>25</volume><fpage>3358</fpage><lpage>3368</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.4227-04.2005</pub-id><pub-id pub-id-type="pmid">15800191</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benkert</surname><given-names>J</given-names></name><name><surname>Hess</surname><given-names>S</given-names></name><name><surname>Roy</surname><given-names>S</given-names></name><name><surname>Beccano-Kelly</surname><given-names>D</given-names></name><name><surname>Wiederspohn</surname><given-names>N</given-names></name><name><surname>Duda</surname><given-names>J</given-names></name><name><surname>Simons</surname><given-names>C</given-names></name><name><surname>Patil</surname><given-names>K</given-names></name><name><surname>Gaifullina</surname><given-names>A</given-names></name><name><surname>Mannal</surname><given-names>N</given-names></name><name><surname>Dragicevic</surname><given-names>E</given-names></name><name><surname>Spaich</surname><given-names>D</given-names></name><name><surname>Müller</surname><given-names>S</given-names></name><name><surname>Nemeth</surname><given-names>J</given-names></name><name><surname>Hollmann</surname><given-names>H</given-names></name><name><surname>Deuter</surname><given-names>N</given-names></name><name><surname>Mousba</surname><given-names>Y</given-names></name><name><surname>Kubisch</surname><given-names>C</given-names></name><name><surname>Poetschke</surname><given-names>C</given-names></name><name><surname>Striessnig</surname><given-names>J</given-names></name><name><surname>Pongs</surname><given-names>O</given-names></name><name><surname>Schneider</surname><given-names>T</given-names></name><name><surname>Wade-Martins</surname><given-names>R</given-names></name><name><surname>Patel</surname><given-names>S</given-names></name><name><surname>Parlato</surname><given-names>R</given-names></name><name><surname>Frank</surname><given-names>T</given-names></name><name><surname>Kloppenburg</surname><given-names>P</given-names></name><name><surname>Liss</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Cav2.3 channels contribute to dopaminergic neuron loss in a model of Parkinson’s disease</article-title><source>Nature Communications</source><volume>10</volume><elocation-id>5094</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-019-12834-x</pub-id><pub-id pub-id-type="pmid">31704946</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bian</surname><given-names>X</given-names></name><name><surname>Zhou</surname><given-names>X</given-names></name><name><surname>Galligan</surname><given-names>JJ</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>R-type calcium channels in myenteric neurons of guinea pig small intestine</article-title><source>American Journal of Physiology. Gastrointestinal and Liver Physiology</source><volume>287</volume><fpage>G134</fpage><lpage>G142</lpage><pub-id pub-id-type="doi">10.1152/ajpgi.00532.2003</pub-id><pub-id pub-id-type="pmid">14988068</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Biglan</surname><given-names>KM</given-names></name><name><surname>Oakes</surname><given-names>D</given-names></name><name><surname>Lang</surname><given-names>AE</given-names></name><name><surname>Hauser</surname><given-names>RA</given-names></name><name><surname>Hodgeman</surname><given-names>K</given-names></name><name><surname>Greco</surname><given-names>B</given-names></name><name><surname>Lowell</surname><given-names>J</given-names></name><name><surname>Rockhill</surname><given-names>R</given-names></name><name><surname>Shoulson</surname><given-names>I</given-names></name><name><surname>Venuto</surname><given-names>C</given-names></name><name><surname>Young</surname><given-names>D</given-names></name><name><surname>Simuni</surname><given-names>T</given-names></name><name><surname>Investigators</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>A novel design of A Phase III trial of isradipine in early Parkinson disease (STEADY-PD III)</article-title><source>Annals of Clinical and Translational Neurology</source><volume>4</volume><fpage>360</fpage><lpage>368</lpage><pub-id pub-id-type="doi">10.1002/acn3.412</pub-id><pub-id pub-id-type="pmid">28589163</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bijlmakers</surname><given-names>MJ</given-names></name><name><surname>Marsh</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>The on–off story of protein palmitoylation</article-title><source>Trends in Cell Biology</source><volume>13</volume><fpage>32</fpage><lpage>42</lpage><pub-id pub-id-type="doi">10.1016/S0962-8924(02)00008-9</pub-id><pub-id pub-id-type="pmid">12480338</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bock</surname><given-names>G</given-names></name><name><surname>Gebhart</surname><given-names>M</given-names></name><name><surname>Scharinger</surname><given-names>A</given-names></name><name><surname>Jangsangthong</surname><given-names>W</given-names></name><name><surname>Busquet</surname><given-names>P</given-names></name><name><surname>Poggiani</surname><given-names>C</given-names></name><name><surname>Sartori</surname><given-names>S</given-names></name><name><surname>Mangoni</surname><given-names>ME</given-names></name><name><surname>Sinnegger-Brauns</surname><given-names>MJ</given-names></name><name><surname>Herzig</surname><given-names>S</given-names></name><name><surname>Striessnig</surname><given-names>J</given-names></name><name><surname>Koschak</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Functional properties of a newly identified c-terminal splice variant of Cav1.3 L-type Ca2+ channels</article-title><source>Journal of Biological Chemistry</source><volume>286</volume><fpage>42736</fpage><lpage>42748</lpage><pub-id pub-id-type="doi">10.1074/jbc.M111.269951</pub-id><pub-id pub-id-type="pmid">21998310</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bolam</surname><given-names>JP</given-names></name><name><surname>Pissadaki</surname><given-names>EK</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Living on the edge with too many mouths to feed: Why dopamine neurons die</article-title><source>Movement Disorders</source><volume>27</volume><fpage>1478</fpage><lpage>1483</lpage><pub-id pub-id-type="doi">10.1002/mds.25135</pub-id><pub-id pub-id-type="pmid">23008164</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bourinet</surname><given-names>E</given-names></name><name><surname>Stotz</surname><given-names>SC</given-names></name><name><surname>Spaetgens</surname><given-names>RL</given-names></name><name><surname>Dayanithi</surname><given-names>G</given-names></name><name><surname>Lemos</surname><given-names>J</given-names></name><name><surname>Nargeot</surname><given-names>J</given-names></name><name><surname>Zamponi</surname><given-names>GW</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Interaction of SNX482 with domains III and IV inhibits activation gating of α1E (CaV2.3) calcium channels</article-title><source>Biophysical Journal</source><volume>81</volume><fpage>79</fpage><lpage>88</lpage><pub-id pub-id-type="doi">10.1016/S0006-3495(01)75681-0</pub-id><pub-id pub-id-type="pmid">11423396</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Branch</surname><given-names>SY</given-names></name><name><surname>Sharma</surname><given-names>R</given-names></name><name><surname>Beckstead</surname><given-names>MJ</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Aging decreases L-type calcium channel currents and pacemaker firing fidelity in substantia nigra dopamine neurons</article-title><source>The Journal of Neuroscience</source><volume>34</volume><fpage>9310</fpage><lpage>9318</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.4228-13.2014</pub-id><pub-id pub-id-type="pmid">25009264</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brichta</surname><given-names>L</given-names></name><name><surname>Shin</surname><given-names>W</given-names></name><name><surname>Jackson-Lewis</surname><given-names>V</given-names></name><name><surname>Blesa</surname><given-names>J</given-names></name><name><surname>Yap</surname><given-names>EL</given-names></name><name><surname>Walker</surname><given-names>Z</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Roussarie</surname><given-names>JP</given-names></name><name><surname>Alvarez</surname><given-names>MJ</given-names></name><name><surname>Califano</surname><given-names>A</given-names></name><name><surname>Przedborski</surname><given-names>S</given-names></name><name><surname>Greengard</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Identification of neurodegenerative factors using translatome-regulatory network analysis</article-title><source>Nature Neuroscience</source><volume>18</volume><fpage>1325</fpage><lpage>1333</lpage><pub-id pub-id-type="doi">10.1038/nn.4070</pub-id><pub-id pub-id-type="pmid">26214373</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buraei</surname><given-names>Z</given-names></name><name><surname>Yang</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>The ß subunit of voltage-gated Ca2+ channels</article-title><source>Physiological Reviews</source><volume>90</volume><fpage>1461</fpage><lpage>1506</lpage><pub-id pub-id-type="doi">10.1152/physrev.00057.2009</pub-id><pub-id pub-id-type="pmid">20959621</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burbulla</surname><given-names>LF</given-names></name><name><surname>Song</surname><given-names>P</given-names></name><name><surname>Mazzulli</surname><given-names>JR</given-names></name><name><surname>Zampese</surname><given-names>E</given-names></name><name><surname>Wong</surname><given-names>YC</given-names></name><name><surname>Jeon</surname><given-names>S</given-names></name><name><surname>Santos</surname><given-names>DP</given-names></name><name><surname>Blanz</surname><given-names>J</given-names></name><name><surname>Obermaier</surname><given-names>CD</given-names></name><name><surname>Strojny</surname><given-names>C</given-names></name><name><surname>Savas</surname><given-names>JN</given-names></name><name><surname>Kiskinis</surname><given-names>E</given-names></name><name><surname>Zhuang</surname><given-names>X</given-names></name><name><surname>Krüger</surname><given-names>R</given-names></name><name><surname>Surmeier</surname><given-names>DJ</given-names></name><name><surname>Krainc</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson’s disease</article-title><source>Science</source><volume>357</volume><fpage>1255</fpage><lpage>1261</lpage><pub-id pub-id-type="doi">10.1126/science.aam9080</pub-id><pub-id pub-id-type="pmid">28882997</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Calorio</surname><given-names>C</given-names></name><name><surname>Gavello</surname><given-names>D</given-names></name><name><surname>Guarina</surname><given-names>L</given-names></name><name><surname>Salio</surname><given-names>C</given-names></name><name><surname>Sassoè-Pognetto</surname><given-names>M</given-names></name><name><surname>Riganti</surname><given-names>C</given-names></name><name><surname>Bianchi</surname><given-names>FT</given-names></name><name><surname>Hofer</surname><given-names>NT</given-names></name><name><surname>Tuluc</surname><given-names>P</given-names></name><name><surname>Obermair</surname><given-names>GJ</given-names></name><name><surname>Defilippi</surname><given-names>P</given-names></name><name><surname>Balzac</surname><given-names>F</given-names></name><name><surname>Turco</surname><given-names>E</given-names></name><name><surname>Bett</surname><given-names>GC</given-names></name><name><surname>Rasmusson</surname><given-names>RL</given-names></name><name><surname>Carbone</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Impaired chromaffin cell excitability and exocytosis in autistic Timothy syndrome TS2-neo mouse rescued by L-type calcium channel blockers</article-title><source>The Journal of Physiology</source><volume>597</volume><fpage>1705</fpage><lpage>1733</lpage><pub-id pub-id-type="doi">10.1113/JP277487</pub-id><pub-id pub-id-type="pmid">30629744</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Damier</surname><given-names>P</given-names></name><name><surname>Hirsch</surname><given-names>EC</given-names></name><name><surname>Agid</surname><given-names>Y</given-names></name><name><surname>Graybiel</surname><given-names>AM</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson’s disease</article-title><source>Brain : A Journal of Neurology</source><volume>122 ( Pt 8)</volume><fpage>1437</fpage><lpage>1448</lpage><pub-id pub-id-type="doi">10.1093/brain/122.8.1437</pub-id><pub-id pub-id-type="pmid">10430830</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Waard</surname><given-names>M</given-names></name><name><surname>Witcher</surname><given-names>DR</given-names></name><name><surname>Pragnell</surname><given-names>M</given-names></name><name><surname>Liu</surname><given-names>H</given-names></name><name><surname>Campbell</surname><given-names>KP</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>Properties of the alpha 1-beta anchoring site in voltage-dependent Ca2+ channels</article-title><source>The Journal of Biological Chemistry</source><volume>270</volume><fpage>12056</fpage><lpage>12064</lpage><pub-id pub-id-type="doi">10.1074/jbc.270.20.12056</pub-id><pub-id pub-id-type="pmid">7744854</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dragicevic</surname><given-names>E</given-names></name><name><surname>Poetschke</surname><given-names>C</given-names></name><name><surname>Duda</surname><given-names>J</given-names></name><name><surname>Schlaudraff</surname><given-names>F</given-names></name><name><surname>Lammel</surname><given-names>S</given-names></name><name><surname>Schiemann</surname><given-names>J</given-names></name><name><surname>Fauler</surname><given-names>M</given-names></name><name><surname>Hetzel</surname><given-names>A</given-names></name><name><surname>Watanabe</surname><given-names>M</given-names></name><name><surname>Lujan</surname><given-names>R</given-names></name><name><surname>Malenka</surname><given-names>RC</given-names></name><name><surname>Striessnig</surname><given-names>J</given-names></name><name><surname>Liss</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Cav1.3 channels control D2-autoreceptor responses via NCS-1 in substantia nigra dopamine neurons</article-title><source>Brain: A Journal of Neurology</source><volume>137</volume><fpage>2287</fpage><lpage>2302</lpage><pub-id pub-id-type="doi">10.1093/brain/awu131</pub-id><pub-id pub-id-type="pmid">24934288</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dragicevic</surname><given-names>E</given-names></name><name><surname>Schiemann</surname><given-names>J</given-names></name><name><surname>Liss</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Dopamine midbrain neurons in health and Parkinson’s disease: emerging roles of voltage-gated calcium channels and ATP-sensitive potassium channels</article-title><source>Neuroscience</source><volume>284</volume><fpage>798</fpage><lpage>814</lpage><pub-id pub-id-type="doi">10.1016/j.neuroscience.2014.10.037</pub-id><pub-id pub-id-type="pmid">25450964</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duda</surname><given-names>J</given-names></name><name><surname>Fauler</surname><given-names>M</given-names></name><name><surname>Gründemann</surname><given-names>J</given-names></name><name><surname>Liss</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Cell-specific RNA quantification in human SN DA neurons from heterogeneous post-mortem midbrain samples by UV-laser microdissection and RT-qPCR</article-title><source>Methods in Molecular Biology</source><volume>1723</volume><fpage>335</fpage><lpage>360</lpage><pub-id pub-id-type="doi">10.1007/978-1-4939-7558-7_19</pub-id><pub-id pub-id-type="pmid">29344870</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Etemad</surname><given-names>S</given-names></name><name><surname>Obermair</surname><given-names>GJ</given-names></name><name><surname>Bindreither</surname><given-names>D</given-names></name><name><surname>Benedetti</surname><given-names>A</given-names></name><name><surname>Stanika</surname><given-names>R</given-names></name><name><surname>Di Biase</surname><given-names>V</given-names></name><name><surname>Burtscher</surname><given-names>V</given-names></name><name><surname>Koschak</surname><given-names>A</given-names></name><name><surname>Kofler</surname><given-names>R</given-names></name><name><surname>Geley</surname><given-names>S</given-names></name><name><surname>Wille</surname><given-names>A</given-names></name><name><surname>Lusser</surname><given-names>A</given-names></name><name><surname>Flockerzi</surname><given-names>V</given-names></name><name><surname>Flucher</surname><given-names>BE</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Differential neuronal targeting of a new and two known calcium channel β4 subunit splice variants correlates with their regulation of gene expression</article-title><source>The Journal of Neuroscience</source><volume>34</volume><fpage>1446</fpage><lpage>1461</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.3935-13.2014</pub-id><pub-id pub-id-type="pmid">24453333</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Evans</surname><given-names>RC</given-names></name><name><surname>Zhu</surname><given-names>M</given-names></name><name><surname>Khaliq</surname><given-names>ZM</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Dopamine inhibition differentially controls excitability of substantia nigra dopamine neuron subpopulations through T-type calcium channels</article-title><source>The Journal of Neuroscience</source><volume>37</volume><fpage>3704</fpage><lpage>3720</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.0117-17.2017</pub-id><pub-id pub-id-type="pmid">28264982</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gantz</surname><given-names>SC</given-names></name><name><surname>Ford</surname><given-names>CP</given-names></name><name><surname>Morikawa</surname><given-names>H</given-names></name><name><surname>Williams</surname><given-names>JT</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>The evolving understanding of dopamine neurons in the substantia nigra and ventral tegmental area</article-title><source>Annual Review of Physiology</source><volume>80</volume><fpage>219</fpage><lpage>241</lpage><pub-id pub-id-type="doi">10.1146/annurev-physiol-021317-121615</pub-id><pub-id pub-id-type="pmid">28938084</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gavello</surname><given-names>D</given-names></name><name><surname>Calorio</surname><given-names>C</given-names></name><name><surname>Franchino</surname><given-names>C</given-names></name><name><surname>Cesano</surname><given-names>F</given-names></name><name><surname>Carabelli</surname><given-names>V</given-names></name><name><surname>Carbone</surname><given-names>E</given-names></name><name><surname>Marcantoni</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Early alterations of hippocampal neuronal firing induced by abeta42</article-title><source>Cerebral Cortex</source><volume>28</volume><fpage>433</fpage><lpage>446</lpage><pub-id pub-id-type="doi">10.1093/cercor/bhw377</pub-id><pub-id pub-id-type="pmid">27999123</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gebhart</surname><given-names>M</given-names></name><name><surname>Juhasz-Vedres</surname><given-names>G</given-names></name><name><surname>Zuccotti</surname><given-names>A</given-names></name><name><surname>Brandt</surname><given-names>N</given-names></name><name><surname>Engel</surname><given-names>J</given-names></name><name><surname>Trockenbacher</surname><given-names>A</given-names></name><name><surname>Kaur</surname><given-names>G</given-names></name><name><surname>Obermair</surname><given-names>GJ</given-names></name><name><surname>Knipper</surname><given-names>M</given-names></name><name><surname>Koschak</surname><given-names>A</given-names></name><name><surname>Striessnig</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Modulation of Cav1.3 Ca2+ channel gating by Rab3 interacting molecule</article-title><source>Molecular and Cellular Neurosciences</source><volume>44</volume><fpage>246</fpage><lpage>259</lpage><pub-id pub-id-type="doi">10.1016/j.mcn.2010.03.011</pub-id><pub-id pub-id-type="pmid">20363327</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giguère</surname><given-names>N</given-names></name><name><surname>Burke Nanni</surname><given-names>S</given-names></name><name><surname>Trudeau</surname><given-names>LE</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>On cell loss and selective vulnerability of neuronal populations in parkinson’s disease</article-title><source>Frontiers in Neurology</source><volume>9</volume><elocation-id>455</elocation-id><pub-id pub-id-type="doi">10.3389/fneur.2018.00455</pub-id><pub-id pub-id-type="pmid">29971039</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grabner</surname><given-names>M</given-names></name><name><surname>Dirksen</surname><given-names>RT</given-names></name><name><surname>Beam</surname><given-names>KG</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Tagging with green fluorescent protein reveals a distinct subcellular distribution of L-type and non-L-type Ca <sup>2+</sup> channels expressed in dysgenic myotubes</article-title><source>PNAS</source><volume>95</volume><fpage>1903</fpage><lpage>1908</lpage><pub-id pub-id-type="doi">10.1073/pnas.95.4.1903</pub-id><pub-id pub-id-type="pmid">9465115</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grace</surname><given-names>AA</given-names></name><name><surname>Bunney</surname><given-names>BS</given-names></name></person-group><year iso-8601-date="1984">1984</year><article-title>The control of firing pattern in nigral dopamine neurons: single spike firing</article-title><source>The Journal of Neuroscience</source><volume>4</volume><fpage>2866</fpage><lpage>2876</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.04-11-02866.1984</pub-id><pub-id pub-id-type="pmid">6150070</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gründemann</surname><given-names>J</given-names></name><name><surname>Schlaudraff</surname><given-names>F</given-names></name><name><surname>Liss</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>UV-laser microdissection and mRNA expression analysis of individual neurons from postmortem Parkinson’s disease brains</article-title><source>Methods in Molecular Biology</source><volume>755</volume><fpage>363</fpage><lpage>374</lpage><pub-id pub-id-type="doi">10.1007/978-1-61779-163-5_30</pub-id><pub-id pub-id-type="pmid">21761319</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guarina</surname><given-names>L</given-names></name><name><surname>Calorio</surname><given-names>C</given-names></name><name><surname>Gavello</surname><given-names>D</given-names></name><name><surname>Moreva</surname><given-names>E</given-names></name><name><surname>Traina</surname><given-names>P</given-names></name><name><surname>Battiato</surname><given-names>A</given-names></name><name><surname>Ditalia Tchernij</surname><given-names>S</given-names></name><name><surname>Forneris</surname><given-names>J</given-names></name><name><surname>Gai</surname><given-names>M</given-names></name><name><surname>Picollo</surname><given-names>F</given-names></name><name><surname>Olivero</surname><given-names>P</given-names></name><name><surname>Genovese</surname><given-names>M</given-names></name><name><surname>Carbone</surname><given-names>E</given-names></name><name><surname>Marcantoni</surname><given-names>A</given-names></name><name><surname>Carabelli</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Nanodiamonds-induced effects on neuronal firing of mouse hippocampal microcircuits</article-title><source>Scientific Reports</source><volume>8</volume><elocation-id>2221</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-018-20528-5</pub-id><pub-id pub-id-type="pmid">29396456</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guzman</surname><given-names>JN</given-names></name><name><surname>Sánchez-Padilla</surname><given-names>J</given-names></name><name><surname>Chan</surname><given-names>CS</given-names></name><name><surname>Surmeier</surname><given-names>DJ</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Robust pacemaking in substantia nigra dopaminergic neurons</article-title><source>The Journal of Neuroscience</source><volume>29</volume><fpage>11011</fpage><lpage>11019</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.2519-09.2009</pub-id><pub-id pub-id-type="pmid">19726659</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guzman</surname><given-names>JN</given-names></name><name><surname>Ilijic</surname><given-names>E</given-names></name><name><surname>Yang</surname><given-names>B</given-names></name><name><surname>Sanchez-Padilla</surname><given-names>J</given-names></name><name><surname>Wokosin</surname><given-names>D</given-names></name><name><surname>Galtieri</surname><given-names>D</given-names></name><name><surname>Kondapalli</surname><given-names>J</given-names></name><name><surname>Schumacker</surname><given-names>PT</given-names></name><name><surname>Surmeier</surname><given-names>DJ</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Systemic isradipine treatment diminishes calcium-dependent mitochondrial oxidant stress</article-title><source>The Journal of Clinical Investigation</source><volume>128</volume><fpage>2266</fpage><lpage>2280</lpage><pub-id pub-id-type="doi">10.1172/JCI95898</pub-id><pub-id pub-id-type="pmid">29708514</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hess</surname><given-names>ME</given-names></name><name><surname>Hess</surname><given-names>S</given-names></name><name><surname>Meyer</surname><given-names>KD</given-names></name><name><surname>Verhagen</surname><given-names>LAW</given-names></name><name><surname>Koch</surname><given-names>L</given-names></name><name><surname>Brönneke</surname><given-names>HS</given-names></name><name><surname>Dietrich</surname><given-names>MO</given-names></name><name><surname>Jordan</surname><given-names>SD</given-names></name><name><surname>Saletore</surname><given-names>Y</given-names></name><name><surname>Elemento</surname><given-names>O</given-names></name><name><surname>Belgardt</surname><given-names>BF</given-names></name><name><surname>Franz</surname><given-names>T</given-names></name><name><surname>Horvath</surname><given-names>TL</given-names></name><name><surname>Rüther</surname><given-names>U</given-names></name><name><surname>Jaffrey</surname><given-names>SR</given-names></name><name><surname>Kloppenburg</surname><given-names>P</given-names></name><name><surname>Brüning</surname><given-names>JC</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>The fat mass and obesity associated gene (Fto) regulates activity of the dopaminergic midbrain circuitry</article-title><source>Nature Neuroscience</source><volume>16</volume><fpage>1042</fpage><lpage>1048</lpage><pub-id pub-id-type="doi">10.1038/nn.3449</pub-id><pub-id pub-id-type="pmid">23817550</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hofer</surname><given-names>NT</given-names></name><name><surname>Tuluc</surname><given-names>P</given-names></name><name><surname>Ortner</surname><given-names>NJ</given-names></name><name><surname>Nikonishyna</surname><given-names>YV</given-names></name><name><surname>Fernándes-Quintero</surname><given-names>ML</given-names></name><name><surname>Liedl</surname><given-names>KR</given-names></name><name><surname>Flucher</surname><given-names>BE</given-names></name><name><surname>Cox</surname><given-names>H</given-names></name><name><surname>Striessnig</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Biophysical classification of a CACNA1D de novo mutation as a high-risk mutation for a severe neurodevelopmental disorder</article-title><source>Molecular Autism</source><volume>11</volume><elocation-id>4</elocation-id><pub-id pub-id-type="doi">10.1186/s13229-019-0310-4</pub-id><pub-id pub-id-type="pmid">31921405</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Horn</surname><given-names>R</given-names></name><name><surname>Marty</surname><given-names>A</given-names></name></person-group><year iso-8601-date="1988">1988</year><article-title>Muscarinic activation of ionic currents measured by a new whole-cell recording method</article-title><source>The Journal of General Physiology</source><volume>92</volume><fpage>145</fpage><lpage>159</lpage><pub-id pub-id-type="doi">10.1085/jgp.92.2.145</pub-id><pub-id pub-id-type="pmid">2459299</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Investigators</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Isradipine versus placebo in early parkinson disease: A randomized trial</article-title><source>Annals of Internal Medicine</source><volume>172</volume><fpage>591</fpage><lpage>598</lpage><pub-id pub-id-type="doi">10.7326/M19-2534</pub-id><pub-id pub-id-type="pmid">32227247</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname><given-names>LP</given-names></name><name><surname>Wei</surname><given-names>SK</given-names></name><name><surname>Yue</surname><given-names>DT</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Mechanism of auxiliary subunit modulation of neuronal alpha1E calcium channels</article-title><source>The Journal of General Physiology</source><volume>112</volume><fpage>125</fpage><lpage>143</lpage><pub-id pub-id-type="doi">10.1085/jgp.112.2.125</pub-id><pub-id pub-id-type="pmid">9689023</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kato</surname><given-names>M</given-names></name><name><surname>Ui-Tei</surname><given-names>K</given-names></name><name><surname>Watanabe</surname><given-names>M</given-names></name><name><surname>Sakuma</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Characterization of voltage-gated calcium currents in gonadotropin-releasing hormone neurons tagged with green fluorescent protein in rats</article-title><source>Endocrinology</source><volume>144</volume><fpage>5118</fpage><lpage>5125</lpage><pub-id pub-id-type="doi">10.1210/en.2003-0213</pub-id><pub-id pub-id-type="pmid">12960038</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kepplinger</surname><given-names>KJ</given-names></name><name><surname>Förstner</surname><given-names>G</given-names></name><name><surname>Kahr</surname><given-names>H</given-names></name><name><surname>Leitner</surname><given-names>K</given-names></name><name><surname>Pammer</surname><given-names>P</given-names></name><name><surname>Groschner</surname><given-names>K</given-names></name><name><surname>Soldatov</surname><given-names>NM</given-names></name><name><surname>Romanin</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Molecular determinant for run-down of L-type Ca2+ channels localized in the carboxyl terminus of the 1C subunit</article-title><source>The Journal of Physiology</source><volume>529 Pt 1</volume><fpage>119</fpage><lpage>130</lpage><pub-id pub-id-type="doi">10.1111/j.1469-7793.2000.00119.x</pub-id><pub-id pub-id-type="pmid">11080256</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>J</given-names></name><name><surname>Wei</surname><given-names>DS</given-names></name><name><surname>Hoffman</surname><given-names>DA</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Kv4 potassium channel subunits control action potential repolarization and frequency-dependent broadening in rat hippocampal CA1 pyramidal neurones</article-title><source>The Journal of Physiology</source><volume>569</volume><fpage>41</fpage><lpage>57</lpage><pub-id pub-id-type="doi">10.1113/jphysiol.2005.095042</pub-id><pub-id pub-id-type="pmid">16141270</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kimm</surname><given-names>T</given-names></name><name><surname>Bean</surname><given-names>BP</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Inhibition of a-type potassium current by the peptide toxin SNX-482</article-title><source>Journal of Neuroscience</source><volume>34</volume><fpage>9182</fpage><lpage>9189</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.0339-14.2014</pub-id><pub-id pub-id-type="pmid">25009251</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kiyonaka</surname><given-names>S</given-names></name><name><surname>Wakamori</surname><given-names>M</given-names></name><name><surname>Miki</surname><given-names>T</given-names></name><name><surname>Uriu</surname><given-names>Y</given-names></name><name><surname>Nonaka</surname><given-names>M</given-names></name><name><surname>Bito</surname><given-names>H</given-names></name><name><surname>Beedle</surname><given-names>AM</given-names></name><name><surname>Mori</surname><given-names>E</given-names></name><name><surname>Hara</surname><given-names>Y</given-names></name><name><surname>De Waard</surname><given-names>M</given-names></name><name><surname>Kanagawa</surname><given-names>M</given-names></name><name><surname>Itakura</surname><given-names>M</given-names></name><name><surname>Takahashi</surname><given-names>M</given-names></name><name><surname>Campbell</surname><given-names>KP</given-names></name><name><surname>Mori</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>RIM1 confers sustained activity and neurotransmitter vesicle anchoring to presynaptic Ca2+ channels</article-title><source>Nature Neuroscience</source><volume>10</volume><fpage>691</fpage><lpage>701</lpage><pub-id pub-id-type="doi">10.1038/nn1904</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koschak</surname><given-names>A</given-names></name><name><surname>Reimer</surname><given-names>D</given-names></name><name><surname>Huber</surname><given-names>I</given-names></name><name><surname>Grabner</surname><given-names>M</given-names></name><name><surname>Glossmann</surname><given-names>H</given-names></name><name><surname>Engel</surname><given-names>J</given-names></name><name><surname>Striessnig</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>α1D (Cav1.3) subunits can form L-type Ca2+ channels activating at negative voltages</article-title><source>Journal of Biological Chemistry</source><volume>276</volume><fpage>22100</fpage><lpage>22106</lpage><pub-id pub-id-type="doi">10.1074/jbc.M101469200</pub-id><pub-id pub-id-type="pmid">11285265</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lacey</surname><given-names>MG</given-names></name><name><surname>Mercuri</surname><given-names>NB</given-names></name><name><surname>North</surname><given-names>RA</given-names></name></person-group><year iso-8601-date="1989">1989</year><article-title>Two cell types in rat substantia nigra zona compacta distinguished by membrane properties and the actions of dopamine and opioids</article-title><source>The Journal of Neuroscience</source><volume>9</volume><fpage>1233</fpage><lpage>1241</lpage><pub-id pub-id-type="pmid">2703874</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lieb</surname><given-names>A</given-names></name><name><surname>Ortner</surname><given-names>N</given-names></name><name><surname>Striessnig</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>C-terminal modulatory domain controls coupling of voltage-sensing to pore opening in Cav1.3 L-type Ca2+ channels</article-title><source>Biophysical Journal</source><volume>106</volume><fpage>1467</fpage><lpage>1475</lpage><pub-id pub-id-type="doi">10.1016/j.bpj.2014.02.017</pub-id><pub-id pub-id-type="pmid">24703308</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lindau</surname><given-names>M</given-names></name><name><surname>Fernandez</surname><given-names>JM</given-names></name></person-group><year iso-8601-date="1986">1986</year><article-title>IgE-mediated degranulation of mast cells does not require opening of ion channels</article-title><source>Nature</source><volume>319</volume><fpage>150</fpage><lpage>153</lpage><pub-id pub-id-type="doi">10.1038/319150a0</pub-id><pub-id pub-id-type="pmid">2417125</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Link</surname><given-names>S</given-names></name><name><surname>Meissner</surname><given-names>M</given-names></name><name><surname>Held</surname><given-names>B</given-names></name><name><surname>Beck</surname><given-names>A</given-names></name><name><surname>Weissgerber</surname><given-names>P</given-names></name><name><surname>Freichel</surname><given-names>M</given-names></name><name><surname>Flockerzi</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Diversity and developmental expression of L-type calcium channel beta2 proteins and their influence on calcium current in murine heart</article-title><source>The Journal of Biological Chemistry</source><volume>284</volume><fpage>30129</fpage><lpage>30137</lpage><pub-id pub-id-type="doi">10.1074/jbc.M109.045583</pub-id><pub-id pub-id-type="pmid">19723630</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liss</surname><given-names>B</given-names></name><name><surname>Franz</surname><given-names>O</given-names></name><name><surname>Sewing</surname><given-names>S</given-names></name><name><surname>Bruns</surname><given-names>R</given-names></name><name><surname>Neuhoff</surname><given-names>H</given-names></name><name><surname>Roeper</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Tuning pacemaker frequency of individual dopaminergic neurons by Kv4.3L and KChip3.1 transcription</article-title><source>The EMBO Journal</source><volume>20</volume><fpage>5715</fpage><lpage>5724</lpage><pub-id pub-id-type="doi">10.1093/emboj/20.20.5715</pub-id><pub-id pub-id-type="pmid">11598014</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liss</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Improved quantitative real-time RT-PCR for expression profiling of individual cells</article-title><source>Nucleic Acids Research</source><volume>30</volume><elocation-id>e89</elocation-id><pub-id pub-id-type="doi">10.1093/nar/gnf088</pub-id><pub-id pub-id-type="pmid">12202777</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liss</surname><given-names>B</given-names></name><name><surname>Striessnig</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>The potential of l-type calcium channels as a drug target for neuroprotective therapy in parkinson’s disease</article-title><source>Annual Review of Pharmacology and Toxicology</source><volume>59</volume><fpage>263</fpage><lpage>289</lpage><pub-id pub-id-type="doi">10.1146/annurev-pharmtox-010818-021214</pub-id><pub-id pub-id-type="pmid">30625283</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>H</given-names></name><name><surname>De Waard</surname><given-names>M</given-names></name><name><surname>Scott</surname><given-names>VE</given-names></name><name><surname>Gurnett</surname><given-names>CA</given-names></name><name><surname>Lennon</surname><given-names>VA</given-names></name><name><surname>Campbell</surname><given-names>KP</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>Identification of three subunits of the high affinity omega-conotoxin MVIIC-sensitive Ca2+ channel</article-title><source>The Journal of Biological Chemistry</source><volume>271</volume><fpage>13804</fpage><lpage>13810</lpage><pub-id pub-id-type="pmid">8662888</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsushita</surname><given-names>N</given-names></name><name><surname>Okada</surname><given-names>H</given-names></name><name><surname>Yasoshima</surname><given-names>Y</given-names></name><name><surname>Takahashi</surname><given-names>K</given-names></name><name><surname>Kiuchi</surname><given-names>K</given-names></name><name><surname>Kobayashi</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Dynamics of tyrosine hydroxylase promoter activity during midbrain dopaminergic neuron development</article-title><source>Journal of Neurochemistry</source><volume>82</volume><fpage>295</fpage><lpage>304</lpage><pub-id pub-id-type="doi">10.1046/j.1471-4159.2002.00972.x</pub-id><pub-id pub-id-type="pmid">12124430</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matt</surname><given-names>L</given-names></name><name><surname>Kim</surname><given-names>K</given-names></name><name><surname>Chowdhury</surname><given-names>D</given-names></name><name><surname>Hell</surname><given-names>JW</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Role of palmitoylation of postsynaptic proteins in promoting synaptic plasticity</article-title><source>Frontiers in Molecular Neuroscience</source><volume>12</volume><elocation-id>8</elocation-id><pub-id pub-id-type="doi">10.3389/fnmol.2019.00008</pub-id><pub-id pub-id-type="pmid">30766476</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mercuri</surname><given-names>NB</given-names></name><name><surname>Bonci</surname><given-names>A</given-names></name><name><surname>Calabresi</surname><given-names>P</given-names></name><name><surname>Stratta</surname><given-names>F</given-names></name><name><surname>Stefani</surname><given-names>A</given-names></name><name><surname>Bernardi</surname><given-names>G</given-names></name></person-group><year iso-8601-date="1994">1994</year><article-title>Effects of dihydropyridine calcium antagonists on rat midbrain dopaminergic neurones</article-title><source>British Journal of Pharmacology</source><volume>113</volume><fpage>831</fpage><lpage>838</lpage><pub-id pub-id-type="doi">10.1111/j.1476-5381.1994.tb17068.x</pub-id><pub-id pub-id-type="pmid">7858874</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miranda-Laferte</surname><given-names>E</given-names></name><name><surname>Ewers</surname><given-names>D</given-names></name><name><surname>Guzman</surname><given-names>RE</given-names></name><name><surname>Jordan</surname><given-names>N</given-names></name><name><surname>Schmidt</surname><given-names>S</given-names></name><name><surname>Hidalgo</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>The N-terminal domain tethers the voltage-gated calcium channel β2e-subunit to the plasma membrane via electrostatic and hydrophobic interactions</article-title><source>The Journal of Biological Chemistry</source><volume>289</volume><fpage>10387</fpage><lpage>10398</lpage><pub-id pub-id-type="doi">10.1074/jbc.M113.507244</pub-id><pub-id pub-id-type="pmid">24519939</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morgenstern</surname><given-names>TJ</given-names></name><name><surname>Park</surname><given-names>J</given-names></name><name><surname>Fan</surname><given-names>QR</given-names></name><name><surname>Colecraft</surname><given-names>HM</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>A potent voltage-gated calcium channel inhibitor engineered from A nanobody targeted to auxiliary Ca<sub>V</sub>β subunits</article-title><source>eLife</source><volume>8</volume><elocation-id>e49253</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.49253</pub-id><pub-id pub-id-type="pmid">31403402</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neher</surname><given-names>E</given-names></name></person-group><year iso-8601-date="1992">1992</year><article-title>Correction for liquid junction potentials in patch clamp experiments</article-title><source>Methods in Enzymology</source><volume>207</volume><fpage>123</fpage><lpage>131</lpage><pub-id pub-id-type="doi">10.1016/0076-6879(92)07008-c</pub-id><pub-id pub-id-type="pmid">1528115</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neuhoff</surname><given-names>H</given-names></name><name><surname>Neu</surname><given-names>A</given-names></name><name><surname>Liss</surname><given-names>B</given-names></name><name><surname>Roeper</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>I(h) channels contribute to the different functional properties of identified dopaminergic subpopulations in the midbrain</article-title><source>The Journal of Neuroscience</source><volume>22</volume><fpage>1290</fpage><lpage>1302</lpage><pub-id pub-id-type="pmid">11850457</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Newcomb</surname><given-names>R</given-names></name><name><surname>Szoke</surname><given-names>B</given-names></name><name><surname>Palma</surname><given-names>A</given-names></name><name><surname>Wang</surname><given-names>G</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Hopkins</surname><given-names>W</given-names></name><name><surname>Cong</surname><given-names>R</given-names></name><name><surname>Miller</surname><given-names>J</given-names></name><name><surname>Urge</surname><given-names>L</given-names></name><name><surname>Tarczy-Hornoch</surname><given-names>K</given-names></name><name><surname>Loo</surname><given-names>JA</given-names></name><name><surname>Dooley</surname><given-names>DJ</given-names></name><name><surname>Nadasdi</surname><given-names>L</given-names></name><name><surname>Tsien</surname><given-names>RW</given-names></name><name><surname>Lemos</surname><given-names>J</given-names></name><name><surname>Miljanich</surname><given-names>G</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Selective peptide antagonist of the class E calcium channel from the venom of the tarantula hysterocrates gigas</article-title><source>Biochemistry</source><volume>37</volume><fpage>15353</fpage><lpage>15362</lpage><pub-id pub-id-type="doi">10.1021/bi981255g</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ortner</surname><given-names>NJ</given-names></name><name><surname>Bock</surname><given-names>G</given-names></name><name><surname>Vandael</surname><given-names>DHF</given-names></name><name><surname>Mauersberger</surname><given-names>R</given-names></name><name><surname>Draheim</surname><given-names>HJ</given-names></name><name><surname>Gust</surname><given-names>R</given-names></name><name><surname>Carbone</surname><given-names>E</given-names></name><name><surname>Tuluc</surname><given-names>P</given-names></name><name><surname>Striessnig</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Pyrimidine-2,4,6-triones are a new class of voltage-gated L-type Ca2+ channel activators</article-title><source>Nature Communications</source><volume>5</volume><elocation-id>3897</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms4897</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ortner</surname><given-names>NJ</given-names></name><name><surname>Bock</surname><given-names>G</given-names></name><name><surname>Dougalis</surname><given-names>A</given-names></name><name><surname>Kharitonova</surname><given-names>M</given-names></name><name><surname>Duda</surname><given-names>J</given-names></name><name><surname>Hess</surname><given-names>S</given-names></name><name><surname>Tuluc</surname><given-names>P</given-names></name><name><surname>Pomberger</surname><given-names>T</given-names></name><name><surname>Stefanova</surname><given-names>N</given-names></name><name><surname>Pitterl</surname><given-names>F</given-names></name><name><surname>Ciossek</surname><given-names>T</given-names></name><name><surname>Oberacher</surname><given-names>H</given-names></name><name><surname>Draheim</surname><given-names>HJ</given-names></name><name><surname>Kloppenburg</surname><given-names>P</given-names></name><name><surname>Liss</surname><given-names>B</given-names></name><name><surname>Striessnig</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Lower Affinity of Isradipine for L-type Ca <sup>2+</sup> channels during substantia nigra dopamine neuron-like activity: implications for neuroprotection in parkinson’s disease</article-title><source>The Journal of Neuroscience</source><volume>37</volume><fpage>6761</fpage><lpage>6777</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.2946-16.2017</pub-id><pub-id pub-id-type="pmid">28592699</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ortner</surname><given-names>NJ</given-names></name><name><surname>Pinggera</surname><given-names>A</given-names></name><name><surname>Hofer</surname><given-names>NT</given-names></name><name><surname>Siller</surname><given-names>A</given-names></name><name><surname>Brandt</surname><given-names>N</given-names></name><name><surname>Raffeiner</surname><given-names>A</given-names></name><name><surname>Vilusic</surname><given-names>K</given-names></name><name><surname>Lang</surname><given-names>I</given-names></name><name><surname>Blum</surname><given-names>K</given-names></name><name><surname>Obermair</surname><given-names>GJ</given-names></name><name><surname>Stefan</surname><given-names>E</given-names></name><name><surname>Engel</surname><given-names>J</given-names></name><name><surname>Striessnig</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>RBP2 stabilizes slow Cav1.3 Ca<sup>2+</sup> channel inactivation properties of cochlear inner hair cells</article-title><source>Pflugers Archiv</source><volume>472</volume><fpage>3</fpage><lpage>25</lpage><pub-id pub-id-type="doi">10.1007/s00424-019-02338-4</pub-id><pub-id pub-id-type="pmid">31848688</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paladini</surname><given-names>CA</given-names></name><name><surname>Roeper</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Generating bursts (and pauses) in the dopamine midbrain neurons</article-title><source>Neuroscience</source><volume>282</volume><fpage>109</fpage><lpage>121</lpage><pub-id pub-id-type="doi">10.1016/j.neuroscience.2014.07.032</pub-id><pub-id pub-id-type="pmid">25073045</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Paxinos</surname><given-names>G</given-names></name><name><surname>Franklin</surname><given-names>KBJ</given-names></name></person-group><year iso-8601-date="2004">2004</year><source>The Mouse Brain in Stereotaxic Coordinates, Compact</source><publisher-name>Elsevier</publisher-name></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pereverzev</surname><given-names>A</given-names></name><name><surname>Leroy</surname><given-names>J</given-names></name><name><surname>Krieger</surname><given-names>A</given-names></name><name><surname>Malécot</surname><given-names>CO</given-names></name><name><surname>Hescheler</surname><given-names>J</given-names></name><name><surname>Pfitzer</surname><given-names>G</given-names></name><name><surname>Klöckner</surname><given-names>U</given-names></name><name><surname>Schneider</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Alternate splicing in the cytosolic II-III loop and the carboxy terminus of human E-type voltage-gated Ca(2+) channels: electrophysiological characterization of isoforms</article-title><source>Molecular and Cellular Neurosciences</source><volume>21</volume><fpage>352</fpage><lpage>365</lpage><pub-id pub-id-type="doi">10.1006/mcne.2002.1179</pub-id><pub-id pub-id-type="pmid">12401453</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Philippart</surname><given-names>F</given-names></name><name><surname>Destreel</surname><given-names>G</given-names></name><name><surname>Merino-Sepúlveda</surname><given-names>P</given-names></name><name><surname>Henny</surname><given-names>P</given-names></name><name><surname>Engel</surname><given-names>D</given-names></name><name><surname>Seutin</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Differential somatic Ca2+ Channel profile in midbrain dopaminergic neurons</article-title><source>The Journal of Neuroscience</source><volume>36</volume><fpage>7234</fpage><lpage>7245</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.0459-16.2016</pub-id><pub-id pub-id-type="pmid">27383597</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pinggera</surname><given-names>A</given-names></name><name><surname>Lieb</surname><given-names>A</given-names></name><name><surname>Benedetti</surname><given-names>B</given-names></name><name><surname>Lampert</surname><given-names>M</given-names></name><name><surname>Monteleone</surname><given-names>S</given-names></name><name><surname>Liedl</surname><given-names>KR</given-names></name><name><surname>Tuluc</surname><given-names>P</given-names></name><name><surname>Striessnig</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>CACNA1D de novo mutations in autism spectrum disorders activate Cav1.3 L-type calcium channels</article-title><source>Biological Psychiatry</source><volume>77</volume><fpage>816</fpage><lpage>822</lpage><pub-id pub-id-type="doi">10.1016/j.biopsych.2014.11.020</pub-id><pub-id pub-id-type="pmid">25620733</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pruszak</surname><given-names>J</given-names></name><name><surname>Just</surname><given-names>L</given-names></name><name><surname>Isacson</surname><given-names>O</given-names></name><name><surname>Nikkhah</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Isolation and culture of ventral mesencephalic precursor cells and dopaminergic neurons from rodent brains</article-title><source>Current Protocols in Stem Cell Biology</source><volume>2</volume><elocation-id>e5</elocation-id><pub-id pub-id-type="doi">10.1002/9780470151808.sc02d05s11</pub-id><pub-id pub-id-type="pmid">19960452</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Puopolo</surname><given-names>M</given-names></name><name><surname>Raviola</surname><given-names>E</given-names></name><name><surname>Bean</surname><given-names>BP</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Roles of subthreshold calcium current and sodium current in spontaneous firing of mouse midbrain dopamine neurons</article-title><source>The Journal of Neuroscience</source><volume>27</volume><fpage>645</fpage><lpage>656</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.4341-06.2007</pub-id><pub-id pub-id-type="pmid">17234596</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qin</surname><given-names>N</given-names></name><name><surname>Platano</surname><given-names>D</given-names></name><name><surname>Olcese</surname><given-names>R</given-names></name><name><surname>Costantin</surname><given-names>JL</given-names></name><name><surname>Stefani</surname><given-names>E</given-names></name><name><surname>Birnbaumer</surname><given-names>L</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Unique regulatory properties of the type 2a Ca2+ channel beta subunit caused by palmitoylation</article-title><source>PNAS</source><volume>95</volume><fpage>4690</fpage><lpage>4695</lpage><pub-id pub-id-type="doi">10.1073/pnas.95.8.4690</pub-id><pub-id pub-id-type="pmid">9539800</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rae</surname><given-names>J</given-names></name><name><surname>Cooper</surname><given-names>K</given-names></name><name><surname>Gates</surname><given-names>P</given-names></name><name><surname>Watsky</surname><given-names>M</given-names></name></person-group><year iso-8601-date="1991">1991</year><article-title>Low access resistance perforated patch recordings using amphotericin B</article-title><source>Journal of Neuroscience Methods</source><volume>37</volume><fpage>15</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.1016/0165-0270(91)90017-t</pub-id><pub-id pub-id-type="pmid">2072734</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Richards</surname><given-names>CD</given-names></name><name><surname>Shiroyama</surname><given-names>T</given-names></name><name><surname>Kitai</surname><given-names>ST</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Electrophysiological and immunocytochemical characterization of GABA and dopamine neurons in the substantia nigra of the rat</article-title><source>Neuroscience</source><volume>80</volume><fpage>545</fpage><lpage>557</lpage><pub-id pub-id-type="doi">10.1016/s0306-4522(97)00093-6</pub-id><pub-id pub-id-type="pmid">9284356</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robinson</surname><given-names>BG</given-names></name><name><surname>Cai</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Bunzow</surname><given-names>JR</given-names></name><name><surname>Williams</surname><given-names>JT</given-names></name><name><surname>Kaeser</surname><given-names>PS</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>RIM is essential for stimulated but not spontaneous somatodendritic dopamine release in the midbrain</article-title><source>eLife</source><volume>8</volume><elocation-id>e47972</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.47972</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sawamoto</surname><given-names>K</given-names></name><name><surname>Nakao</surname><given-names>N</given-names></name><name><surname>Kobayashi</surname><given-names>K</given-names></name><name><surname>Matsushita</surname><given-names>N</given-names></name><name><surname>Takahashi</surname><given-names>H</given-names></name><name><surname>Kakishita</surname><given-names>K</given-names></name><name><surname>Yamamoto</surname><given-names>A</given-names></name><name><surname>Yoshizaki</surname><given-names>T</given-names></name><name><surname>Terashima</surname><given-names>T</given-names></name><name><surname>Murakami</surname><given-names>F</given-names></name><name><surname>Itakura</surname><given-names>T</given-names></name><name><surname>Okano</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Visualization, direct isolation, and transplantation of midbrain dopaminergic neurons</article-title><source>PNAS</source><volume>98</volume><fpage>6423</fpage><lpage>6428</lpage><pub-id pub-id-type="doi">10.1073/pnas.111152398</pub-id><pub-id pub-id-type="pmid">11353855</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schiemann</surname><given-names>J</given-names></name><name><surname>Schlaudraff</surname><given-names>F</given-names></name><name><surname>Klose</surname><given-names>V</given-names></name><name><surname>Bingmer</surname><given-names>M</given-names></name><name><surname>Seino</surname><given-names>S</given-names></name><name><surname>Magill</surname><given-names>PJ</given-names></name><name><surname>Zaghloul</surname><given-names>KA</given-names></name><name><surname>Schneider</surname><given-names>G</given-names></name><name><surname>Liss</surname><given-names>B</given-names></name><name><surname>Roeper</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>K-ATP channels in dopamine substantia nigra neurons control bursting and novelty-induced exploration</article-title><source>Nature Neuroscience</source><volume>15</volume><fpage>1272</fpage><lpage>1280</lpage><pub-id pub-id-type="doi">10.1038/nn.3185</pub-id><pub-id pub-id-type="pmid">22902720</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schindelin</surname><given-names>J</given-names></name><name><surname>Arganda-Carreras</surname><given-names>I</given-names></name><name><surname>Frise</surname><given-names>E</given-names></name><name><surname>Kaynig</surname><given-names>V</given-names></name><name><surname>Longair</surname><given-names>M</given-names></name><name><surname>Pietzsch</surname><given-names>T</given-names></name><name><surname>Preibisch</surname><given-names>S</given-names></name><name><surname>Rueden</surname><given-names>C</given-names></name><name><surname>Saalfeld</surname><given-names>S</given-names></name><name><surname>Schmid</surname><given-names>B</given-names></name><name><surname>Tinevez</surname><given-names>JY</given-names></name><name><surname>White</surname><given-names>DJ</given-names></name><name><surname>Hartenstein</surname><given-names>V</given-names></name><name><surname>Eliceiri</surname><given-names>K</given-names></name><name><surname>Tomancak</surname><given-names>P</given-names></name><name><surname>Cardona</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Fiji: an open-source platform for biological-image analysis</article-title><source>Nature Methods</source><volume>9</volume><fpage>676</fpage><lpage>682</lpage><pub-id pub-id-type="doi">10.1038/nmeth.2019</pub-id><pub-id pub-id-type="pmid">22743772</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schlick</surname><given-names>B</given-names></name><name><surname>Flucher</surname><given-names>BE</given-names></name><name><surname>Obermair</surname><given-names>GJ</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Voltage-activated calcium channel expression profiles in mouse brain and cultured hippocampal neurons</article-title><source>Neuroscience</source><volume>167</volume><fpage>786</fpage><lpage>798</lpage><pub-id pub-id-type="doi">10.1016/j.neuroscience.2010.02.037</pub-id><pub-id pub-id-type="pmid">20188150</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schneider</surname><given-names>T</given-names></name><name><surname>Dibué</surname><given-names>M</given-names></name><name><surname>Hescheler</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>How “pharmacoresistant” is cav2.3, the major component of voltage-gated r-type ca2+ channels?</article-title><source>Pharmaceuticals</source><volume>6</volume><fpage>759</fpage><lpage>776</lpage><pub-id pub-id-type="doi">10.3390/ph6060759</pub-id><pub-id pub-id-type="pmid">24276260</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schneider</surname><given-names>T</given-names></name><name><surname>Alpdogan</surname><given-names>S</given-names></name><name><surname>Hescheler</surname><given-names>J</given-names></name><name><surname>Neumaier</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>In vitro and in vivo phosphorylation of the Ca<sub>v</sub>2.3 voltage-gated R-type calcium channel</article-title><source>Channels</source><volume>12</volume><fpage>326</fpage><lpage>334</lpage><pub-id pub-id-type="doi">10.1080/19336950.2018.1516984</pub-id><pub-id pub-id-type="pmid">30165790</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scott</surname><given-names>VES</given-names></name><name><surname>De Waard</surname><given-names>M</given-names></name><name><surname>Liu</surname><given-names>H</given-names></name><name><surname>Gurnett</surname><given-names>CA</given-names></name><name><surname>Venzke</surname><given-names>DP</given-names></name><name><surname>Lennon</surname><given-names>VA</given-names></name><name><surname>Campbell</surname><given-names>KP</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>Beta subunit heterogeneity in N-type Ca2+ channels</article-title><source>The Journal of Biological Chemistry</source><volume>271</volume><fpage>3207</fpage><lpage>3212</lpage><pub-id pub-id-type="doi">10.1074/jbc.271.6.3207</pub-id><pub-id pub-id-type="pmid">8621722</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shin</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Single-cell rna-seq of mouse dopaminergic neurons informs candidate gene selection for sporadic parkinson disease</article-title><source>American Journal of Human Genetics</source><volume>102</volume><fpage>427</fpage><lpage>446</lpage><pub-id pub-id-type="doi">10.1016/j.ajhg.2018.02.001</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sochivko</surname><given-names>D</given-names></name><name><surname>Pereverzev</surname><given-names>A</given-names></name><name><surname>Smyth</surname><given-names>N</given-names></name><name><surname>Gissel</surname><given-names>C</given-names></name><name><surname>Schneider</surname><given-names>T</given-names></name><name><surname>Beck</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>The Ca(V)2.3 Ca(2+) channel subunit contributes to R-type Ca(2+) currents in murine hippocampal and neocortical neurones</article-title><source>The Journal of Physiology</source><volume>542</volume><fpage>699</fpage><lpage>710</lpage><pub-id pub-id-type="doi">10.1113/jphysiol.2002.020677</pub-id><pub-id pub-id-type="pmid">12154172</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soong</surname><given-names>TW</given-names></name><name><surname>Stea</surname><given-names>A</given-names></name><name><surname>Hodson</surname><given-names>CD</given-names></name><name><surname>Dubel</surname><given-names>SJ</given-names></name><name><surname>Vincent</surname><given-names>SR</given-names></name><name><surname>Snutch</surname><given-names>TP</given-names></name></person-group><year iso-8601-date="1993">1993</year><article-title>Structure and functional expression of a member of the low voltage-activated calcium channel family</article-title><source>Science</source><volume>260</volume><fpage>1133</fpage><lpage>1136</lpage><pub-id pub-id-type="doi">10.1126/science.8388125</pub-id><pub-id pub-id-type="pmid">8388125</pub-id></element-citation></ref><ref id="bib84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Subramaniam</surname><given-names>M</given-names></name><name><surname>Althof</surname><given-names>D</given-names></name><name><surname>Gispert</surname><given-names>S</given-names></name><name><surname>Schwenk</surname><given-names>J</given-names></name><name><surname>Auburger</surname><given-names>G</given-names></name><name><surname>Kulik</surname><given-names>A</given-names></name><name><surname>Fakler</surname><given-names>B</given-names></name><name><surname>Roeper</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Mutant α-synuclein enhances firing frequencies in dopamine substantia nigra neurons by oxidative impairment of A-type potassium channels</article-title><source>The Journal of Neuroscience</source><volume>34</volume><fpage>13586</fpage><lpage>13599</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.5069-13.2014</pub-id><pub-id pub-id-type="pmid">25297088</pub-id></element-citation></ref><ref id="bib85"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Surmeier</surname><given-names>DJ</given-names></name><name><surname>Guzman</surname><given-names>JN</given-names></name><name><surname>Sanchez-Padilla</surname><given-names>J</given-names></name><name><surname>Goldberg</surname><given-names>JA</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>The origins of oxidant stress in Parkinson’s disease and therapeutic strategies</article-title><source>Antioxidants &amp; Redox Signaling</source><volume>14</volume><fpage>1289</fpage><lpage>1301</lpage><pub-id pub-id-type="doi">10.1089/ars.2010.3521</pub-id><pub-id pub-id-type="pmid">20712409</pub-id></element-citation></ref><ref id="bib86"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Surmeier</surname><given-names>DJ</given-names></name><name><surname>Obeso</surname><given-names>JA</given-names></name><name><surname>Halliday</surname><given-names>GM</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Selective neuronal vulnerability in Parkinson disease</article-title><source>Nature Reviews. Neuroscience</source><volume>18</volume><fpage>101</fpage><lpage>113</lpage><pub-id pub-id-type="doi">10.1038/nrn.2016.178</pub-id><pub-id pub-id-type="pmid">28104909</pub-id></element-citation></ref><ref id="bib87"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tomagra</surname><given-names>G</given-names></name><name><surname>Picollo</surname><given-names>F</given-names></name><name><surname>Battiato</surname><given-names>A</given-names></name><name><surname>Picconi</surname><given-names>B</given-names></name><name><surname>De Marchis</surname><given-names>S</given-names></name><name><surname>Pasquarelli</surname><given-names>A</given-names></name><name><surname>Olivero</surname><given-names>P</given-names></name><name><surname>Marcantoni</surname><given-names>A</given-names></name><name><surname>Calabresi</surname><given-names>P</given-names></name><name><surname>Carbone</surname><given-names>E</given-names></name><name><surname>Carabelli</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Quantal release of dopamine and action potential firing detected in midbrain neurons by multifunctional diamond-based microarrays</article-title><source>Frontiers in Neuroscience</source><volume>13</volume><elocation-id>288</elocation-id><pub-id pub-id-type="doi">10.3389/fnins.2019.00288</pub-id><pub-id pub-id-type="pmid">31024230</pub-id></element-citation></ref><ref id="bib88"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tottene</surname><given-names>A</given-names></name><name><surname>Volsen</surname><given-names>S</given-names></name><name><surname>Pietrobon</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>α <sub>1E</sub> Subunits form the pore of three cerebellar r-type calcium channels with different pharmacological and permeation properties</article-title><source>The Journal of Neuroscience</source><volume>20</volume><fpage>171</fpage><lpage>178</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.20-01-00171.2000</pub-id><pub-id pub-id-type="pmid">10627594</pub-id></element-citation></ref><ref id="bib89"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tringham</surname><given-names>E</given-names></name><name><surname>Powell</surname><given-names>KL</given-names></name><name><surname>Cain</surname><given-names>SM</given-names></name><name><surname>Kuplast</surname><given-names>K</given-names></name><name><surname>Mezeyova</surname><given-names>J</given-names></name><name><surname>Weerapura</surname><given-names>M</given-names></name><name><surname>Eduljee</surname><given-names>C</given-names></name><name><surname>Jiang</surname><given-names>X</given-names></name><name><surname>Smith</surname><given-names>P</given-names></name><name><surname>Morrison</surname><given-names>JL</given-names></name><name><surname>Jones</surname><given-names>NC</given-names></name><name><surname>Braine</surname><given-names>E</given-names></name><name><surname>Rind</surname><given-names>G</given-names></name><name><surname>Fee-Maki</surname><given-names>M</given-names></name><name><surname>Parker</surname><given-names>D</given-names></name><name><surname>Pajouhesh</surname><given-names>H</given-names></name><name><surname>Parmar</surname><given-names>M</given-names></name><name><surname>O’Brien</surname><given-names>TJ</given-names></name><name><surname>Snutch</surname><given-names>TP</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>T-type calcium channel blockers that attenuate thalamic burst firing and suppress absence seizures</article-title><source>Science Translational Medicine</source><volume>4</volume><elocation-id>121ra119</elocation-id><pub-id pub-id-type="doi">10.1126/scitranslmed.3003120</pub-id><pub-id pub-id-type="pmid">22344687</pub-id></element-citation></ref><ref id="bib90"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vandesompele</surname><given-names>J</given-names></name><name><surname>De Preter</surname><given-names>K</given-names></name><name><surname>Pattyn</surname><given-names>F</given-names></name><name><surname>Poppe</surname><given-names>B</given-names></name><name><surname>Van Roy</surname><given-names>N</given-names></name><name><surname>De Paepe</surname><given-names>A</given-names></name><name><surname>Speleman</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes</article-title><source>Genome Biology</source><volume>3</volume><elocation-id>research0034</elocation-id><pub-id pub-id-type="doi">10.1186/gb-2002-3-7-research0034</pub-id><pub-id pub-id-type="pmid">12184808</pub-id></element-citation></ref><ref id="bib91"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>G</given-names></name><name><surname>Dayanithi</surname><given-names>G</given-names></name><name><surname>Newcomb</surname><given-names>R</given-names></name><name><surname>Lemos</surname><given-names>JR</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>An R-type Ca(2+) current in neurohypophysial terminals preferentially regulates oxytocin secretion</article-title><source>The Journal of Neuroscience</source><volume>19</volume><fpage>9235</fpage><lpage>9241</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.19-21-09235.1999</pub-id><pub-id pub-id-type="pmid">10531427</pub-id></element-citation></ref><ref id="bib92"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watanabe</surname><given-names>M</given-names></name><name><surname>Sakuma</surname><given-names>Y</given-names></name><name><surname>Kato</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>High expression of the R-type voltage-gated Ca2+ channel and its involvement in Ca2+-dependent gonadotropin-releasing hormone release in GT1-7 cells</article-title><source>Endocrinology</source><volume>145</volume><fpage>2375</fpage><lpage>2383</lpage><pub-id pub-id-type="doi">10.1210/en.2003-1257</pub-id><pub-id pub-id-type="pmid">14736732</pub-id></element-citation></ref><ref id="bib93"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weiergräber</surname><given-names>M</given-names></name><name><surname>Henry</surname><given-names>M</given-names></name><name><surname>Südkamp</surname><given-names>M</given-names></name><name><surname>de Vivie</surname><given-names>E-R</given-names></name><name><surname>Hescheler</surname><given-names>J</given-names></name><name><surname>Schneider</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Ablation of Ca(v)2.3 / E-type voltage-gated calcium channel results in cardiac arrhythmia and altered autonomic control within the murine cardiovascular system</article-title><source>Basic Research in Cardiology</source><volume>100</volume><fpage>1</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1007/s00395-004-0488-1</pub-id><pub-id pub-id-type="pmid">15490203</pub-id></element-citation></ref><ref id="bib94"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>ME</given-names></name><name><surname>Marubio</surname><given-names>LM</given-names></name><name><surname>Deal</surname><given-names>CR</given-names></name><name><surname>Hans</surname><given-names>M</given-names></name><name><surname>Brust</surname><given-names>PF</given-names></name><name><surname>Philipson</surname><given-names>LH</given-names></name><name><surname>Miller</surname><given-names>RJ</given-names></name><name><surname>Johnson</surname><given-names>EC</given-names></name><name><surname>Harpold</surname><given-names>MM</given-names></name><name><surname>Ellis</surname><given-names>SB</given-names></name></person-group><year iso-8601-date="1994">1994</year><article-title>Structure and functional characterization of neuronal alpha 1E calcium channel subtypes</article-title><source>Journal of Biological Chemistry</source><volume>269</volume><fpage>22347</fpage><lpage>22357</lpage><pub-id pub-id-type="doi">10.1016/S0021-9258(17)31796-9</pub-id></element-citation></ref><ref id="bib95"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilson</surname><given-names>SM</given-names></name><name><surname>Toth</surname><given-names>PT</given-names></name><name><surname>Oh</surname><given-names>SB</given-names></name><name><surname>Gillard</surname><given-names>SE</given-names></name><name><surname>Volsen</surname><given-names>S</given-names></name><name><surname>Ren</surname><given-names>D</given-names></name><name><surname>Philipson</surname><given-names>LH</given-names></name><name><surname>Lee</surname><given-names>EC</given-names></name><name><surname>Fletcher</surname><given-names>CF</given-names></name><name><surname>Tessarollo</surname><given-names>L</given-names></name><name><surname>Copeland</surname><given-names>NG</given-names></name><name><surname>Jenkins</surname><given-names>NA</given-names></name><name><surname>Miller</surname><given-names>RJ</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>The status of voltage-dependent calcium channels in alpha 1E knock-out mice</article-title><source>The Journal of Neuroscience</source><volume>20</volume><fpage>8566</fpage><lpage>8571</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.20-23-08566.2000</pub-id><pub-id pub-id-type="pmid">11102459</pub-id></element-citation></ref><ref id="bib96"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>W</given-names></name><name><surname>Lipscombe</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Neuronal Ca(V)1.3alpha(1) L-type channels activate at relatively hyperpolarized membrane potentials and are incompletely inhibited by dihydropyridines</article-title><source>The Journal of Neuroscience</source><volume>21</volume><fpage>5944</fpage><lpage>5951</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.21-16-05944.2001</pub-id><pub-id pub-id-type="pmid">11487617</pub-id></element-citation></ref><ref id="bib97"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yasuda</surname><given-names>T</given-names></name><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Barr</surname><given-names>W</given-names></name><name><surname>McRory</surname><given-names>JE</given-names></name><name><surname>Lewis</surname><given-names>RJ</given-names></name><name><surname>Adams</surname><given-names>DJ</given-names></name><name><surname>Zamponi</surname><given-names>GW</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Auxiliary subunit regulation of high-voltage activated calcium channels expressed in mammalian cells</article-title><source>The European Journal of Neuroscience</source><volume>20</volume><fpage>1</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1111/j.1460-9568.2004.03434.x</pub-id><pub-id pub-id-type="pmid">15245474</pub-id></element-citation></ref><ref id="bib98"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ye</surname><given-names>JH</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Xiao</surname><given-names>C</given-names></name><name><surname>Kong</surname><given-names>JQ</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Patch-clamp studies in the CNS illustrate a simple new method for obtaining viable neurons in rat brain slices: glycerol replacement of NaCl protects CNS neurons</article-title><source>Journal of Neuroscience Methods</source><volume>158</volume><fpage>251</fpage><lpage>259</lpage><pub-id pub-id-type="doi">10.1016/j.jneumeth.2006.06.006</pub-id><pub-id pub-id-type="pmid">16842860</pub-id></element-citation></ref><ref id="bib99"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zamponi</surname><given-names>GW</given-names></name><name><surname>Striessnig</surname><given-names>J</given-names></name><name><surname>Koschak</surname><given-names>A</given-names></name><name><surname>Dolphin</surname><given-names>AC</given-names></name><name><surname>Sibley</surname><given-names>DR</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>The physiology, pathology, and pharmacology of voltage-gated calcium channels and their future therapeutic potential</article-title><source>Pharmacological Reviews</source><volume>67</volume><fpage>821</fpage><lpage>870</lpage><pub-id pub-id-type="doi">10.1124/pr.114.009654</pub-id><pub-id pub-id-type="pmid">26362469</pub-id></element-citation></ref></ref-list></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.67464.sa0</article-id><title-group><article-title>Editor's evaluation</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Colecraft</surname><given-names>Henry M</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00hj8s172</institution-id><institution>Columbia University</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><related-object id="sa0ro1" object-id-type="id" object-id="10.1101/2021.02.10.430224" link-type="continued-by" xlink:href="https://sciety.org/articles/activity/10.1101/2021.02.10.430224"/></front-stub><body><p>This study finds that voltage-gated calcium channel auxiliary β2a and β2e splice variants confer gating properties on Cav2.3 channels that enable them to contribute sustained Ca<sup>2+</sup> influx during pacemaking in substantia nigra dopaminergic neurons. This sustained Ca<sup>2+</sup> influx may contribute to the selective vulnerability of substantia nigra dopaminergic neurons to neurodegeneration in Parkinson's disease. The work will be of great interest to ion channel biophysicists and neuroscientists interested in mechanisms of neurodegeneration.</p></body></sub-article><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.67464.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Colecraft</surname><given-names>Henry M</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00hj8s172</institution-id><institution>Columbia University</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group></front-stub><body><boxed-text id="sa2-box1"><p>Our editorial process produces two outputs: (i) <ext-link ext-link-type="uri" xlink:href="https://sciety.org/articles/activity/10.1101/2021.02.10.430224">public reviews</ext-link> designed to be posted alongside <ext-link ext-link-type="uri" xlink:href="https://www.biorxiv.org/content/10.1101/2021.02.10.430224v2">the preprint</ext-link> for the benefit of readers; (ii) feedback on the manuscript for the authors, including requests for revisions, shown below. We also include an acceptance summary that explains what the editors found interesting or important about the work.</p></boxed-text><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;Alternative splicing of auxiliary β2-subunits stabilizes Cav2.3 ca<sup>2+</sup> channel activity in midbrain dopamine neurons&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by 3 peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Richard Aldrich as the Senior Editor. The reviewers have opted to remain anonymous.</p><p>The reviewers have discussed their reviews with one another, and the Reviewing Editor has drafted this to help you prepare a revised submission.</p><p>Essential revisions:</p><p>1) More direct evidence of the putative role of b2a and b2e in supporting Cav2.3 channels in substantia nigra dopaminergic (SN DA) neurons should be provided. Ideally, this would be provided by knockdown experiments showing reduced pacemaking and CaV2.3 currents in response to inhibiting b2a and b2e expression in SN DA neurons. As an alternative, a proximity ligation assay could be done to at least show assembly of b2 and CaV2.3 in SN DA neurons.</p><p>2) As suggested by Reviewer 2 the narrative and organization of the manuscript could be improved for more effective communication. The reviewer makes some good suggestions for reorganizing the manuscript that should be considered.</p><p>3) Reviewer 1 raised concerns about the adequacy of pharmacological isolation of CaV2.3 currents in the slice recordings that should be addressed. If possible, the isolated CaV2.3 steady-state activation and inactivation curves should be obtained in the cultured neuron preparation where there seems to be better control of pharmacological block of the different Cav channel isoforms.</p><p><italic>Reviewer #2 (Recommendations for the authors):</italic></p><p>Additional comments and suggestions are:</p><p>1) The two paragraphs starting on page 7, lines 165-189 should be moved under the header starting on the current page 7, line 191, as it introduces that section.</p><p>2) Order of figures and supplemental figures could be improved to follow a revised narrative and clarity. Note that Supp Figure 1 is referenced in the paper after citing Supp Figure 2 and 3.</p><p>3) Figure 1: In Figure 1A, it is unclear that the expanded action potentials are representative of the area highlighted. Please revised. The action potential traces in Figure 1C do not seem to be a good representation of the maximum time-derivative of voltage. Please revise.</p><p>4) Figure 2: To appreciate the results better, it will help to include control (no drugs) traces and their comparison with the different components.</p><p>5) Consider rearranging the order of Figures 3, 4, 5 and 6. The reviewer's suggestion is to make current Figure 5 the new Figure 3. Figure 4 should remain as such. Current Figure 3 and Figure 6 should be merged into new Figure 5. Alternative, current Figure 3 should become a supplemental figure of new Figure 5 (current Figure 6).</p><p>6) Current Supp Figure 3 should be included as part of the main figures, specifically as new panel D in current Figure 4.</p><p>7) Current Figure 5: Please replace bar plots with scatter plots to visualize the spread of the data. Panel C of this figure is not mentioned in the main text. Please correct. In fact, this panel could go into a supplemental figure.</p><p>8) Figure 7: Labels are very small and difficult to read. Please correct.</p><p>9) The Supplemental Methods section should be merged with the regular methods section for a comprehensive overview of the methods in a single section.</p><p>10) Data in current Supp Figure 1B do not seem to have sufficient statistical power to support conclusions. Please verify.</p><p><italic>Reviewer #3 (Recommendations for the authors):</italic></p><p>#1 Since the crux of this manuscript is the effect of β subunit variants on contribution of CaV2.3 channel in Parkinson's disease, references about the relative expression of β subunit variants in human brain would be extremely relevant and valuable in putting this paper into the context of human disease.</p><p>#2 The author's reference to past exploration of the role of β subunits on CaV2.3 should be further expanded. In particular, the assertion that β2a and β2e subunits likely exhibit incomplete inactivation at voltages positive to threshold is not entirely novel and the authors' description (lines 165-179) is slightly misleading. While the authors appropriately cite Jones et al., and Yasuda et al., as having described β subunit effects on the channels, they seem to imply that these papers did not uncover the incomplete inactivation described in the current manuscript. As currently written, the authors imply that these two papers validate the statement in line 173 that R-type currents fully inactivate at voltages positive to -50mV. In fact, after accounting for the different experimental solutions, both papers demonstrate that these β subunits would likely result in available channels at voltages positive to threshold. Reviewer recommends that this point be further clarified in the text.</p><p>#3 Currently, the authors make no distinction between the two forms of inactivation in CaV2.3 channels. The experiments are performed in ca<sup>2+</sup>, such that both voltage- and ca<sup>2+</sup>- dependent inactivation will be present. However, past literature indicates that the β subunit effect is primarily on the voltage inactivation of the channel. This should be clearly described.</p><p>#4 In Figure 7, the authors have shown the effect of the β2a subunit on the run-down of CaV2.3 channel. How about the β2e subunit? Does it demonstrate similar properties?</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.67464.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>1) More direct evidence of the putative role of b2a and b2e in supporting Cav2.3 channels in substantia nigra dopaminergic (SN DA) neurons should be provided. Ideally, this would be provided by knockdown experiments showing reduced pacemaking and CaV2.3 currents in response to inhibiting b2a and b2e expression in SN DA neurons. As an alternative, a proximity ligation assay could be done to at least show assembly of b2 and CaV2.3 in SN DA neurons.</p></disp-quote><p>We fully agree with the reviewers that it is a relevant point but we do not see how this would be technically feasible. We ask the reviewers to consider the following:</p><p>a. Knockdown experiments in SN DA neurons: We do not see how reduced pacemaking would be a suitable readout for more direct evidence of the role of β2a and β2e in supporting Cav2.3 channels in SN DA neurons. We have already shown that, while SNX-482 reduces pacemaking in cultured embryonic dopamine neurons (this paper), neither Cav2.3 KO nor acute pharmacological Cav2.3 channel inhibition (by SNX-482) in SN DA neurons from adult mouse brain slices reduces pacemaker activity (<italic>Benkert et al., Nature Commun 2019; 1</italic>). However, what is reduced by genetic or pharmacological Cav2.3 inhibition in SN DA neurons is the action potential-triggered ca<sup>2+</sup> influx (<italic>1</italic>), i.e. the potentially harmful ca<sup>2+</sup>-load in these neurons. Hence, the readout of such an experiment would have to be the activity-dependent somatic ca<sup>2+</sup> influx. To allow unperturbed activity and intracellular signaling, these experiments need to be carried out in perforated-patch configuration. Even without a knockdown approach, these are already challenging experiments in these highly vulnerable SN DA neurons (but feasible, see <italic>1</italic>). Please consider that we would not expect a reduced bulk Cav- or SNX-482-sensitive Cav current in SN DA neurons due to β2a- and β2e-knockdown, but a rather small shift to more negative potentials of the steady-state Cav current inactivation. To address this, a neuron-selective, in vivo AAV viral based Crispr/CAS9 or siRNA approach would be necessary. At the same time, we do not see how it could be possible to demonstrate the cell-specific knockdown of the β2a-and β2e-subunits in the cells recorded from. In order to identify transfected cells and still be able to carry out electrophysiology, one would need to co-transfect a marker like GFP. But, as we have previously shown, GFP itself affects the activity pattern of SN DA neurons (<italic>Schiemann et al., Nature Neurosci 2011; 2</italic>). Again, it would be hardly possible to detect successful recombination, in successfully transfected neurons, and still be able to record from them. With the help of Larry Zweifel (<italic>Hunker et al., Cell Reports 2020; 3</italic>) we have indeed established such an approach for tyrosine hydroxylase (TH), where, however, successful recombination is visible by loss of TH staining. But unlike for TH, we are not aware of a β2-specific antibody expected to work in immunohistochemistry (see new experiments below). These would be required for β2 knockdown verification using juxtacellular labelling, followed by post-PFA fixation and antibody staining (as we did for other targets e.g. in <italic>Lammel et al., Neuron 2008; 4</italic>). Alternatively, one could carry out e.g. a deep sequencing approach but it is difficult to see how this should be possible in combination with prior brain slice electrophysiology/ca<sup>2+</sup> imaging.</p><p>Independent of the arguments above, we also would like the reviewers to consider that a cell-specific β2a+β2e knockdown would also affect other high-voltage-activated Cav channel currents (e.g. P/Q-, N- and L-type), which must also associate with these β-subunits in SN DA neurons. These effects are likely to interfere with the effects on Cav2.3 currents.</p><p>Given all these considerations, we unfortunately feel the suggested more direct electrophysiological proof the reviewer asked for is, at present, not feasible.</p><p>b. Proximity ligation assay: Another alternative suggested was &quot;… a proximity ligation assay could be done to at least show assembly of β2 and CaV2.3 in SN DA neurons&quot;. This is indeed an option, which we thought we could pursue. Since this requires two antibodies from different species, we were searching for and tested suitable anti-Cav2.3 and anti-β2 antibodies. The only anti-Cav2.3 antibody we identified is the one used by us already in the paper Benkert et al., 2019 (<italic>1)</italic> (Cat# 27225-1-AP, Proteintech). It is raised in rabbits and works very nicely in Western-blots (<xref ref-type="fig" rid="sa2fig1">Author response image 1</xref>). We were unable to locate a commercial or non-commercial source for an anti-Cav2.3 antibody from another species. We identified two monoclonal mouse anti-β2 antibodies (antibodies specific for β2a- or β2e-splice variants do not exist) which we tested for specificity.</p><fig id="sa2fig1" position="float"><label>Author response image 1.</label><caption><title>Western blot using membrane preparations from tsA201 cells transiently transfected with Cav2.3e α1, β3/β2a and α2δ1 or an empty vector (pUC) and mouse whole brain protein preparations were used as described by us previously (14, 15).</title><p>Tris‐acetate gel: Primary antibodies: rabbit anti‐Cav2.3 (1:15,000; Proteintech, Cat# 27225‐1‐AP) and mouse anti‐tubulin (1:30,000; Sigma‐Aldrich, Cat# CP06). Secondary antibodies: goat anti‐rabbit IgG (1:40,000; Sigma, Cat# A6545) and goat anti‐mouse IgG (1:8,000; Invitrogen, Cat# 31430). M: Marker PageRuler Plus Prestained Protein Ladder (ThermoScientific, Cat# 26619); M2: Marker Spectra Multicolor High Range Protein Ladder (Thermo Scientific, Cat# 26625).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-67464-sa2-fig1-v4.tif"/></fig><p>As shown in <xref ref-type="fig" rid="sa2fig2">Author response image 2</xref>, the anti-β2 antibody from Antibodies Inc (Cat# 75-065) weakly recognized β2 (but not β3). However, it also strongly cross-reacted with a ~210 kDa band in HEK-cells as well as a ~140 kDa band (<xref ref-type="fig" rid="sa2fig2">Author response image 2A</xref>, Tris-acetate gel) in mouse brain membranes (calculated molecular mass of the recombinant β2a subunit construct is 68.2 kDa). We also tested different experimental conditions (e.g. Tris-acetate vs. Tris-glycine gels, blotting with or without SDS in transfer buffer) which, however, still revealed this strong non-specific staining (<xref ref-type="fig" rid="sa2fig2">Author response image 2B</xref>, Tris-glycine gel).</p><fig id="sa2fig2" position="float"><label>Author response image 2.</label><caption><title>Western blot (A: Tris‐acetate gel; B: Tris‐glycine gel) using membrane preparations from tsA201 cells transiently transfected with Cav2.3e α1, β3/β2a and α2δ1 or an empty vector (pUC) and mouse whole brain protein preparationsas described by us previously (1, 2).</title><p>Primary antibody: mouse anti‐β2 (A: 1:1,000; B: 1:800; Antibodies Inc, Cat# 75‐065), secondary antibody: goat anti‐mouse IgG (A: 1:5,000; B: 1:3,000; Invitrogen, Cat# 31430). M: Marker PageRuler Plus Prestained Protein Ladder (Thermo Scientific, Cat# 26619); M2: Marker Spectra Multicolor High Range Protein Ladder (Thermo Scientific, Cat# 26625).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-67464-sa2-fig2-v4.tif"/></fig><p><xref ref-type="fig" rid="sa2fig3">Author response image 3</xref> shows the results with the anti-β2 antibody from Santa Cruz (Cat# sc-81890). This antibody stained β2 but cross-reacted with β3 as shown with recombinant β-subunits. This was a problem in mouse brain where β3 is much more abundant and therefore it was the only β-subunit stained by this β2-antibody (<xref ref-type="fig" rid="sa2fig3">Author response image 3</xref>).</p><p>We are not aware of any other suitable anti-β2 or anti-Cav2.3 antibodies. Anti-β2 antibodies from other colleagues were raised in rabbits.</p><fig id="sa2fig3" position="float"><label>Author response image 3.</label><caption><title>Western blot using membrane preparations from tsA201 cells transiently transfected with Cav2.3e α1, β3/β2a and α2δ1 or an empty vector (pUC) and mouse whole brain protein preparations as described by us previously (1, 2).</title><p>Tris‐acetate gel: Primary antibody: mouse anti‐β2 (1:800; Santa Cruz, Cat# sc‐81890), secondary antibody: goat anti‐mouse IgG (1:8,000; Invitrogen, Cat# 31430). M: Marker PageRuler Plus Prestained Protein Ladder (Thermo Scientific, Cat# 26619).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-67464-sa2-fig3-v4.tif"/></fig><disp-quote content-type="editor-comment"><p>2) As suggested by Reviewer 2 the narrative and organization of the manuscript could be improved for more effective communication. The reviewer makes some good suggestions for reorganizing the manuscript that should be considered.</p></disp-quote><p>As mentioned above we considered this important criticism, when re-writing major parts of the manuscript, which was necessary because of additional data from novel experiments, some of them suggested by essential revisions 3 (see below). Our data now show different inactivation properties of SNX-482-sensitive Cav2.3 channels in SN DA cells and cultured midbrain neurons within a voltage-range that can be explained by the different contribution of membrane-bound and cytosolic β-subunits. Therefore, the data in cultured neurons are now presented together with those of SN DA neurons (<italic>Figures 6 and 7</italic>) recorded in brain slices. This is outlined in more detail below.</p><disp-quote content-type="editor-comment"><p>3) Reviewer 1 raised concerns about the adequacy of pharmacological isolation of CaV2.3 currents in the slice recordings that should be addressed. If possible, the isolated CaV2.3 steady-state activation and inactivation curves should be obtained in the cultured neuron preparation where there seems to be better control of pharmacological block of the different Cav channel isoforms.</p></disp-quote><p>The reviewer raised concerns about the isolation of R-type current components. His criticism hits an important point: R-type current is defined as current remaining after pharmacological block of all other Cavs. However, several studies found that R-type current components are still present in some cells even after complete knockout of Cav2.3 α1-subunits (e.g. 5, 6) indicating the contribution of other Cavs to Rtype current. In contrast, SNX-482 at 100 nM concentrations is considered a selective inhibitor of Cav2.3 and therefore isolates only Cav2.3-mediated currents, which we are particularly interested in based on their potential pathophysiological role (1) and for which we provide detailed data for β2-splice variant modulation.</p><p>Therefore, we not only studied steady-state activation and inactivation of SNX-482-sensitive currents in cultured neurons (as suggested by the reviewer) but also performed such experiments in SN DA neurons in vital brain slices. These findings now reveal:</p><p>i. SNX-482-sensitive currents in SN DA neurons inactivate at positive potentials (<italic>Figure 6, Table 3</italic>) very similar to the R-type currents reported in our original manuscript. These data are in agreement with a substantial fraction Cav2.3 channels being stabilized by β2a and/or β2e subunits and therefore resistant to inactivation during pacemaking. ii. The inactivation voltage-range in cultured DA neurons is more negative than in SN DA neurons (but more positive than expected for β3-association) suggesting that inactivation is indeed fine-tuned in neurons along a range of inactivation voltages. For better comparison, data from cultured DA neurons (<italic>Figure 7</italic>) are now presented together with those of SN DA neurons from brain slices (<italic>Figure 6</italic>) at the end of the result section.</p><disp-quote content-type="editor-comment"><p>Reviewer #2 (Recommendations for the authors):</p><p>Additional comments and suggestions are:</p><p>1) The two paragraphs starting on page 7, lines 165-189 should be moved under the header starting on the current page 7, line 191, as it introduces that section.</p></disp-quote><p>In the restructured manuscript, information of the first of these paragraphs is now included in the introduction. The second paragraph is now moved to the beginning of the result section to define our experimental approach. We believe that restructuring the manuscript in this way now makes it much easier to follow.</p><disp-quote content-type="editor-comment"><p>2) Order of figures and supplemental figures could be improved to follow a revised narrative and clarity. Note that Supp Figure 1 is referenced in the paper after citing Supp Figure 2 and 3.</p></disp-quote><p>Suppl. Figure 1 ( = <italic>Figure 1—figure supplement 1</italic>) is now referenced first. The order of figures in the revised manuscript was changed based on additional data previous <italic>Figure 1</italic> is now presented as <italic>Figure 7</italic> together with parts moved into new <italic>Figure 7—figure supplement 1</italic>.</p><disp-quote content-type="editor-comment"><p>3) Figure 1: In Figure 1A, it is unclear that the expanded action potentials are representative of the area highlighted. Please revised. The action potential traces in Figure 1C do not seem to be a good representation of the maximum time-derivative of voltage. Please revise.</p></disp-quote><p>These data have been changed as requested (see revised <italic>Figure 7—figure supplement 1</italic>). In the original version the expanded action potentials were inserted twice, which we believe is redundant. We therefore selected two action potentials from the upper trace <italic>Figure 7—figure supplement 1</italic> (indicated by the asterisks) and show the corresponding expanded trace and phase-plane plots in panel C.</p><disp-quote content-type="editor-comment"><p>4) Figure 2: To appreciate the results better, it will help to include control (no drugs) traces and their comparison with the different components.</p></disp-quote><p>We thank the reviewer for this comment. We did not include such a trace because recordings over this time period were stable and run-down in the absence of drugs was less than 1% under these experimental conditions. This is now mentioned in the figure legend (now <italic>Figure 7</italic>) as follows: &quot;Current rundown in the absence of drugs during 150 s was less than 1% (0.48±0.18%; n=4 cells).&quot;</p><disp-quote content-type="editor-comment"><p>5) Consider rearranging the order of Figures 3, 4, 5 and 6. The reviewer's suggestion is to make current Figure 5 the new Figure 3. Figure 4 should remain as such. Current Figure 3 and Figure 6 should be merged into new Figure 5. Alternative, current Figure 3 should become a supplemental figure of new Figure 5 (current Figure 6).</p></disp-quote><p>We merged old Figures 3 and 6 as suggested into new <italic>Figure 3</italic>. We now start with discussing the biophysical properties of co-expressing different β-subunits (old Figure 4 is now <italic>Figure 1</italic>).</p><disp-quote content-type="editor-comment"><p>6) Current Supp Figure 3 should be included as part of the main figures, specifically as new panel D in current Figure 4.</p></disp-quote><p>These data were moved as suggested (now in <italic>Figure 1</italic> as panel D).</p><disp-quote content-type="editor-comment"><p>7) Current Figure 5: Please replace bar plots with scatter plots to visualize the spread of the data. Panel C of this figure is not mentioned in the main text. Please correct. In fact, this panel could go into a supplemental figure.</p></disp-quote><p>We changed to scatter plot as suggested. Panel C was actually mentioned in the text (4<sup>th</sup> line below the heading “β-subunit transcripts in mouse SN and VTA&quot; in the old manuscript). It is also mentioned in the text of the revised version.</p><disp-quote content-type="editor-comment"><p>8) Figure 7: Labels are very small and difficult to read. Please correct.</p></disp-quote><p>We increased the labels and, based on this valuable feedback, also increased small labels in Figure 8 (now <italic>Figure 5</italic>).</p><disp-quote content-type="editor-comment"><p>9) The Supplemental Methods section should be merged with the regular methods section for a comprehensive overview of the methods in a single section.</p></disp-quote><p>The sections have been merged as suggested.</p><disp-quote content-type="editor-comment"><p>10) Data in current Supp Figure 1B do not seem to have sufficient statistical power to support conclusions. Please verify.</p></disp-quote><p>These are qualitative control experiments (now shown as <italic>Figure 2—figure supplement 1</italic>) that could have been omitted. Yet, we felt to include them in the manuscript. We now mention (and show in Supplementary file 2) that the number of experiments was actually higher because we additionally performed experiments with a mixture of the specific with mismatching β-subunit DNA at ratios of 1:1, 1:2, and 1:5, and only the 1:10 mix is shown (similar CT values for all combinations).</p><disp-quote content-type="editor-comment"><p>Reviewer #3 (Recommendations for the authors):</p><p>#1 Since the crux of this manuscript is the effect of β subunit variants on contribution of CaV2.3 channel in Parkinson's disease, references about the relative expression of β subunit variants in human brain would be extremely relevant and valuable in putting this paper into the context of human disease.</p></disp-quote><p>To address this important point, we now include a reference for a recent transcriptomic analysis of laser-captured SN DA neurons form 18 human post mortem brains (Aguila et al.; 13) in the Discussion (page 13, bottom/page 14, top paragraph). The results obtained in this study (45% β4, 30% β2, 15% β3, 8% β1) compare nicely with the data obtained by our RT-qPCR assay in mouse substantia nigra: β4 (~65%) and β2 (~27%) represented the most abundant β-subunit transcripts, followed by β1 and β3 (~5 – 7%).</p><disp-quote content-type="editor-comment"><p>#2 The author's reference to past exploration of the role of β subunits on CaV2.3 should be further expanded. In particular, the assertion that β2a and β2e subunits likely exhibit incomplete inactivation at voltages positive to threshold is not entirely novel and the authors' description (lines 165-179) is slightly misleading. While the authors appropriately cite Jones et al., and Yasuda et al., as having described β subunit effects on the channels, they seem to imply that these papers did not uncover the incomplete inactivation described in the current manuscript. As currently written, the authors imply that these two papers validate the statement in line 173 that R-type currents fully inactivate at voltages positive to -50mV. In fact, after accounting for the different experimental solutions, both papers demonstrate that these β subunits would likely result in available channels at voltages positive to threshold. Reviewer recommends that this point be further clarified in the text.</p></disp-quote><p>We thank the reviewer for pointing out this weakness in citing the literature of our colleagues. We now have completely rewritten this paragraph not only to point out the wide range of SNX-482-sensitive Rtype currents reported in neurons but also clearly state that previous work has already shown that βsubunits tightly control V0.5,inact of Cav2.3 channels and that membrane-anchored β2 subunit splice variants β2a and β2e induce strong positive shifts of V0.5,inact of Cav2.3 channels and slow inactivation</p><p>(Introduction: page 4, bottom paragraph; page 5, top paragraph; Results: page 6, bottom paragraph).</p><disp-quote content-type="editor-comment"><p>#3 Currently, the authors make no distinction between the two forms of inactivation in CaV2.3 channels. The experiments are performed in ca<sup>2+</sup>, such that both voltage- and ca<sup>2+</sup>- dependent inactivation will be present. However, past literature indicates that the β subunit effect is primarily on the voltage inactivation of the channel. This should be clearly described.</p></disp-quote><p>We believe that this is a more mechanistic aspect not relevant in the context of a study that tries to reproduce physiological conditions in which both inactivation processes must happen together. However, we now also include this information as follows (page 5, top paragraph): ….the membrane anchored β2 subunit splice variants β2a and β2e induce strong positive shifts of V0.5,inact of Cav2.3 channels and slow the time course of voltage-dependent inactivation (Jones et al., 1998; Pereverzev et al., 2002; Soong et al., 1993; Williams et al., 1994; Yasuda et al., 2004).</p><disp-quote content-type="editor-comment"><p>#4 In Figure 7, the authors have shown the effect of the β2a subunit on the run-down of CaV2.3 channel. How about the β2e subunit? Does it demonstrate similar properties?</p></disp-quote><p>We did not measure run-down of Cav2.3 currents in association with β2e and can therefore not state if the effect would be the same. However, based on the current modulation by both “slow” β-subunits, we would assume a similar effect.</p><p>References:</p><list list-type="order"><list-item><p>Benkert, J., et al., Cav2.3 channels contribute to dopaminergic neuron loss in a model of Parkinson's disease. Nat Commun, 2019. 10(1): p. 5094.</p></list-item><list-item><p>Schiemann, J., et al., K-ATP channels in dopamine substantia nigra neurons control bursting and novelty-induced exploration. Nat Neurosci, 2012. 15(9): p. 1272–80.</p></list-item><list-item><p>Hunker, A.C., et al., Conditional Single Vector CRISPR/SaCas9 Viruses for Efficient Mutagenesis in the Adult Mouse Nervous System. Cell Rep, 2020. 30(12): p. 4303–4316.e6.</p></list-item><list-item><p>Lammel, S., et al., Unique properties of mesoprefrontal neurons within a dual mesocorticolimbic dopamine system. Neuron, 2008. 57(5): p. 760–73.</p></list-item><list-item><p>Sochivko, D., et al., The Ca(V)2.3 Ca(2+) channel subunit contributes to R-type Ca(2+) currents in murine hippocampal and neocortical neurones. J Physiol, 2002. 542(Pt 3): p. 699–710.</p></list-item><list-item><p>Wilson, S.M., et al., The status of voltage-dependent calcium channels in α 1E knock-out mice. J Neurosci, 2000. 20(23): p. 8566–71.</p></list-item><list-item><p>Chan, C.S., et al., 'Rejuvenation' protects neurons in mouse models of Parkinson's disease. Nature, 2007. 447(7148): p. 1081–6.</p></list-item><list-item><p>Dragicevic, E., J. Schiemann, and B. Liss, Dopamine midbrain neurons in health and Parkinson’s disease: Emerging roles of voltage-gated calcium channels and ATP-sensitive potassium channels. Neuroscience, 2015. 284: p. 798–814.</p></list-item><list-item><p>Ortner, N.J., et al., Lower Affinity of Isradipine for L-Type ca<sup>2+</sup> Channels during Substantia Nigra Dopamine Neuron-Like Activity: Implications for Neuroprotection in Parkinson's Disease. J Neurosci, 2017. 37(28): p. 6761–6777.</p></list-item><list-item><p>Puopolo, M., E. Raviola, and B.P. Bean, Roles of subthreshold calcium current and sodium current in spontaneous firing of mouse midbrain dopamine neurons. J Neurosci, 2007. 27(3): p. 645–56.</p></list-item><list-item><p>Mercuri, N.B., et al., Effects of dihydropyridine calcium antagonists on rat midbrain dopaminergic neurones. Br J Pharmacol, 1994. 113(3): p. 831–8.</p></list-item><list-item><p>Guzman, J.N., et al., Robust pacemaking in substantia nigra dopaminergic neurons. J Neurosci, 2009. 29(35): p. 11011–9.</p></list-item><list-item><p>Aguila, J., et al., Spatial RNA Sequencing Identifies Robust Markers of Vulnerable and Resistant Human Midbrain Dopamine Neurons and Their Expression in Parkinson’s Disease. Frontiers in Molecular Neuroscience, 2021. 14.</p></list-item><list-item><p>Scharinger, A., et al., Cell-type-specific tuning of Cav1.3 Ca(2+)-channels by a C-terminal automodulatory domain. Frontiers in Cellular Neuroscience, 2015. 9: p. 309.</p></list-item><list-item><p>Pinggera, A., et al., CACNA1D de novo mutations in autism spectrum disorders activate Cav1.3 Ltype calcium channels. Biol Psychiatry, 2015. 77(9): p. 816–22.</p></list-item></list></body></sub-article></article>